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ABSTRACT 
RATIONAL DESIGN AND SYNTHESIS OF BODIPY DYES FOR 
MOLECULAR SENSING, LIGHT 
HARVESTING AND PHOTODYNAMIC APPLICATIONS 
Tuğba Özdemir Kütük 
PhD in Materials Science and Nanotechnology 
Supervisor: Prof. Dr. Engin Umut Akkaya 
September, 2014 
BODIPY dyes have been addressed in many applications due to highly important 
features. These unique properties can be summarized as high photostability, high 
extinction coefficient, easy functionality, etc. Thus, tremendous studies have been 
published and, ion sensing, photodynamic therapy, dye-sensitized solar cells and 
light harvesting are some of the areas that BODIPY dyes have been utilized. In this 
thesis, BODIPY dyes were functionalized to be used for different concepts. In the 
first study, the main purpose was to seek for ion signaling differences of two 
isomeric tetra-styryl BODIPY dyes  with charge donor ligand located at 1,7 versus 
3,5 positions.  Second work focuses on the light harvesting concept with the use of 
tetra-styryl BODIPY derivatives. Third study describes the coupling of energy 
transfer with internal charge transfer to monitor the alterations in intensity ratios, so, 
dynamic range of the fluorescent probe is improved. Design and synthesis of 
BODIPY dyes for detection of biological thiols in aqueous solution both 
chromogenically and fluorogenically was given in fourth study. Another biologically 
important molecule, hydrogen sulfide is selectively detected via BODIPY-based 
probe and depicted in the fifth study. In the sixth work, persistent luminescent 
nanoparticles are attached to BODIPY-based photosensitizer to activate the 
photodynamic action. 
Keywords: ion sensing, excitation energy transfer, light harvesting, biological thiols, 
hydrogen sulfide, photodynamic therapy, BODIPY. 
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ÖZET 
BODIPY BOYASININ MOLEKÜLER SENSÖRLER, IŞIK HASAT 
EDEBİLEN SİSTEMLER VE FOTODİNAMİK TERAPİ 
UYGULAMALARI İÇİN RASYONEL TASARIMI VE SENTEZİ  
Tuğba Özdemir Kütük 
Malzeme Bilimi ve Nanoteknoloji, Doktora 
Tez Yöneticisi: Prof. Dr. Engin Umut Akkaya 
Eylül, 2014 
BODIPY sahip olduğu çok önemli özelliklerinden dolayı, birçok uygulamada 
kullanılmaktadır. Bu önemli özellikler, ışık altında bozulmaması, yüksek ektinksiyon 
katsayısına sahip olması, kolaylıkla fonksiyonlandırılabilmesi olarak özetlenebilir. 
Bu sebeple, yüksek sayıda yayınlar yapılmaktadır ve iyon sensörleri, fotodinamik 
terapi, boya duyarlı güneş pilleri, ışık hasat edebilen sistemler, BODIPY boyasının 
kullanıldığı alanlardan bazılarıdır. Bu tezde, BODIPY boyası farklı konseptler için 
fonksiyonlandırılmıştır. İlk çalışmada, başlıca amaç, iki adet tetra-stiril isomerik 
BODIPY boyalarının, yük verici ligandın 1 ve 7 veya 3 ve 5 pozisyonlarına 
bağlanmasına göre vereceği sinyalin farklılığının incelenmesidir. İkinci çalışma tetra-
stiril BODIPY türevleri kullanılarak, ışık hasat edebilen sistemler konseptini 
içermektedir. Üçüncü çalışma, enerji transferi konsepti ile molekül içi yük transferi 
konsepti, sinyal şiddeti oranlarındaki farklılıkları gözlemlemek üzere birleştirilmiştir 
ve böylece fluoresans probun dinamik aralığı geliştirilmiştir. BODIPY boyalarının 
biyolojik tiyollerin suda kromojenik ve florojenik algılanmasının tasarımı ve sentezi 
dördüncü çalışmada verilmiştir. Biyolojik açıdan büyük öneme sahip olan hidrojen 
sülfür molekülünün, BODIPY-tabanlı boya kullanılarak seçici olarak algılanması 
beşinci çalışmanın konusunu oluşturmaktadır. Altıncı çalışmada, kalıcı lüminesans 
özelliği gösteren nanopartiküllerin, BODIPY tabanlı fotosensitizere kovalent olarak 
bağlanması ve fotodinamik terapinin aktifleşmesi hedeflenmektedir. 
Anahtar kelimeler: iyon sensörü, ekzitasyon enerji transferi, ışık hasat edebilen 
sistemler, biyolojik tiyoller, hidrojen sülfür, fotodinamik terapi, BODIPY. 
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CHAPTER 1 
INTRODUCTION 
During the last three decades, BODIPY has been used widely as a fluorescent probe 
and it still maintains its popularity. This popularity arises due the superior 
characteristics of BODIPY.  To begin with, its derivatives can have strong absorption 
and/or fluorescence in the visible and near-IR region. Derivatization on the BODIPY 
core, which has seven positions suitable for functionalization, provides versatile 
characteristics. In addition, BODIPY dyes can be functionalized to be soluble in both 
organic and water.  Moreover, they have high quantum yields and large extinction 
coefficients and they are stable under continuous illumination. Besides, they are 
almost insensitive to solvent polarity and pH of the medium and have narrow 
absorption and emission bandwidths, and so they give sharp peaks on emission 
spectra compared to other fluorophores such as fluorescein. In all chapters, BODIPY 
dyes were utilized for different applications. 
In Chapter 3, the design and syntheses of two isomeric tetra-styryl BODIPY dyes 
and investigation of the signaling differences in terms of Hg (II) binding were 
described. The fluorescent detection and biological imaging of the specific molecules 
which are crucial in living systems have aroused attention due to its highly sensitive 
nature, cheapness and ease of processability compared to handling radioactive tracers 
for most biochemical measurements. Therefore, fluorescent chemosensors have a 
significant value for their simplicity and high sensitivity. According to the presence 
(or concentration) of the analyte which binds to the sensor, there can be changes in 
the fluorescence intensity, lifetime or a shift in fluorescence wavelength can occur.  
Nowadays, in the design of the chemosensors, near-IR dyes are widely used. Near- 
IR dyes having the spectral range between 650-900 nm are very advantageous. 
Firstly, background signal is reduced and light scattering turns out to be low. 
Therefore, deep penetration becomes feasible and it allows fluorescence imaging in 
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vivo and open the way for applications in photodynamic therapy. In this project, our 
aim was to investigate that according to attached positions, photophysical response 
of the BODIPY dyes upon ion binding are different. To explore this idea, we 
synthesized two isomeric tetrastryrl BODIPY dyes with Hg (II) responsive crown 
moiety. In the first design, crown moieties are placed on 1 and 7 positions of 
BODIPY core by Knoevenagel condensation. In the second one, these crown 
moieties are attached to 3 and 5 positions. When we performed the spectral 
measurements, we investigated some differences in terms of ion responses. Since the 
improvements in water soluble fluorescent probes are highly demanding for 
biological applications, to make these dyes biologically applicable, we synthesized 
the water soluble versions of the BODIPY dyes. Introduction of polyethylene glycol 
methyl ether and triethylene glycol groups enhances the water solubility; this is why 
we incorporated the PEG2000 and TEG groups to BODIPY unit. Theoretical 
calculations were conducted and principles underlying different spectroscopic 
properties and fluorescence turn on responses were explained via orbital analysis.   
Chapter 4 describes the use of tetra-styryl BODIPY derivatives as light harvesters 
and the determination of energy transfer efficiency is discussed. The crucial role of 
excitation energy transfer arises as a result of involving in the biological processes 
such as photosynthesis which is a light harvesting system. In photosynthesis, the sun 
light is collected and the energy transferred to the reaction center to induce the 
initiation of reaction in chlorophyll. Excitation energy involves donor and acceptor 
parts and these parts are not conjugated, so this energy transfer is named as “through 
space” energy transfer. Since there is no conjugation between the units, the spectral 
overlap, the distance between them and relative orientation of the transition dipoles 
are required to be optimal in order to achieve efficient “through space” energy 
transfer. Efficacious harvesting of solar radiation needs careful design of 
chromophores. Multichromophoric systems which involve more than one donor 
chromophore to get absorbance in entire visible spectrum and near-IR is needed. The 
efficiency of energy transfer can be determined by using quantum yields or lifetime. 
However, it is estimated that the efficiency of multichromophoric assembles 
involving flexible linkers are originally bimolecular model showing upper limit for 
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calculated energy transfer. With this study, we tried to clarify the calculation of 
energy transfer efficiency which holds some permanent mistakes. Thus, in our 
design, we synthesized two tetra-styryl BODIPY harvesters and investigate the 
energy transfer efficiencies. 
In Chapter 5, we coupled excitation energy transfer with internal charge transfer 
which is a standard signal transduction process. The importance of energy transfer 
and Hg (II) sensing is discussed above. In this design, since the energy transfer is 
efficient, an important amount of pseudo-Stokes shifts are obtained successfully.  
Another important achievement is that modulation of the excitation energy transfer 
via ion binding allows monitoring the changes in intensity ratios at a wider range, 
consequently, increasing the dynamic range of the molecular sensor. With this sense, 
we attached donor and acceptor BODIPY moieties with Click chemistry. Binding of 
Hg (II) to crown part causes a blue shift in emission, which correspondingly 
increases the spectral overlap between the donor and the acceptor. Additionally, 
ratiometric response is a bonus that is achieved with this design. 
In Chapter 6, BODIPY was designed to give response for biological thiols both 
chromogenically and fluorogenically in aqueous solution. Both extracellular and 
intracellular concentrations of cysteine, homocysteine and glutathione are important 
biological parameters. Cysteine (Cys) deficiency may lead to childhood 
developmental problems, hair depigmentation, edema, lethargy, liver damage, and 
skin lesions.  Homocysteine (Hcy) is a risk factor for Alzheimer’s disease and may 
also indicate deficiencies in folate and cobalamine (Vit. B12).  In addition, Hcy 
deficiency has been linked to cardiovascular disease as well. Glutathione (GSH) is a 
primary defense agent against oxidative damage with its high concentration that can 
go up to 5 mM inside the cells.  In healthy cells and tissues, 90 % of it is present in 
the reduced GSH form, whereas 10 % is found in the oxidized disulfide form 
(GSSG). Due to above reasons, imaging of biological thiols with fluorescent probes 
that respond to these thiols by color change, emission wavelength change, or both is 
of prime importance. In our study, we designed two BODIPY dyes carrying 
nitroethenyl substituents in conjugation with the BODIPY core which yields probes 
that responds to biological thiols upon change in both absorbance and emission 
4	  
	  
wavelength. Both probes showed very fast and sensitive responses with color 
changes and “turn-on” fluorescence. As expected, this fluorescence enhancement is 
because of the reduction in the efficiency of the PeT process upon the reaction 
between Cys and nitroethenyl substituent on the probe yielding an increment in the 
energy level of the BODIPY centered LUMO. Under identical conditions, other 
biological thiols, such as homocysteine (Hcy) and glutathione (GSH), are resulted 
similar turn on fluorescence responses. Yet, controlling reaction time leads to faster 
response of Cys than that to Hcy and GSH.  
Chapter 7 describes the design and synthesis of a BODIPY based, highly selective 
probe for hydrogen sulfide. This probe is then studied in living cells. Hydrogen 
sulfide (H2S) is known as characteristic repulsive odor of rotten eggs, and attracts 
attention due to the roles on biological processes. As in the case of the other two 
gaseous signaling molecules, carbon monoxide (CO) and nitric oxide (NO), 
hydrogen sulfide is a biosynthetic gasotransmitter. Their production and function of 
these small gaseous molecules are different from the other messenger molecules.  
Also, having small size and charge neutrality, they can easily pass through the 
cellular membranes without affecting any cell signaling response. H2S plays 
important role on many metabolic processes, such as cardiovascular protection, 
neuroprotective effect, arrangement of cell growth, calcium homeostasis and 
regulation of neurotransmission. Thus, the detection and real-time monitoring of H2S 
is very crucial. In our design, two arylazido groups were used because H2S is able to 
reduce this group. The reduction causes change in the charge transfer characteristics 
of the 3,5-distyryl substituents on the BODIPY core, producing a 20 nm 
bathochromic spectral shift in the absorption band, and quenching of the emission by 
85% compared to the original intensity, through photoinduced electron transfer. The 
selectivity and fast responding properties offer the potential utility of the probe. In 
addition, hydrophilic moieties in its structure make the probe water soluble and thus 
appropriate for biological applications. Furthermore, added H2S was successfully 
imaged inside the cells, suggesting that imaging of endogenously produced H2S in 
real-time and in the near IR region of the spectrum can be realized.	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Chapter 8 is related to the activation of photodynamic action with use of persistent 
luminescent nanoparticles. Photodynamic therapy has been considered to be a 
promising alternative to traditional cancer therapy methodologies such as surgery, 
chemotherapy and radiation therapy. However, its broader acceptance by the medical 
community is hampered since an external light energy is required to active the 
therapy. Light, even at the most tissue penetrating wavelengths (red to near IR) can 
go through mammalian tissues only a few millimeters. This limits the application of 
PDT to surface tumors, or those to which light can be delivered by fiber-optics. In 
our research group, we are trying to offer alternative methodologies to sensitize the 
dye (photosensitizers) component, so that external photonic excitation would not be 
needed. Once the photosensitizer is excited (by any means) it is expected to transfer 
its excitation energy to the dissolved oxygen in tumor tissues and thus generate 
singlet oxygen, which is the primary cytotoxic agent in photodynamic therapy. In 
this project, we are planning to use persistent luminescent nanoparticles (PLNP), 
which once excited, keep on emitting light for 24-48 hours. The photosensitizers that 
we synthesized were attached to the PLNP covalently. However, continuous 
excitation is not desired, as that would be harmful to the tissues starting from the 
injection site. To control the activity, we will incorporate a quencher unit, which will 
stop singlet oxygen generation unless it is cleaved from the PLNP by high 
glutathione concentrations found in cancer cells. So, the nanoconstruct, will not 
generate singlet oxygen in most tissues, but it will be activated in cancer cells, 
resulting in a selective agent which will destroy tumors the way PDT does, but 
without any need for external excitation. We studied the activity of our system by 
following singlet oxygen generation using chemical traps. The project is likely to 
offer a solution to remove one of the bottlenecks for the widespread application of 
photodynamic therapy. 
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CHAPTER 2 
BACKGROUND 
 Photophysical Processes in Fluorescent Probes 2.1.
Fluorescence sensing and imaging are highly demanding and strong techniques for 
detection of different chemical and biological analytes. After the report of Roger Y. 
Tsien’s fluorescent probe for Ca
2+ 
in 1980,1 this technique drew remarkable attention 
in the past two decades. Important requirements must be satisfied for the sensor to be 
applicable in biological applications and these requirements can vary according to 
application. Selectivity for a specific analyte in presence of other analytes is one of 
the most important parameter.2 Also, water-solubility is another key parameter for 
biological applications.  For certain probes, cell-permeability, excitation at near-IR 
wavelength to reduce background fluorescence and low-toxicity can become the 
major considerations. Beside, ratiometric analysis allows more reliable quantitative 
analysis by minimizing extraneous factors such as photobleaching.3 Although there 
are several parameters to consider, in general, fluorescent probes are superior 
compared to other techniques in terms of higher selectivity, sensitivity, fast response 
and higher resolution. Fluorescent sensors are mainly composed of two main 
moieties: receptor (recognition part) and fluorophore (reporter). The receptor part 
should have specific affinity towards the analyte and so it should not be affected by 
the light, pH, temperature, etc. The fluorophore part reports differences in signal 
when receptor binds to analyte. These differences can be in fluorescence intensity, 
shift in fluorescence wavelength or lifetime.4  
In the design of the fluorescent probes, non-covalent interactions (hydrogen bonding, 
electrostatic, hydrophobic, hydrophilic, π-π, anion-π and coordination-based 
interactions) as well as many different types of reactions can be utilized.5  
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 Photoinduced Electron Transfer (PeT) 2.1.1.
In PeT process, there are three units: fluorophore (signaling unit), receptor for 
recognition of analyte and spacer between these two parts.  
 
 
Figure 1. Molecular orbital diagrams for reductive PeT. 
In the design of the PeT based probes, fluorophore is attached to high energy non-
bonding electron pair containing (like nitrogen atom) receptor part via spacer unit. In 
the “off” state, the electron transfer from unbound receptor part to excited 
fluorophore causes fluorescence quenching. Yet, “on” state occurs when the receptor 
binds to analyte and so electron transfer is blocked and fluorescence intensity 
increases. With the irradiation of fluorophore, an electron in the highest occupied 
molecular orbital (HOMO) is raised to the lowest unoccupied molecular orbital 
(LUMO). If the non-bonding electron pair in the HOMO of the receptor has more 
energy than HOMO of the fluorophore, intramolecular PeT process becomes active 
and so fluorescence quenching occurs. With the binding of receptor to analyte, 
energy of the HOMO of the bound receptor decreases since oxidation potential of the 
donor increases. As a result, fluorescence enhancement takes place. (Figure 1) The 
principle of PeT process is the comPeTition between electron transfer and 
fluorescence.6  
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PeT based mechanism of sensing has been widely utilized in literature. For example, 
as shown in Figure 2, ZnAB was designed to detect Zn (II) cation by 
functionalization of BODIPY core at meso position with N,N-Bis (2-pyridyl-
methyl)ethylenediamine.7 N,N-Bis(2-pyridyl-methyl)ethylenediamine was used for 
acceptor moiety for Zn (II) and attached to BODIPY part via benzene ring. PeT 
 
Figure 2. PeT-based probe for Zn (II). 
mechanism is controlled by benzene ring at meso position because the dihedral angle 
between the benzene ring and BODIPY core is almost 90o. Before addition of Zn 
(II), PeT process quenches the fluorescence so the emission intensity is low. On the 
other hand, with coordination of Zn (II), the reduction potential of the meso-
substituent will be more negative and PeT process is blocked so fluorescence 
intensity increases. 
 
Figure 3. Some examples of fluorescent PET sensors for biomacromolecules. 
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 PeT process is one of the most widely used sensing mechanisms in design of the 
small molecule fluorescent probes for bioimaging. Tremendous amount of examples 
are available in the literature and some of them are given in Figure 3. In the first 
example, “off-on” fluorescent probe for GST (Glutathione S-transferase, important for 
biological processes such as drug metabolism, protecting our body against endogenous 
reactive oxygen species (ROS)) is designed on the basis of PeT mechanism.8 Second 
example decribes the PeT-based NAT (Arylamine N-acetyltransferases, having role on 
various significant pharmacological and toxicological reactions such as bioactivation 
reactions of arylamine carcinogens) fluorescent probe.9 Fluorescent probe for COX-2 
(Cyclooxygenase-2, biomarker for almost all cancer cell lines and used to differentiate 
cancer cells from normal ones) is well established based on PeT pathway as described in 
the third example.10 
 Internal Charge Transfer (ICT) 2.1.2.
In the ICT type probes, receptor is directly attached to the fluorophore without spacer 
between the fluorophore and receptor parts, in other words, there is a conjugation 
between receptor and the π-electron system fluorophore moiety.  In this design, 
fluorophore must include an electron-donating group such as –NH2 and an electron-
pulling group. With the excitation, ICT occurs from donor to acceptor.11  Upon 
interaction of a receptor (electron- pushing moiety) with a cation, electron- pushing 
character of receptor decreases. Therefore, the conjugation is affected and blue shift 
is observed in the absorption spectrum.  Charge-dipole interactions can be used to 
clarify this mechanism. With excitation, amino group will be positively charged and 
due to the interaction between this positively charged amino group and the cation, 
the excited state will be destabilized.  Energy gap between S0 and S1 will increase 
and as a consequence of this process, blue shift is observed.  Moreover, if the 
acceptor group like carbonyl group interacts with the cation, electron-pulling 
character of the receptor increases.  According to charge-dipole interactions, the 
acceptor group is affected by the electron receptor and so the excited state is 
stabilized. Finally, red shift occurs upon decrease in energy gap between S0 and S1.12 
(Figure 4) 
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Figure 4. Band gap changes on interactions with cations of ICT type sensors. 
 
 
Figure 5. Example for ICT type sensor for Hg (II). 
Figure 5 shows an example of ICT-based probe for Hg (II) ions.13 Two chelating 
moieties were attached to BODIPY core via Knoevenagel condensation. In this 
design, dithia-dioxa-aza macrocycle is used as receptor part and known as Hg (II) 
selective ligand. In the absorbance spectrum, blue shift is observed due to the 
blocking of ICT process upon coordination of Hg (II) ions to the nitrogen donor 
atoms. Moreover, in absence of Hg (II), fluorescence is highly quenched due to the 
ICT process from crown moiety to BODIPY core. However, in presence of Hg (II), 
decrease in electron donation ability of two amino groups leads to strong 
fluorescence intensity with a large blue shift.   
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 Energy Transfer Mechanism 2.1.3.
In nature, photosynthesis involves light harvesting antenna system and light 
harvesting chromophores can seize photons from sunlight and channels its energy to 
the single reaction center. In this process, charge-separated states result in 
transformation of solar energy to chemical potential energy.14   With this manner, 
design and synthesis of supramolecular systems that serve as artificial light 
harvesting systems have aroused great deal of interest in the past decade.15 In energy 
transfer process, there are two main parts: donor (D) and acceptor (A). Energy is 
transferred from a chromophore in excited state (D) to the other chromophore in 
ground state (A).16 Energy transfer can be observed via comparison of lifetimes, 
quantum yields, quenching of the donor emission or increase in acceptor emission.  
 
 
Figure 6. Schematic illustration of Förster and Dexter types of energy transfer. 
 
Various deactivation pathways of the excited system can affect the energy transfer so 
appropriate chromophores should be used to overcome such distractions.17  
There are two different types energy transfer mechanism which are Förster and 
Dexter mechanisms. (Figure 6) 
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2.1.3.1. Dexter Type Energy Transfer 
Dexter type energy transfer is also known as electron transfer by “electron 
exchange”. In this type, orbital overlap is required to enable the exchange of 
electrons from the highest occupied level of the donor to the lowest unoccupied level 
of the acceptor.18 (Figure 7)  
	  
Figure 7. Schematic representation of Dexter electron exchange mechanism. 
 
Rate constant equation for this type of energy transfer is given below. 
                       
Kdexter = K J exp(-2RDA / L) 
 
where K is orbital interaction, J is the normalized spectral overlap integral, RDA is the 
distance between donor and acceptor and finally L is the sum of van der Waals 
radii.17  
Since orbital interaction decreases exponentially with distance from nuclei, the 
transfer probability changes almost exponentially with the donor-acceptor distance. 
Therefore, to get efficient Dexter type of energy transfer, very short distances 
between D-A is required so that overlap of electronic orbitals is fulfilled.19 Dexter 
type of energy transfer is also called as short range energy transfer. 
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Figure 8. Literature example for through bond energy transfer. 
In the example shown in Figure 8, two BODIPY units have been linked to a terminal 
acceptor BODIPY unit via aromatic linkers having various lengths.20	    Because of 
polyaromatic spacer units, absorption of these compounds shifts to the longer 
wavelengths with the increasing length of the spacer units. The absorbed energy was 
transferred quantitatively to the terminal BODIPY. The distance between the 
acceptor and donor units are 18, 24, 31, and 38 Å for n = 0, 1, 2 and 3, respectively. 
It is shown that as the distance between acceptor and donor substituents increases, 
energy transfer rate decreases. 
2.1.3.2. Förster Type Energy Transfer 
Fluorescence (Förster) Resonance Energy Transfer (FRET) refers to the energy 
transfer from excited donor chromophore to the acceptor chromophore through a 
non-radiative pathway. Theory of electronic excitation transfer was given first by 
Förster in 1948 and this phenomenon was used by several biologists to investigate 
certain distances in proteins.14 The energy transfer efficiency is dependent on several 
parameters. One of them is that the donor chromophore must be fluorescent and 
since efficiency of this process is highly dependent on the distance between donor-
acceptor pair, the distance between donor and acceptor is highly important. The 
efficiency is inversely proportional with the sixth power of the radius, where radius 
is the distance between the centers of the donor and acceptor dipoles. Another 
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important requirement is the spectral overlap between emission of the donor 
molecule and absorption of the acceptor chromophore. FRET is a valuable technique 
to investigate protein-protein interactions, protein -DNA interactions, protein -
membrane interactions and the three dimensional structure of molecules in living 
cells,14  in molecular imaging,21 biosensors,22 DNA mechanical movements.23   
 
 
 
Figure 9.	  Schematic representation of FRET. 
 
As depicted in Figure 9, the donor chromophore is excited to the lowest excited 
singlet state, S1. If the acceptor is close enough, the energy released while electron 
goes back to the ground state (S0) can excite the donor chromophore at the same 
time. This radiationless pathway is called as “resonance”. Upon excitation, a photon 
is emitted by the acceptor moiety and returns to the ground state, when other 
deactivation processes does not occur. 
 
Figure 10. Schematic representation of Förster energy transfer mechanism. 
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Förster mechanism involves a dipole-dipole interaction between the electronic states 
of the donor and the acceptor. Long range Coulombic forces are responsible for 
through space interaction and the interaction between dipole of excited donor 
(excited electron in LUMO) and dipole of ground state acceptor (electron in the 
HOMO) is the basis of the mechanism. (Figure 10) The rate of Förster energy 
transfer is calculated as shown below: 
 
where τD is the excited state lifetime of donor in the absence acceptor, and d is the 
distance of donor–acceptor pair. Rc is critical radius (the distance at which the 
energy transfer rate kET is equal to the intrinsic decay rate of the donor) and equation 
of Rc is given below: 
 
where K2 is the orientation factor (related to the relative orientation of the donor and 
acceptor dipoles), ΦD is the emission quantum yield of donor in the absence of 
acceptor, n is the refractive index of the solvent, N is the Avogadro’s number and J is 
the spectral overlap integral.24  
	  
Figure 11. Literature example of Förster mechanism. 
To attach three different emitting BODIPY units to get through space energy transfer 
array, click chemistry has been utilized (Figure 11).25	   The styryl groups were 
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attached to BODIPY core to acquire absorption and emission at longer wavelength. 
When the excitation was performed at 501 nm (BODIPY core) and 572 nm (mono-
styryl part), emission intensity was seen at 662 nm (di-styryl part). It was stated that 
the energy transfer efficiency was 99% in both situation. 
2.1.3.3. FRET-based Fluorescent Probes 
The FRET operation is often employed for the design of the fluorescent probes since 
large pseudo Stokes shifts and ratiometric probes can be obtained. There are three 
types of FRET-based metal ion probes as shown in Figure 12.  
	  
Figure 12.  Design principles of FRET-based fluorescent probes (Copyright © 2013, 
American Chemical Society, Reprinted with permission from ref (26)).26  
In the first type, ionophore (receptor part) is attached to the non-emissive acceptor 
fluorophore and upon binding of metal ion, non-emissive acceptor fluorophore 
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turns into highly emissive fluorophore. For example, probe 9 in Figure 13 is a 
FRET-based Cu (II) probe consisting of coumarin and rhodamine as the donor –
fluorophore (D-F) and acceptor- fluorophore (A-F), respectively. Before addition 
of Cu (II), since the rhodamine is in the ring-closed form, coumarin does not 
transfer its energy to the rhodamine unit. Therefore, FRET is not active in this 
case. However, in presence of Cu (II), ring-closed form of rhodamine is converted 
to the ring-opened form due to the hydrolysis of rhodamine-B hydrazide to 
rhodamine-B. In this form, FRET turns on and emission of rhodamine part is 
observed upon excitation of coumarin unit.27  
	 
	  
Figure 13. Fluorescent probes 1–3 based on a FRET mechanism. 
	 
In the second type, the ionophore (receptor) unit is directly attached to the D-F or A-
F and upon metal addition, change in overlap between the emission spectrum of D-F 
and absorption spectrum of A-F triggers a FRET-based response. Design given in 
Figure 14 is an example for this kind. In this example, 5-(4-methoxystyryl)-50-
methyl- 2,20-bipyridine (bpy) with diamino-substituted naphthalimide (NDI) were 
chosen as D-F and A-F, respectively. In absence of Zn (II), since the overlap between 
the emission spectrum of D-F and the absorption spectrum of A-F, FRET does not 
occur. On the other hand, coordination of bpy with Zn (II) causes a bathochromic 
shift in emission spectrum of bpy-Zn (II). Thus, spectral overlap between the 
emission of the bpy/Zn2+ complex and the absorption band of NDI increases and 
FRET is on state.28 
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Figure 14. Fluorescent probes 1–3 based on a FRET mechanism. 
 The last item for FRET-based fluorescent probes can be achieved basically by 
modulation of the dipole–dipole distance between D-F and A-F upon metal 
coordination. This design requires ionophore not only as a receptor but also as a 
spacer unit. Before metal coordination, the distance between D-F and A-F is longer 
than 100 A and so as expected, FRET is not in action. Yet, metal coordination leads 
to a change in the spacer form and resulting decrease in distance between D-F and A-
F, causes FRET to become active. Protein-based probes are mostly this type. In 
Figure 15, Zn (II) binding domain was attached between a cyan fluorescent protein 
(CFP) and a yellow fluorescent protein (YFP).29 The distance and orientation of the 
fluorophores with respect to each other affects the dipole-dipole coupling, so Zn (II) 
binding causes a conformational change in the system and a change in the energy 
transfer between the two fluorophores. 
	  
Figure 15. Fluorescent probes 1–3 based on a FRET mechanism (Copyright © 2009, 
American Society for Biochemistry and Molecular Biology, Reprinted with permission from 
ref (29)).29 
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2.1.3.4. Determination of FRET Efficiency 
 
The FRET efficiency of a donor-acceptor pair can be determined mainly in two ways 
experimentally: steady state and time-resolved.4 Steady state technique depends on 
the decrease in quantum yield of donor unit. The equation is given below: 
E = 1 - ΦDA / ΦD 
 
where ΦDA and ΦD represents quantum yield of donor in the presence and absence of 
acceptor respectively. Another equation to determine energy transfer efficiency which, 
uses excitation spectra or enhancement in fluorescence emission of the acceptor, is 
below: 
 
E = AA (λD) / AD (λD) * [IAD(λAem) / IA(λAem) - 1]  
 
where AA and AD is absorbance values of acceptor and donor at the maximum 
absorbance wavelength of donor. The integrated emission area of the acceptor in the 
presence and absence of the donor at λAem is IAD and IA, respectively. 
Energy transfer efficiency determination based on steady state is more prone to 
errors because of the differences in reference and sample. Extra care should be taken 
in order to avoid inaccurate measurements while using the concentration or the 
absorbance of the sample.  
Time-resolved technique offers more reliable data because lifetime of donor is not 
dependent on the concentration. This technique requires the lifetime of donor in 
presence of acceptor and without acceptor and equation is stated below: 
E = 1 - τDA/τD 
where E is the energy transfer efficiency,  τD and τDA indicates the excited state lifetime of 
donor in the absence and presence of acceptor respectively. 
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 Excimer Formation 2.1.4.
A weak interaction between a fluorophore in the excited state and another fluorophore in 
the ground state, facilitates the formation of an excimer. These interactions can be π–π* 
stacking. There are many probes based on this approach in the literature. In these 
type of probes, two same fluorophores are linked with a spacer (ionophore). Upon 
metal coordination, these two fluorophores approach each other and this results in a 
weak interactions between them. (Figure 16) 
	  
Figure 16. Schematic representation of excimer formation (Copyright © 2013, American 
Chemical Society, Reprinted with permission from ref (26)).26 
Emission of an excimer is characteristically red-shifted and broad with respect to the 
monomer emission. Difficulty in prediction of the distance between fluorophores and 
poor water solubility limits the utilization of this kind of sensing mechanism.  
 
	  
Figure 17. Literature example of fluorescent probes functioning via excimer formation. 
A pyrene-based Hg (II) probe consisting of an azadiene group was designed by Yao 
and coworkers (Figure 17).30 Weak pyrene monomer emissions turns out to strong 
pyrene excimer emission because Hg (II) addition induces the conformational 
alteration. 
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 Near-Infrared Fluorescent Probes 2.2.
Near-IR dyes in the range of 650-900 have attracted intensive attention owing to 
their diverse applications in imaging science, biomedical materials, molecular 
biology, material science, analytical and environmental chemistry, drug discovery 
and tissue diagnostics.31 Ongoing interest arises from their unique advantages. Near-
IR dyes ensure improved sensitivity by reducing interference of absorption and 
fluorescence from biological molecules (autofluorescence) and scattering is low at 
this region. The excitation source (laser diodes) is relatively inexpensive. Another 
important feature of this region is that tissue penetration depth increases.32  For 
practical biological applications, some features should be incorporated to these dyes. 
They should be water-soluble, chemically stable, functionalizable for further 
modifications and have high quantum yield.33 Great efforts have been focused to 
minimize these problems and to improve photochemical and photophysical features. 
There are a few categories of near-IR dyes available in the literature. These can be 
classified as cyanines, rhodamine analogs, 4,4-difluoro-4-bora-3a,4a-diaza-s-
indacene (BODIPYs), squaraines, phthalocyanines, and porphyrin derivatives. The 
chemical structures of these probes are given in Figure 18. Phthalocyanine and 
squaraine dyes in biological systems are not suitable because of poor water solubility 
and formation of aggregates. Although cyanine dyes have strong absorption and 
fluorescence, their fundamentally small Stokes shift causes scattered light 
interferences.32 The main focus will be given widely used 4,4-difluoro-4-bora-3a,4a-
diaza-s-indacene (BODIPYs) because of their distinct properties. 
	  
Figure 18. Some of the common dyes used in fluorescent probes. 
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 BODIPY  2.2.1.
BODIPY is the abbreviation of 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene and was 
firstly described by Treibs and Kreuzer in 1968. BODIPY has a fully delocalized 
system since the BF2 bridge enhances the planarity of the dipyrrin, thus, facilitating 
the fluorescence. Nucleophilic and electrophilic substitutions can be performed on 
the corresponding reaction sites of the BODIPY core and ease of modification make 
the BODIPY core applicable for diverse fields.34 
	  
Figure 19. The numbering in BODIPY core. 
	 
There are numerous superior properties of BODIPY compared to other fluorophores. 
For example, BODIPY dyes have strong narrow absorption and emission in the 
visible, even in near-IR region, high molar absorption coefficients and high quantum 
yields. Moreover, they generally show thermal and photostability not only in solution 
but also in solid form. Its solubility in organic solvents is good and it is insensitive to 
pH and polarity of the medium.  
To improve water solubility, shift the absorption and emission wavelength to the 
longer wavelength, functionalize for bioconjugation, and make BODIPY application 
for various applications (photodynamic therapy, dye-sensitized solar cells, 
chemosensors, etc.), in short, to tune the photophysical properties of BODIPY core, 
synthetic modifications can be performed by using different methodologies. 
Modification on the C-8 (meso) position is carried out with acid-catalyzed 
condensation of pyrrole with suitable aryl aldehydes or acyl chlorides. With this 
functionalization, donor-acceptor moieties, water-solubilizing units and ligands can 
be incorporated to BODIPY core towards different application areas. Meanwhile, 
owing to orthogonal geometry of the meso substituent and the BODIPY fluorophore, 
the influence of electron-donating and electron-withdrawing groups on the 
photophysical properties of BODIPY dyes is not drastic. 
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To functionalize 2 and/or 6-positions of BODIPY, electrophilic substitution reactions 
are needed because these positions hold less positive charge. These electron rich 
positions allow sulfonation,35 nitration,36 halogenation,37 and formylation38 on the 
BODIPY core.  
	  
Figure 20. Available positions for electrophilic substitution on BODIPY core. 
Introduction of heavy atoms like iodine and bromine to 2 and/or 6-positions of 
BODIPY triggers the intersystem crossing, thus, fluorescence decreases. For 
photodynamic therapy application, these atoms are incorporated for generation of 
singlet oxygen. Moreover, functionalization on these positions with conjugated 
systems via palladium-mediated coupling can result in extension of π-conjugation.39 
Modifications on 1, 3, 5, 7 positions can be performed by a number of reactions and 
different properties of BODIPY dyes could be attained depending on the type of 
modification. Presence of good leaving groups at these positions lets nucleophilic 
aromatic substitutions on the electron poor BODIPY core as well as different 
palladium-catalyzed couplings such as Heck, Sonogashira, Stille and Suzuki. 
Another widely used reaction to modify 1, 3, 5, 7 positions is Knoevenagel 
condensation.40 The acidity of the 3,5-methyl groups on the BODIPY core are 
comparatively acidic to condense with aromatic aldehydes to give Knoevenagel 
reaction.41 This condensation requires basic medium and water should be removed 
from reaction mixture. To remove water from medium, Dean-Stark apparatus is 
generally used. This reaction is easy to handle and less time-consuming compared to 
other approaches. Also, wide range of electron donating and electron withdrawing 
aldehydes can be introduced to BODIPY core. The generation of styryl substituents 
with these aldehydes allows tunability of the BODIPY absorption and emission 
spectra. For example, since p-dimethylaminostyryl is used as an aldehyde, electron 
donating ability pushes BODIPY emission into near-IR region (Figure 21).42  
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Figure 21. Knoevenagel condensation of 3,5-methyl substituents with aromatic aldehydes.  
In 2009, Akkaya group reported that the methyl groups on positions 1 and 7 are as 
acidic as 3,5-methyls and tetra-styryl BODIPY dyes could be synthesized utilizing 
this acidity.43 In this work, bromine atoms and pyridine groups were introduced in 
order to increase the acidity further (Figure 22).  
 
	  
Figure 22. Structures of the tetra-styryl BODIPY derivatives. 
After this report, Ziessel and coworkers published tri and tetra substituted derivatives 
of BODIPY dyes by using different aldehydes.44  It was stated that these new dyes 
had absorption peaks near 720 nm and emission wavelengths approximately at 800 
nm (Figure 23). Both Akkaya and Ziessel’s work demonstrated that methyl groups 
located in 3,5- positions are relatively more reactive than those located in 1,7- 
positions to give Knoevenagel condensation. Meanwhile, the introduction of 
dimethylamino and phenol groups on those positions makes these dyes acid and base 
sensitive. Thus, these dyes enable the modulation of optical characteristics over a 
broad wavelength range with change in pH. 
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Figure 23. Schematic view of 1,3,5,7-tetrastyryl BODIPY derivatives. 
Another tetra styryl derivative was reported by Liu group (Figure 24).45 In this study, 
it was shown that if 6- or 2,6- positions involve formyl group, methyl groups at the 7, 
and 1,7-positions are more prone to undergo Knoevenagel condensations rather than 
3,5- positions. The presence of styryl groups at 7-, and 1,7-positions allows another 
Knoevenagel reactions of the methyl groups at the 3,5- positions. They introduced 
oligo (ethylene glycol) methyl ether units to improve the water solubility and so, 
these dyes can operate as building blocks for conjugated oligomers and sensing 
materials.  
	  
Figure 24. Illustration of tetra-styryl derivatives including formyl groups at 7-, and 1,7-
positions. 
In addition, in this study, tetra-styryl BODIPY including oligo (ethylene glycol) 
methyl ether as a water soluble units and formyl moieties as a cysteine reactive group 
was shown as fluorescent probe for cysteine. When formyl groups on 1- and 7- 
positions react with cysteine, thiazolidine is formed and π-conjugation is disrupted so 
absorption spectrum shows blue shift (from green to blue). (Figure 25) In presence of 
cysteine, emission intensity is enhanced and this dye can be used as a potential water 
soluble near-IR sensing and labeling probe for N-terminal cysteine residues in 
peptides or proteins. 
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Figure 25. The visual representation of tetra styryl BODIPY dye in PBS buffer pH 7.4 in the 
absence and presence of L-cysteine. 
Proper and straightforward derivatization of BODIPY dyes with four styryl moieties 
assure that these new chromophores can be used in different fields such as 
photodynamic therapy, dye sensitized solar cells, dendritic light harvesting and 
supramolecular building blocks. 
 
 Significance of Mercury (II) 2.3.
The mercury cycling in the ecosystem is rather complicated and affected by various 
elements such as human activities, climate variations and natural disasters. Mercury 
is thought as highly toxic and major source of mercury contamination is pollution in 
natural waters. There are two main sources of mercury release: Industrial and natural. 
Coal and gold mining, fossil fuel combustion and wood pulping are industrial 
sources. The other major cause of mercury pollution is resulted from volcanic and 
oceanic emissions.46 If there is no inadvertent use, seafood consumption is the only 
source for human exposure. Mercury ions can smoothly cross the biological 
membranes and have severe effects on the central nervous system and endocrine 
system.47 Furthermore, they lead to oxidative stress48 and lipid peroxidation49 and 
prevent neuron division and migration at cellular level. 
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 Hg (II) Fluorescent Probes 2.3.1.
Considering the importance of the effect of mercury ion (Hg (II)) on environmental and 
biological aspects, the detection of Hg (II) becomes an important task for scientists. 
Within the different approaches, fluorescence-based techniques attract more attention 
due to their superior characteristics such as high sensitivity, selectivity and being 
inexpensive and user-friendly. Additionally, fluorescence-based methods give the 
opportunity to study in living systems and environmental samples.50  
Intrinsic characteristics of Hg (II) allow modulation of affinity and selectivity of 
receptor unit. Due to its 5d106s2 electronic configuration and absence of ligand field 
stabilization energy, Hg (II) can have diverse coordination numbers and geometries. 
Widely known types are two-coordinate linear and four coordinate tetrahedral ones. 
In the design of the receptor unit for Hg (II), soft donor atoms like sulfur and 
nitrogen are generally used to improve the affinity because Hg (II) is known to be a 
soft acid. Another parameter to get the rational design is the signaling unit. 
Depending on the desired absorption and emission wavelength, fluorophore should 
be chosen or functionalized properly. Water solubility is a key parameter that must 
be fulfilled and usually it is difficult to get water-soluble probes. Therefore, the water 
soluble probes are rare in the literature. Photoinduced electron transfer (PeT) and 
internal charge transfer (ICT) have both been utilized commonly to tune absorption 
and emission properties of the fluorophore. In addition, ICT-based probes offer 
ratiometric sensing which is important to get rid of artifacts and quantify the analyte. 
FRET-based fluorescent probes also provide ratiometric analysis as well as a large 
Stokes shift can be obtained and so sensitivity of the probe is improved. 
	  
Figure 26. FRET-based fluorescent probe for detection of Hg (II).  
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A FRET-based fluorescent probe for detection of Hg (II) is demonstrated in Figure 
26.50 Rhodamine and BODIPY dyes were selected as a donor and acceptor moieties, 
respectively. Also, leuco-rhodamine specie was used as a receptor part because upon 
reaction with Hg (II), ring opening reaction enhances fluorescence emission of 
rhodamine. In this design, phenyl-ethynyl-phenyl groups are used to facilitate the 
through-space energy transfer.  In presence of Hg (II), fluorescence of BODIPY unit 
decreases and rhodamine emission increases. As a result, it can be concluded that 
FRET process was modulated upon addition of Hg (II) and ratiometric probe was 
studied in living cells. 
 
	  
Figure 27. BODIPY-based fluorescent probe for detection of Hg (II). 
 
Qian and Wang reported a BODIPY based probe working with PET mechanism for 
Hg (II) detection in aqueous solution as depicted in Figure 27.51 In absence of Hg 
(II), electron-donating property of receptor part quenches the emission of BODIPY 
core via PET mechanism. On the other hand, addition of two equivalent of Hg (II) 
blocks the PET process and fluorescence of BODIPY enhances. 
 
	  
Figure 28.  BODIPY-based fluorescent probe utilizing PET and ICT processes for detection 
of Hg (II). 
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In another example, both PET and ICT mechanisms were utilized in a single 
molecule in Figure 28.52 BODIPY core was functionalized with two crown ether 
moieties on meso and 3- positions. The dithia-dioxa-aza macrocycle on the meso 
position facilitates PET process; however, dithia-dioxa-aza macrocycle on the 3- 
position causes ICT process due to the conjugation directly to BODIPY fluorophore. 
With addition of Hg (II), PET process is blocked due to the decrease in electron-
donating ability of dithia-dioxa-aza macrocycle and ICT process causes blue shift 
owing to lack of electron-donation ability of dithia-dioxa-aza macrocycle. The 
authors proposed that PET process causes 7-fold increase in emission intensity, but, 
ICT mechanism triggers the big changes in both absorption and fluorescence 
properties. 
 
 Importance of Biological Thiols 2.4.
Biological thiols such as cysteine (Cys) (27), homocysteine (Hcy) (28) and 
glutathione (GSH) (29) are essential physiological components because of the strong 
nucleophilicity of the sulfhydryl group. Being excellent nucleophiles, they play key 
roles on enzyme functionality and maintenance of redox states.53 The variations in 
the levels of biological thiols is attributed to many diseases such as premature 
arteriosclerosis, occlusive vascular and neurodegenerative disorders, leukemia, 
diabetes, and acquired immunodeficiency syndrome.54  
	  
Figure 29. Chemical structures of cysteine, homocysteine and glutathione. 
Cysteine (Cys) is produced in the liver and appears in a wide range of biological 
processes such as synthesis of certain proteins and removal of toxins.55 The low 
concentration of Cys can cause slow growth, and liver and skin damage whereas high 
concentrations leads to the neurotoxicity.56 Homocysteine (Hcy) is another 
sulfhydryl-containing amino acid, synthesized in the body. Demethylation of 
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methionine leads to production of Hcy. Elevated levels of Hcy are linked to 
cardiovascular disease and Alzheimer’s disease. Glutathione (GSH) is a tripeptide of 
glutamate, glycine and cysteine and γ-glutamylcysteine synthetase and GSH 
synthetase are used as catalysts sequentially in the synthesis of GSH. GSH is 
responsible for antioxidant response, regulation of gene expression, cell proliferation, 
etc. Deficiency in GSH can result in Alzheimer’s disease, Parkinson’s disease, AIDS, 
cancer and heart attack.57  
Thus, detection of these thiol containing molecules is of great importance towards 
biological applications. Once again, fluorescence-based techniques drew significant 
attention due to the simplicity and sensitivity. Additionally, allowing the study in 
intracellular environment brings fluorescence-based approach in the first place. 
Efficient nucleophilic character and high affinity towards metal ions are two widely 
used properties of thiols in the design of fluorescence-based probes. For thiol 
reactive probes, various types of reactions can be employed including nucleophilic 
substitution, Michael addition, cyclization, cleavage of disulfide bond, metal 
complexes coordination, and redox reactions. Due to effect of pH on nucleophilicity 
of the sulfhydryl group (pKa of SH in Cys: 8.15, Hcy: 8.7, GSH: 8.56), pH of the 
medium becomes an important parameter that should be taken into account for 
reaction rates.56 
 Detection of Thiols Based on Michael Addition  2.4.1.
Owing to strong nucleophilicity of the sulfhydryl group, Michael acceptors which are 
good electrophiles are attached to fluorophore to give Michael addition.58 PET, ICT 
and FRET processes can be utilized to get desired optical properties.  
	  
Figure 30. Some examples for thiol probe based on Michael addition. 
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Maleimide groups (30) are widely used in the design of the fluorescent probes. The 
detection limits of nearly 20 nm for Cys was achieved and human metastatic breast 
cancer cells (MDA-MB 231) were studied for imaging.59 Although maleimides are 
frequently used as thiol reactive groups, the quinone groups (31) are also highly utilized 
in fluorescent probes. For instance, compound 31 was designed to detect thiols based on 
ICT mechanism. Before addition of thiols, the absorption peak was centered at 582 nm 
owing to ICT process. In presence of thiols, nucleophilic addition of thiols on the 
quinone unit decreases the absorption peak and emission intensity increases.59 
	  
Figure 31. Example for thiol probe based on open chain Michael addition.  
For the design of the fluorescence-based probes for thiols, open chain Michael 
acceptor can also be used. For example, as can be seen in Figure 31, α, β-unsaturated 
ketone derivative was non-fluorescent, but, presence of thiol groups disturbs the 
conjugation and emission of coumarin turns “on” state.60 
	  
Figure 32. Thiol probe based on nitro-olefin moiety.  
In the sensing of thiols, nitro Michael acceptors are frequently utilized due to the 
high reactivity of sulfhydryl groups towards these acceptors. Wang and coworkers 
utilized fluorescein as a fluorophore part and nitro alkene unit which is thiol reactive 
group to detect the thiols in water (Figure 32).61 Before the addition of thiols, PeT 
process is in action due to the electron deficiency on nitro group so fluorescence is 
low. In presence of thiols, conjugate addition to nitroalkenes takes place and as a 
result, PeT mechanism is blocked and fluorescence is restored. Meanwhile, ICT 
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process from the phenyl carboxyl acid group to the electron-poor nitroalkene moiety 
leads a blue shifted absorption peak upon thiol addition. This probe is further studied 
in intracellular medium and imaging of thiols in living cells were investigated. 
	  
Figure 33. Thiol probe based on ring opening Michael addition.  
Michael addition based ring opening reaction is applied in the design of the biothiol 
probes. In 2010, a fluorescein-based thiol probe was addressed (Figure 33).62 1,4-
addition of thiol to α,β-unsaturated ketone in the sensor followed by the spiro ring 
opening of fluorescein triggers the increment in emission intensity and absorption 
peak is shifted from 454 nm to 500 nm. 
 Detection of Thiols Based on Cleavage of Sulfonamide and 2.4.2.
Sulfonate 
Cleavage of sulfonamides and sulfonates is a promising way to detect the biothiols 
and highly employed in the design of the fluorescence-based probes. 
	  
Figure 34. PeT-based thiol probe based on Michael addition. 
For example, Itoh and coworkers utilized PeT mechanism together with Michael 
addition reaction for detection of thiols (Figure 34).63 Electron-deficient of the 
phenyl unit on the 2,4-dinitrophenyl sulfonyl (DNBS) is incorporated into 
fluorescein fluorophore. From fluorescein moiety to electron deficient DNBS unit, 
PeT process occurs. In presence of thiols, DNBS undergoes de-sulfonylation, as a 
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result, fluorescence of fluorescein is restored. Low detection limits for GSH and Cys 
were achieved and this probe was studied in cholinesterase assays.  
 Detection of Thiols Based on Cyclization with Aldehydes 2.4.3.
Selectivity among thiols is indispensable when taking into consideration the different 
biological roles different thiols. Therefore, unique detection makes the quantification 
of these thiols more useful. Also, the concentration of each thiol differs in biological 
medium and selectivity becomes more important to investigate the disease that 
occurs due to the fluctuations in the levels of these individual thiols.    
The reaction between aldehydes and N-terminal cysteines to form thiazolidines is a 
type of reaction that utilized for detection of Hcy and Cys. In this reaction, a rapid 6- 
or 5-membered ring formation occurs with 1,3- or 1,2-aminothiols. Hence GSH does 
not give any response because GSH does not form any ring.	 
	  
Figure 35. Thiol probe based on cyclization of aldehydes. 
Efficient detection of Cys and Hcy was achieved by the compound 36.64 Bisaldehyde 
was used as a thiol reactive group and the reaction between the aldehyde moiety and 
Cys yields thiazolidine and shifts the absorption peak 25 nm to the longer 
wavelength and emission intensity decreases. Hcy showed similar optical changes 
with the formation of six-membered ring. However, monoaldehyde derivative of this 
compound demonstrated the selectivity to Cys over Hcy. The reason of the 
selectivity may come from the favored formation of a five-membered ring.65 
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 Detection of Thiols Based on Disulfide Bond Cleavage 2.4.4.
Thiols are known with their strong reducing character and this property allows the 
detection of them via the reduction of disulfide bond. Disulfide bond can be inserted 
into the fluorophores to get fluorescence-based response upon addition of thiols. 
	  
Figure 36. Thiol probe based on disulfide bond cleavage. 
The promising example for this type of detection is given in Figure 36.66 Coumarin 
and tetrakis(4-hydroxyphenyl)porphyrin fluorophores were selected as donor and 
acceptor moieties, respectively were attached by a disulfide bond. Before the 
addition of thiols, emission of the coumarin is quenched because of the FRET 
process from the coumarin as a donor to porphyrin as an acceptor. With the addition 
of thiols, disulfide bond is cleaved and FRET process is blocked. Thus, fluorescence 
of coumarin is enhanced. 
 Detection of Thiols Based on Metal Ions 2.4.5.
Another distinctive property of biothiols is their high affinity towards metal ions and 
this feature allows the detection of these species by using metal ions. Additionally, 
this metal ion based system has a distinct advantage in the investigation of biological 
samples since metal ionic pairs intrinsically assist the water-solubility. 
	  
Figure 37. Thiol probe based on metal ions. 
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Kim et. al. were reported iminocoumarin–Cu(II) derivative to detect the biothiols at 
pH 7.4 under aqueous conditions (10 mM PBS buffer, pH 7.4, 1.0% DMSO). In the 
presence of thiols, decomplexation of the Cu (II) ion from non-fluorescent 38 takes 
place followed by hydrolytic cleavage of the resulted Schiff base to yield highly 
emissive coumarinaldehyde.67 This turn–on probe was further studied in detection of 
intracellular thiols.  
 
 Significance of Hydrogen Sulfide (H2S) 2.5.
Hydrogen sulfide (H2S) is a type of reactive sulfur species because it gives redox 
reactions with proteins to influence their actions. In the past, it was thought as a toxic 
gas, however, recently, H2S have known as the third gaseous endogenously-produced 
signaling molecule after nitric oxide (NO) and carbon monoxide (CO). Other typical 
feature of this small gasotransmitter is the foul odor (rotten egg smell). It is 
synthesized endogenously from L-cystathionine, L-homocysteine and L-cysteine 
with the help of four different enzymes: cystathionine betasynthetase (CBS, 
EC4.2.1.22), cystathionine g-lyase (CSE, EC4.4.1.1), 3-mercaptopyruvate sulfur 
transferase (3-MST, EC 2.8.1.2) and cysteine lyase (CL, EC 4.4.1.10) (Figure 38).68 
Non-enzymatic synthesis involves the production by reduction of elemental sulfur.  
 
	  
Figure 38. Endogenous synthesis of H2S in mammalian cells (Copyright © 2013, American 
Chemical Society, Reprinted with permission from ref (69)).69  
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The ordinary concentration of H2S in blood is between 10 and 100 µm.70 Hydrogen 
sulfide is a weak acid (pKa1: 6.76, pKa2: 19.6) so it appears especially as SH– (82%) 
rather than H2S (18%) or S2– (< 0.1%) under physiological conditions. This 
hydrosulfide anion has more nucleophilic character than Cys or reduced glutathione 
(GSH) under physiological conditions due to the lower pKa of this small 
gasotransmitter compared to Cys or GSH.69 H2S diffuses easily through the cell 
membranes and takes part in different type of biological processes such as regulation 
of cell growth,71 cardiovascular protection,72 stimulation of angiogenesis,73 
antioxidative effects74 and modulation of neurotransmission.75 Recent studies have 
proven that altered levels of H2S can be linked with different types of diseases such 
as diabetes, arterial and pulmonary hypertension, liver cirrhosis, and Alzheimer’s 
disease.68  
Of course, there are several obstacles are present in the detection of H2S. First of all, 
the reactions should be bioorthogonal to study in native cellular medium. Secondly, 
probe should give fast response to monitor H2S due to its transient nature. Another 
requirement is that probe should selectively respond to H2S, in other words, it should 
not interfere with other thiols.76   Traditional techniques such as electrochemical or 
gas chromatography are not convenient for detection of H2S because sample 
preparation is complex and monitoring of transient species is not trivial. On the other 
hand, small molecule fluorescence-based techniques tender high sensitivity, real-time 
monitoring and ease of operation. To design these probes, H2S-specific reactions are 
employed in order to get desired optical properties. Thanks to its dual 
nucleophilicity, high reducing character, high binding affinity towards copper ions 
and specific addition reaction towards unsaturated double bonds, there are several 
type of H2S-reactive reactions.77 The most utilized reactions in the design of the 
fluorescence-based probes can be categorized as reduction-based, Michael-addition 
based and copper ion-based. 
 H2S Probes Based on Reduction reactions 2.5.1.
H2S is a strong reducing agent and this feature can be used in the design of the 
fluorescence-based probes. In this sense, azides and nitro groups can be reduced via 
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H2S. Although azides have been reduced by using H2S over 30 years, the usage of 
this reaction in the H2S probes is very recent. Furthermore, even the reduction 
potential of H2S is lower than Cys or GSH, it can reduce azides or nitro groups faster 
than GSH and other biothiols.69  
	  
Figure 39. Examples for fluorescent H2S probe based on azide reduction. 
Based on this strategy, Chang et. al. utilized two fluorescent probes for detection of 
H2S (Figure 39).78 In these probes, fluorescein dyes are linked directly to azido units. 
In presence of H2S, azido groups are reduced to amino groups and fluorescence of 
the dyes are restored. Another important criterion is fulfilled with these molecules 
which are the selectivity among other species such as GSH, Cys, Na2SO3, NO, H2O2 
and O2−. These probes were further studied in vivo cell imaging in HEK293T cells. 
	  
Figure 40. Another example for fluorescent H2S probe based on azide reduction. 
Another azide reduction based fluorescent probe for cellular H2S was reported by 
Han group.79 In their design, ICT process is utilized within NIR heptamethine 
cyanine dye (41) to develop optical changes in absorption and fluorescence spectra 
with addition of H2S. When the electron withdrawing azido group is reduced with 
electron donor amino group, absorption peak is shifted to the longer wavelength and 
fluorescence signal of the cyanine dye increases, as a result, ratiometric detection of 
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H2S is achieved. In this work, compound 41 was investigated to detect various 
intracellular H2S in RAW264.7 cells. 
	 
	  
Figure 41. Reduction-based H2S fluorescent probes in the literature. 
Owing to the good selectivity and reactivity, reduction-based type is promising and 
useful in sensing of H2S. Therefore, reduction-based detection is rapidly emerging as 
a H2S sensing strategy and various fluorophores have been employed such as 
phenanthroimidazole,80 resorufamine,81 nitrobenzofurazan,82 benzathiazole fluorine83 
and cresyl violet (Figure 41).84  
 H2S Probes Based on Nucleophilic Attack 2.5.2.
Besides its reducing ability, H2S is a strong nucleophile. At physiological pH, it 
exists as SH– while other biothiols are in neutral state. Thus, the different in pKas 
makes H2S more nucleophilic under these conditions. For sensing of H2S becomes 
promising considering the diprotic nature and its potential to undergo two sequential 
nucleophilic attacks. 
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Figure 42. H2S detection based on nucleophilic attack to an aldehyde followed by 
intramolecular attack on an olefin. 
On the basis of dual nucleophilic character, H2S initially attacks to the aldehyde and 
thiol is formed leading to second attack on α-β-unsaturated olefin. This mechanism 
was utilized in compound 47. Addition of H2S results in fluorescence enhancement 
and selectivity 3-4 fold over Cys and GSH is achieved. Another example is given in 
compound 48. BODIPY based fluorophore is well established to detect H2S. In a 
recent example, it was shown that reaction completion takes 3-4 hours and so the rate 
of fluorescence enhancement is slow.85 This challenge was overcame by using more 
electrophilic olefin which facilitates faster nucleophilic addition of SH- to electron 
poor C=C double bond. Thus, compound 48 reacts with H2S more rapidly and detects 
H2S in 30 minutes. With this modification, compound 48 was studied in blood 
plasma and brain tissue of mice to detect the H2S.76   
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Figure 43. H2S detection based on nucleophilic attack on an activated electrophile followed 
by attack on an ester-bound fluorophore. 
Another similar approach based on the electrophilic olefins has been employed in 
H2S sensing. As shown in Figure 43, compound 49 has both nitrile and ester 
functionality to improve the electrophilicity. In presence of H2S, Michael addition-
cyclization sequence takes place and fluorescence turn “on” is achieved.  
	  
Figure 44. The reaction mechanism for Michael addition-cyclization for H2S and other 
thiols. 
Moreover, due to the good selectivity over other biothiols, Cys and glutathione did 
not give response. The reaction between Michael acceptors and biothiols is generally 
reversible and does not yield intramolecular cyclization.86  
 
	  
Figure 45. H2S detection based on nucleophilic attack on an electrophilic center to break 
fluorophore conjugation. 
Dual nucleophilicity of H2S is employed for the distruption of the conjugation of the 
fluorophores. Guo and coworkers reported a falvylium dye-based ratiometric probe 
for H2S working with nucleophilic attack of H2S on the electrophilic center of 
benzopyrylium group (Figure 45). Addition of H2S  resulted in a 240 nm blue shift in 
absorption spectrum and fluorescence increase at 500 nm is observed.87  
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 H2S Probes Based on Copper ion 2.5.3.
The strong interaction between sulfide and copper ion inspires the scientists to 
develop H2S probe using fluorescence techniques. 
	  
Figure 46. H2S detection based on copper ion affinity of sulfides. 
Chang et. al. developed a fluorescein based H2S probe by using dipicolylamine 
moiety as a binding unit for Cu (II) (Figure 46).88 Due to the chelation between Cu 
(II) and dipicolylamine, fluorescence was quenched. On the other hand, in presence 
of H2S in 10 mM HEPES buffer at pH 7.0, Cu (II) was released and CuS was 
formed. Thus, fluorescence of fluorescein moiety was enhanced.   
 
 Photodynamic Therapy 2.6.
Photodynamic therapy (PDT) is a very effective and novel methodology for cancer 
treatment. It is non-invasive compared to chemotherapy or radiotherapy. 
Photodynamic therapy is based on the activation of a nontoxic photosensitizer by an 
appropriate light source in the presence of molecular oxygen. In other words, there 
are three main components of photodynamic therapy: photosensitizer, light, and O2. 
There are many advantages of PDT compared to chemotherapy and radiotherapy. To 
begin with, long-term side effects are minimal due to the local implementation. 
Additionally, both photosensitizer and light enable dual selectivity. Another 
significant advantage is that it can be applied before, after or simultaneously with 
another type of therapies and performed many times at the same location without 
causing any harmful effects. Modulation of photosensitizers, drug carriers and drug-
light time intervals and ability to target diverse cellular components opens the way 
for different type of applications. The main drawback of this therapy is the lack of 
penetration of the light through the tissue. This limitation is the reason why PDT is 
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not as widespread as it is thought to be. Even when longer wavelength light sources 
are used, the maximum penetration depth reaches 5-10 mm.89  
 Fundamentals of Photophysics behind PDT 2.6.1.
The basic theory behind the photodynamic therapy is that drug (photosensitizer) is 
injected and then light especially in the near-IR region is applied. The photophysical 
processes that are involved in PDT are shown in Figure 47. Photosensitizers (dyes) 
possess highly conjugated delocalized π systems. When photosensitizers are in their 
ground state, they have two electrons with opposite spins in low energy orbital. The 
proper absorption of light causes excitation of one electron  
	  
Figure 47. Photophysical processes in PDT.90 
from highest occupied molecular orbital to the lowest unoccupied molecular orbital 
with conversion of spin. This first excited singlet state is not stable and short-lived so 
it releases its energy by different paths such as fluorescence, internal conversion or 
intersystem crossing. By intersystem crossing, the spin of the excited electron inverts 
to generate long-lived excited triplet-state having the electron spins parallel. The 
reason why triplet state of photosensitizer has a long time is that loss of energy via 
the phosphorescence process is spin-forbidden. Therefore, spin allowed nature of 
triplet-triplet transition allows the reaction between the triplet of photosensitizer and 
molecular oxygen which has triplet character in its ground state. The reaction 
generates highly reactive singlet oxygen species.91 
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 Fundamentals of Photochemistry behind PDT 2.6.2.
As it is stated above, molecular oxygen has triplet character in ground state meaning 
that the two outmost orbitals have unpaired and spin-parallel electrons. 
Photosensitizer in the triplet state can react with triplet oxygen in two different ways. 
Type I involves the direct reaction with a substrate like cell membrane or a molecule 
via an electron transfer or occasionally together with proton donation to triplet 
oxygen to generate superoxide anion which is not reactive to give oxidative damage. 
However, this superoxide anion reacts with itself to generate other ROS such as the 
hydroxyl radical and hydrogen peroxide.92 Hydrogen peroxide is a biologically 
important species and capable of passing through the cell membranes. It plays 
fundamental roles on functionality of enzymes and its reaction with ferric iron 
(Fenton reaction) generates hydroxyl radical.  
H2O2 + Fe2+ → OH- + •OH + Fe3+ 
The ferrous iron, Fe2+, catalyzes the homolytic cleavage of oxygen-oxygen bond in 
hydrogen peroxide and produces a hydroxyl radical (•OH) and a hydroxide ion (OH-
). Reaction between the superoxide and a hydroxyl radical (•OH) forms singlet 
oxygen and when superoxide reacts with nitric oxide (NO-) to generate peroxynitrite 
(OONO-), which is a strong oxidizing agent. Similar to hydrogen peroxide, hydroxyl 
radical (•OH) is also permeable through cells and it can add to and oxidize the 
organic substances. This oxidized species become a radical, which induces other 
reactions. Thus, resulted chain reactions give oxidative damage to lipids or fatty 
acids.93  
In Type II mechanism, spin of the outmost triplet oxygen electron inverts and moves 
into the orbital containing the other electron so one orbital becomes completely 
unoccupied. This highly reactive singlet oxygen has a short lifetime and reacts 
directly with biological components. Singlet oxygen reacts with double bonds and 
sulfur groups with highly complex mechanisms. For example, oxidative cleavage of 
DNA involves a [4 + 2] cycloaddition to the C-4 and C-8 carbons of the purine ring 
resulting an unstable endoperoxide. The sequential complex reactions and the 
product are dependent on the presence of guanine unit on double stranded DNA.94  
44	  
	  
In PDT, Type I and Type II reactions take place at the same time but the percentage 
differs according to the photosensitizers used and the concentrations of the substrate 
and molecular oxygen.95 Because of the high reactivity and short half-life of singlet 
oxygen, it gives damage locally where the photosensitizer is present. It is estimated 
that in the half-life, it diffuses approximately 40 nm, thus, the radius of the activity is 
of the order of 20 nm.96 
 Importance of Light 2.6.3.
From sunlight to highly complex light sources, light used in PDT has been subject to 
a transformation over the years. Advancement in the optical technology offers new 
light delivery device and novel light sources.97 The light sources utilized in PDT can 
be divided into two groups as lasers and non-laser sources. Laser systems offer high 
quality because they are highly intense, monochromatic, have minimal thermal 
influence and can be modified for fiber optic delivery. However, conventional laser 
(potassium-titanyl-phosphate (KTP) dye, metal vapor lasers) sources have some 
drawbacks. For example, they are highly expensive and have large size. 
Development of diode lasers offers some advantages compared to conventional laser 
sources such that they are less expensive, portable and most importantly, they can be 
modified to have multi-channel unit to accomplish the complicated PDT process 
(Ceralas PDT 762 nm; CeramOptec GmbH of Biolitec AG).98 Also, non-laser 
systems bring some superior features. First of all, they are cheaper, user-friendly and 
smaller in size. Besides, they can cover a broad range of the spectrum. However, 
they suffer from the thermal effect and lower intensities. All in all, light emitting 
diodes are up-to-date non-laser sources exhibiting easy-handling and non-coherent 
properties. 
The developments of laser sources are crucial in PDT because in target tissue, the 
spatial and temporal distribution of light affects the PDT efficiency. Applied light 
can be absorbed or scattered in tissue. Depending on the tissue type and wavelength, 
the amount of these processes can vary. There are some obstacles while dealing with 
biological tissue. To begin with, presence of macromolecules, organelles, cell layer, 
etc. causes inhomogeneity and turbidity causes significant scattering and loss of 
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directionality.93 Also, the absorption of molecules such as hemoglobin is another 
issue that must be addressed. The low absorption wavelength of natural components 
along with minimal light scattering at longer wavelengths and presence of water 
absorption above 1300 nm results in an “optical window” that PDT can be effective. 
The average penetration depth is 1-3 mm at 630 nm and this number nearly doubles 
at 700-850 nm.99  
To conclude, in PDT, light must pass through the tissue to activate photosensitizer. 
In this manner, not only the optical characteristics of the tissue but also the 
wavelength of the light plays crucial role for penetration efficiency (depth where 
light has to reach). The maximum penetration through tissue can be obtained at the 
near – IR (700- 1100 nm). In this region, the absorption of the natural tissue 
chromophores (oxyhemoglobin, deoxyhemoglobin, melanin) is weak. However, most 
photosensitizers rarely absorb above 800 nm and this limits the application of PDT. 
To overcome light delivery problem, we proposed a novel PDT system in which 
persistent luminescent nanoparticles are used (see Chapter 8). 
 Photosensitizers 2.6.4.
Photosensitizers are generally highly conjugated aromatic organic molecules. 
Modifications allow the change in the delocalization system and so absorption 
properties can be modulated.90 Photosensitizers should have high absorption in 
therapeutic window and high singlet oxygen quantum yield. Also, they must have 
low dark toxicity, in other words, it should be active only when they are irradiated 
and photobleaching should be low. Moreover, they should accumulate preferentially 
accumulate in the target tissue and show high chemical stability. A considerable 
amount of photosensitizers has been synthesized since 1980. Typically, they can be 
classified into two groups as natural-porphyrin-based and non-porphyrin-based. First 
generation natural-porphyrin-based photosensitizer, Photofrin, is approved for 
clinical applications. However, first generation photosensitizers show weak 
absorption intensity at 630 nm which prevents the deep penetration of light. 
Additionally, due to the planar structures, π-π stacking causes aggregation in 
solutions. Furthermore, synthesis of porphyrin is not straightforward and selectivity 
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is not achieved. Thus, second generation photosensitizers have been developed to 
address the drawbacks of the first generation. These photosensitizers involve the 
synthetic version of natural porphyrins such as chlorins, purpurins, bacteriochlorins, 
phthalocyanine, squarine and perylene diimide.100 However, the chemical- and 
photo-stability upon storage and aggregation in polar medium are major issues that 
need to be addressed. Additionally, phthalocyanine dyes can chelate to diamagnetic 
metals such as aluminum, zinc which contributes to phototoxicity. A second 
generation non-phorphyrin dye, rose bengal, shows low singlet oxygen yield so 
decreases the PDT efficiency.101 Third generation photosensitizers are non-naturally-
occurring, conjugated pyrrolic ring systems and contain modified photosensitizers 
and biological components like antibodies or liposomes.  
2.6.4.1. BODIPY Dyes as Photosensitizers 
BODIPY dyes have attracted great attention as suitable photosensitizers for 
photodynamic therapy owing to their intrinsic characteristics. They can be modified 
to have strong absorption in near-IR region and high stability in ambient conditions 
is another important feature. Besides its stability, the light to dark toxicity ratio is 
higher than other photosensitizers. To get better photodynamic action, some 
modifications have been employed on the BODIPY core. The main aim is to increase 
the triplet sensitization. Halogenation, using fullerene C60 derivatives and logically 
designed BODIPY dimers have been utilized frequently in this sense and are 
described below. 
Halogenation: To begin with, “heavy atom effect” is a way of increasing intersystem 
crossing and so triplet sensitization offers singlet oxygen generation. Incorporation of 
heavy atoms like iodine or bromine improves the spin-orbit coupling and this leads to 
an improvement of intersystem crossing without energy loss from excited states.102 
Nagano and coworkers reported non-halogenated and halogenated tetramethyl 
BODIPY dyes as shown in Figure 48.103 Non-halogenated derivative showed strong 
fluorescence so low singlet oxygen generation yield. On the other hand, diiodo- 
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Figure 48. Molecular structures of non-halogenated and halogenated BODIPY dyes 
tetramethyl BODIPY derivative demonstrated low fluorescence intensity and high 
efficiency in generation of singlet oxygen. The decrease in fluorescence quantum 
yield explains the effect of intersystem crossing due to the presence of iodine atoms. 
As it was mentioned before, the strong absorption in near-IR region and water-
solubility are important criteria to meet in the design of photosensitizers. Akkaya et. 
al. synthesized novel compounds to achieve the desired properties.37 The group 
attached the triethylene glycol moieties to improve the water solubility and bromine 
atoms to enhance the intersystem crossing (Figure 49). Besides, they used distyryl 
BODIPYs to get absorption in near-IR region to have deep penetration. These water-
soluble, near-IR absorbing BODIPY dyes produced singlet oxygen efficiently and 
was tested in K562 human erythroleukemia cells. 
	  
Figure 49. Halogenated BODIPY derivatives for photodynamic therapy application.37 
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Incorporation of C60 unit: In addition to heavy atoms, fullerene C60 is another way to 
increase spin-orbit coupling to enhance intersystem crossing. Excitation of C60 by 
light causes transition of singlet excited state to triplet excited state with the help of 
intersystem crossing with almost quantitative efficiency.104 Only C60 is not suitable 
for photodynamic therapy because of low absorption in the near-IR region, however, 
this low absorption is enough to get intramolecular energy transfer in C60-organic 
dyes conjugates. To accomplish efficient photosensitizers, Zhao group designed and 
synthesized BODIPY- C60 conjugate (55).105 In the design, they used di-styryl 
BODIPYs to get strong absorption in nearly 660 nm and C60 moiety to behave as 
spin convertor. With this construction, long-lived triplet excited state was achieved. 
The measurement and evaluation of the data showed that BODIPY-C60 conjugate 
demonstrated great performance in terms of singlet oxygen generation efficiency and 
stability over commonly used photosensitizers such as methylene blue and 
tetraphenylporphyrin. The paper also indicated that there was not much difference in 
photodynamic therapy efficiency when the number of C60 was increased.  
	  
 
Figure 50. BODIPY- C60 derivative for photodynamic therapy application. 
BODIPY dimers: Triplet sensitization can be obtained with substituents which have 
molecular orbitals with suitable multiplicity and energy levels. Lately, Akkaya group 
published a new category of bis(BF2)-2,2‘-bidipyrrins (BisBODIPYs) showing 
interesting properties (compound 57 and 58). These dimers are able to undergo 
intersystem crossing efficiently compared to the monomer derivatives. They 
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consolidated their design with computational studies. Computational studies suggest 
that BODIPY monomer exhibits low triplet quantum yield and in the excited state, 
there are two orbitals with single occupancy. On the other hand, orthogonal BODIPY 
dimers show doubly-substituted excited state configuration which promotes singlet 
excited state and triplet excited state coupling. In this publication, it was shown that 
singlet oxygen quantum yield of orthogonal BODIPY dimers is comparably high and 
photocytotoxicity experiments were conducted well in K562, human erythroleukemia 
cells. 
	  
Figure 51. Orthogonal BODIPY dimers for photodynamic therapy application. 
 Modes of Cell Death 2.6.5.
There are two main types of cell death triggered by photodynamic therapy. First type 
is apoptosis and second one is named as necrosis. Which type of cell death is 
dominant is dependent on several elements such as type of cell, the subcellular 
localization of the photosensitizers, the concentration of photosensitizer and the 
applied light dose to stimulate photosensitizer locally.106 In addition, it is suggested 
that lower dose of photodynamic therapy dominates apoptosis, whereas higher doses 
contributes significantly to necrosis.107 
Apoptosis is a highly complicated process and includes several steps. This 
programmed cell-death mode is encoded genetically in all cells in the body.108 
Generally, mitochondrial release of cytochrome c initiates the apoptosis. This event 
causes the activation of caspase cascades termed as executioner caspases including 
caspase-3, -6 and -7.109 These caspases bring about the cleavage of cellular 
components that causes the changes in biochemistry and morphology processes seen 
in dying cells.110 After cleavage of nuclear lamins, chromatin condensation and 
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nuclear shrinkage take place successively. Then, DNA fragmentation is caused by 
cleavage of inhibitor of the DNaseCAD (caspase activated deoxyribonuclease). 
Finally, cleavage of proteins in cytoskelaton cause cell fragmentation and apoptotic 
bodies.111 The main characteristics of the apoptosis are cell shrinkage, plasma 
membrane blebbing and organelles. 
Necrosis is the second type of cell-death mode in photodynamic therapy. Unlike 
apoptosis, this type of mode is known as highly violent and an accidental cell death. 
Its main features are cytoplasm swelling, damaging of organelles and demolishment 
of the plasma membrane. With these series of events, intracellular substituents are 
released and inflammation takes place.112 In necrosis, dying of the cells happens 
accidentally and it is termed as unprogrammed cell death. The biochemical and 
morphological changes can be explained as pyknotic nucleus, cytoplasmic swelling 
and loss of integrity in cytoplasmic membranes.  
Apoptosis and necrosis are the direct tumor cell killing modes as well as they play 
role on the vascular damage and immune response which are other mechanism in 
tumor cell destruction.113 Direct tumor cell killing, vascular damage (shutting down 
of tumor vascular causes lack of nutrients and oxygen) and immune response (release 
of cytokinase and stress response proteins) affect each other and it should be 
highlighted that combination of those contributes the photodynamic therapy 
efficiency.92 
 Activatable Probe Design 2.6.6.
In photodynamic therapy, one of the main superiority is that delivery of light and 
localization of photosensitizer can lead to dual-specificity. In contrast to other 
mechanisms, delivery of light in a localized area offers high specificity and healthy 
cells far from this area are not affected from generation of singlet oxygen. As a third 
item for specificity, molecular activation attracts attention. In other words, the 
combination of localization of photosensitizers in tumor tissue, the activation of 
photosensitizer by tumor tissue and applied light in specific area promote the damage 
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of targeted tumor cells. Thus, activatable probes hold great potential towards 
differentiation between healthy and unhealthy tissue.114  
At first, the activatable probes is non-fluorescent owing to the spatial proximity 
between dye and quencher moieties and with the interaction between the biological 
stimuli, fluorescence of the probe is restored upon the cleavage of the linker located 
between the dye and inhibitor. Activation can be done via proteolytic activity, 
disulfide bridge and pH-sensitive hydrozone groups.115 
The activatable probes can be divided into three groups based on photochemistry 
namely; self-quenching based, inorganic component based and energy transfer based 
(between donor and acceptor dyes).  
Before describing each group in detail, a brief quenching mechanism should be given 
for clarity. There are two types of quenching: dynamic and static quenching. 
Dynamic quenching involves Förster resonance energy transfer, Dexter type energy 
transfer and exciplex formation. In all these processes, donor and acceptor parts are 
not in contact with each other and the excited state is involved. However, in static 
quenching, bonding between the donor and acceptor moieties occurs in ground state 
and ground state complex shows its own properties. For example, owing to the 
hydrophobic interactions, stacking between dye molecules causes dye aggregation. 
Self-quenching based activatable probes rely on the aggregation formation in 
aqueous medium. To illustrate, Texier and coworkers utilized Cy5.5 dye, disulfide 
bridge and RAFT-(cRGD)4 (Figure 52).116 In the first case, dimerization of Cy5.5 
was shown by absorption spectrum and decrease in fluorescence quantum yield. 
However, in presence of mercaptoethanol, with the cleavage of disulfide, absorption 
peak of Cy5.5 appeared and fluorescence quantum yield increased.
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Figure 52. Self-quenching based activable probe. 
For inorganic structure based activation, gold nanoparticles and gold nanorods have 
been employed frequently. Tuang group reported gold nanorod based probe for 
photodynamic therapy.117 In their design, they used Aptamer Sgc8 to target leukemia 
T cells specifically and this aptamer is hybridized with chlorin e6 as a photosensitizer 
for formation of a DNA double helix as depicted in Figure 53. In the absence of 
leukemia T cells, due to quenching of chlorin e6, there was no photodynamic action. 
On the other hand, presence of target cells caused the change in structure of Aptamer 
Sgc8, so with the applied light, released chlorin e6 generated singlet oxygen 
efficiently. 
	  
Figure 53. Gold nanorod based activable probe (Copyright © 2013, John Wiley and Sons, 
Reprinted with permission from ref (117)). 
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Last group depends on the organic dye and quencher conjugates. These quenchers 
are utilized with resonance energy transfer. The spectral overlap between the 
emission of the dye and absorption of quencher facilitates the energy transfer. The 
most employed near-IR quenchers are BHQ3, Cy7Q, QSY21, FluoQuench 661, etc. 
besides convenient near-IR dyes. 
 Disulfide Bridge as a Clevable Linker-activation by Glutathione 2.6.7.
Glutathione is a thiol containing tripeptide and its concentration in tumor cells is 
higher up to 1000-fold.  In tumor cells, the irregular blood flow causes hypoxic state, 
decreased oxygen level and so the activity of reductive enzymes increases (high 
glutathione concentrations).118 In previous studies, it was well stated that GSH is 
elevated in breast cancer119 and colon cancer120 cells, etc. In the presence of high 
intracellular concentration of glutathione, disulfide bonds are broken. On the other 
hand, disulfide bonds are thermodynamically stable and provide reasonably good 
stability in the bloodstream in the absence of sulfhydryl groups. Therefore, synthesis 
of glutathione-activatable photosensitizers via a disulfide linker is a promising 
strategy to develop photodynamic therapy reagents. This design is not very common 
in the literature.  
As shown in Figure 54, disulfide reduction is utilized in BODIPY and rhodamine 
based folate-FRET probe for imaging application.121 Folic acid is decorated because 
it shows high affinity toward folate receptor and to improve water solubility, 
hydrophilic peptide spacer is used. Also, BODIPY and rhodamine derivatives are 
placed as donor and acceptor moieties, respectively. BODIPY and rhodamine is 
linked to folate by an amide and disulfide bond, respectively. With the disulfide 
reduction, FRET is blocked due to the release of rhodamine unit and the fluorescence 
of BODIPY is enhanced. 
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Figure 54. Disulfide reduction based FRET probe. 
In another example, disulfide bridge is used as well as a hydrazone linker, which can 
be activated by acidic environment.122 In this example, two ferrocenyl units (donor) 
are attached to silicon (IV) phtalocynanine moeity (acceptor and photosensitizer 
compartment) via disulfide and hydrazone groups (Figure 55). These groups offer 
dual-activation and so specifity is enhanced. Since tumor cells environment is 
slightly acidic (pH = 4.5−6.8), hydrazone unit is activated by acid. Moreover, 
reducing environment of tumor tissues allows the reduction of disulfide bridge. 
Presence of both acid and dithiothreitol causes cleavage of hydrazone and disulfide 
linker, thus releasing of two-ferrocenyl units and blocking of FRET. As a result, 
singlet oxygen generation is achieved with the application of light. 
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Figure 55. Disulfide reduction based FRET probe (Copyright © 2014, American Chemical 
Society, Reprinted with permission from ref (122)). 
Nanoparticles offer several advantages compared to bulk materials in application of 
photodynamic therapy. Due to their small size and light weighing, they can be 
modified easily to enhance water solubility. In addition to increase water solubility 
and to minimize surface energy, stabilizers are used. Stabilizers can vary according 
to types of nanoparticles. Moreover, high surface to volume ratio, presence of 
dangling bonds makes them electrically charged. Thus, nanoparticles can adsorb 
charged ions and Coulombic forces make the nanoparticles repel each other so they 
can be dispersed in water. Another important advantage is that they can easily pass 
through the cells due to their small size. These mentioned properties allow 
nanoparticles to be applied in biological environment. Persistent luminescent 
nanoparticles are one of the biologically important nanosystems to be used in 
imaging and photodynamic action. 
 Persistent Luminescence 2.6.8.
The term “luminescence” is referred to non-thermal emission of light contrary to the 
incandescence. Sometimes, it is called as “cold” light and results from electron 
transitions from higher energy states to lower energy states. There are different types 
of luminescence according to their energy source such as chemiluminescence caused 
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by chemical reaction or electroluminesence resulting from electric current passing 
through a material, etc. Photoluminescence is another type of luminescence and its 
source is excitation of electrons to higher energy states via absorption of 
electromagnetic radiations. The work described in this thesis is mainly concerned 
with photoluminescence which covers fluorescence, phosphorescence and persistent 
luminescence (afterglow) (Figure 56). From the point of duration of the emission 
after turning off the excitation source, there are three types of luminescence: 
fluorescence, phosphorescence and afterglow. Since fluorescence is described in the 
previous parts, phosphorescence and afterglow will be explained here. The lifetime 
of fluorescence is approximately 10-8 s, however, in the phosphorescence; it reaches 
to milliseconds even seconds. Phosphorescence is known as a spin-forbidden 
process. When an electron absorbs energy, it goes to higher energy levels in the first 
singlet excited state. Then, upon spin conversion, this electron goes to triplet state via 
intersystem crossing and then does phosphorescence while going back to the ground 
state. 
 
	  
Figure 56. Schematic representation of energy diagram for fluorescence, phosphorescence 
and afterglow. 
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In the persistent luminescence, sometimes mixed with phosphorescence, the stored 
excitation energy by traps is released slowly and thermally to emitting centers and 
the light emission can last for hours.123 The excitation sources can be visible or 
ultraviolet (UV) light or X-rays, etc. The “persistent luminescence” event dates back 
to 17th century.124 Although the ancient Chinese paintings described the persistent 
luminescence obtained by combining the colors with a different type of pearl shell, 
first scientific description was made by Italian shoemaker and alchemist V. 
Casciarolo in 1602. He discovered the intense luminescence caused by a mineral 
barite, BaSO4, known as Bologna Stone. At first, it was thought that barium sulfate is 
the main reason, however, actually the reason why this stone luminesce for hours is 
the natural impurities like monovalent copper. The interest for persistent 
luminescence was intensified by the end of 20th century. For example, zinc sulfide 
doped with copper or cobalt has been used commercially for glow-in-dark products 
or paintings.125 To increase the usage of these products for practical goals, the 
duration of the luminescence as well as the brightness should be improved. In this 
sense, radioactive elements (promethium, tritium) were incorporated in these 
materials, however, to achieve reasonable brightness, considerable amount of 
material should be used. In the persistent luminescence compounds, generally, rare 
earth ions are introduced as dopants in the host lattice to activate inorganic host 
matrix.124 Matsuzawa and coworkers reported green-emitting afterglow SrAl2O4:Eu2+ 
codoped with the rare earth dysprosium (Dy3+) showing long-lasting bright emission 
after cessation of excitation source.126 This material showed superior properties 
compared to ZnS:Cu,Co. After their work, lots of publications have reported 
afterglow materials with different properties. These studies showed that in persistent 
luminescent materials, there are two centers named as emitters and traps. Emitters 
are responsible for radiation emitting after excitation, while traps, which can be 
lattice defects or codopants, are present to store and then release the excitation 
energy. Thus, it can be stated that the emitters determine the emission wavelength 
and traps are responsible for the observed intensity and duration of afterglow.127 As a 
result, near-IR persistent luminescent materials are generally have a proper emitter 
being able to emit near-IR light and an appropriate host having capacity for 
generating traps and boosting the persistence of the afterglow. The brightness and 
58	  
	  
duration of the afterglow materials are dependent on many factors such as codoping 
with rare earth, choice of starting material, dopant and codopant concentration, etc.128 
2.6.8.1. Persistent Luminescent Nanoparticles 
Optical imaging probes have attracted great attention for biomedical applications. In 
this type of imaging, light is used to activate the luminescent component in tissues 
and detection is done with capturing the transmitted or reflected light.129 
Developments in optical techniques have brought optical imaging to a convincing 
method for biomedical applications. Although optical probes offers significant 
outputs in early detection that is an essential item for the timely diagnosis and 
efficacious treatment of all cancer types, conventional optical probes suffer from 
some limitations for practical use. Cytotoxicity, poor signal-to-noise ratio from tissue 
autofluorescence under external light, cell death resulting from short-wavelength 
irradiation are some of the drawbacks.130 To overcome such problematic issues, 
persistent luminescent nanoparticles (PLNPs) arise as optical imaging tool. These 
materials are capable of luminescence several hours after irradiation source has been 
switched off. The irradiation source can be UV or visible light. Optical excitation 
before injection is another promising property of these materials. Improved signal-to-
noise ratio is achieved because of the removal of background fluorescence caused by 
in situ excitation and deep penetration is achieved. Thus, real-time monitoring 
becomes feasible and these materials with their unique properties draw attention for 
biological applications. However, in the literature, the use of PLNPs in biological 
applications is limited maybe due to the difficulty in the synthesis of these materials. 
The synthesis of PLNPs requires high temperature and yields are generally very low.  
	  
Figure 57. PLNPs in in vivo imaging.131 
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In 2007, Scherman et. al. reported red emitting PLNP whose composition is 
Ca0.2Zn0.9Mg0.9Si2O6 doped with Eu2+, Dy3+ and Mn2+.131 In this work, nanometric 
size red emitting long lasting afterglow was first described and in vivo imaging 
studies were shown successfully. These nanoparticles were used in real-time 
monitoring of living mice for more than 1 hour after intravenous injection without 
any external excitation. These nanoparticles showed very narrow size distribution 
between 50-100 nm and the emission intensity is centered at 690 nm. After synthesis 
of PLNPs, surface modification was performed to explore the biodistribution 
properties. For this purpose, hydroxy-functionalized NPs were coated with amino, 
carboxyl and polyethylene (PEG) groups. The accumulation and circulation time is 
changed according to the type of modification.  
 
	  
Figure 58. Modification of PLNP with biotin and Rak-2. 
In another work, Scherman and coworkers further developed these PEG containing 
nanoparticles with attaching targeting groups to increase the accumulation in targeted 
tissue.132 They used two different small targeting moieties which are biotin and Rak-
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2. (Figure 58) Biotin functionalized PEG containing PLNP showed affinity to 
streptavidin coated plate and Rak-2 demonstrated affinity towards PC-3 cells. After 
characterization of modified nanoparticles by different methods, in vitro studies were 
conducted. These studies showed that PLNP-PEG-Biotin conjugate binds to 
streptavidin plate and PLNP-PEG-Rak-2 conjugate binds to prostate cancer cells. 
 
	  
Figure 59. Schematic demonstration of the FRET based inhibition assay for AFP using 
PLNPs. 
Another important work was described by Yan group shown in Figure 59.133 In this 
study, water soluble PLNPs whose composition is Ca1.86Mg0.14ZnSi2O7 doped with 
Eu2+ and Dy3+ were used to get FRET based inhibition assay for α-fetoprotein (AFP) 
excreted during cancer cell growth. AFP is known as serum biomarker for 
hepatocellular carcinoma (HCC) in which survival rates are very low due to the 
difficulty in prognosis. Rapid liver cancer cell growth and cirrhosis increases the 
level of AFP so detection of the AFP allows the early diagnosis of HCC. Due to the 
spectral overlap between emissions of polyethylene imine coated PLNPs which is 
positively charged and absorbance of antibody coated gold nanoparticles which is 
negatively charged, FRET process occurs. After interaction between AFP, FRET 
process is blocked, thus, the emission from PLNPs were observed. 
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CHAPTER 3 
Rational Design of Ion Responsive, Isomeric Near- 
IR BODIPY Dyes 
 
This work is partially described in the following publication: 
Ozdemir, T.;   Kostereli, Z.;   Guliyev, R.;   Yalcin, S.;   Dede, Y.; Akkaya, E. U. RSC Adv., 
2014,4, 14915-14918. 
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 Objective 3.1.
Tetrastyryl-substituted BODIPY dyes are likely to evolve into a new class of near IR 
fluorophores.  In this work we demonstrate that 1,7 and 3,5-positions show marked 
differences in charge transfer characteristics.  Using a Hg (II) selective ligand, the 
signal transduction potentials were explored:  One isomer shows a large blue shift in 
electronic absorption spectrum, while the other just shows an intensity increase in the 
emission spectrum.  Electronic structure calculations were undertaken to elucidate 
the reasons for different signals on metal ion binding in relation to core BODIPY 
properties. 
 
 Introduction 3.2.
Fluorescent dyes exhibiting near-IR absorption and emission are rare,134-136 and 
considering their potential utility in many fields such as biological imaging,137 
photodynamic therapy,138 light harvesters,139 solar cells,140 there is a strong 
motivation for developing such organic compounds.  Longer wavelength emitting 
fluorescent dyes are relatively free from background signals, resulting either from 
Rayleigh scattering or autofluorescence in biological media.141 BODIPY dyes are 
truly unique in their capacity for chemical modifications at all positions of the parent 
dye.40  Derivatization at the 1,3,5,7 positions via Knoevenagel condensation results 
in large bathochromic shifts, pushing the S0→S1 absorption band towards near IR.  
Recently, tetra-styryl BODIPY derivatives have been successfully synthesized and 
shown to be stable chromophores with reasonable fluorescence quantum yields. 
Following our initial report,43 quadruple Knoevenagel condensation on 1,3,5,7-
tetramethyl BODIPY dyes has become a well-established protocol and even 
controlled sequential reaction of methyl groups at these positions with different 
aldehydes being demonstrated.45 Tetrastyryl-BODIPYs are now very well-positioned 
to become a structurally flexible class of near IR dyes.    
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In the present work, our aim was to explore the ion signaling potential of the dyes 
with charge donor ligands placed in conjugation at 1,7 versus 3,5 positions of the 
BODIPYs, i.e., four isomeric tetra-stryryl BODIPY compounds which were 
functionalized with Hg(II) selective dithiaazacrown ligands (Figure 60).  
   
 
Figure 60. Structures of target compounds 1, 2, 3, 4 (Copyright © 2014, Royal Society of 
Chemistry, Reprinted with permission from ref (142)).142 
 Results and Discussions 3.3.
These derivatives were readily synthesized based on already established protocols 
(Figure 61). Appropriate aromatic aldehydes undergo Knoevenagel reaction in the 
presence of acetic acid and piperidine using a Dean-Stark trap. Besides, being a 
convenient and efficient reaction, Knoevenagel condensation gives reasonable yields.  
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Figure 61. Synthesis of target compounds (Copyright © 2014, Royal Society of Chemistry, 
Reprinted with permission from ref (142)). 
Investigation of the electronic absorption and fluorescence spectra of the isomeric 
probes reveals a very different spectral response pattern regarding ion response. In 
electronic absorption spectra, an impressive hypsochromic shift was observed for 1 
in response to Hg (II) ions (Figure 62). Initially, the absorbance band has a peak 
centered at 800 nm in THF and upon the addition of Hg (II) ions, a blue shift is 
observed and the peak maximum moves to 715 nm. Also, when excited at 710 nm, 
the emission intensity is essentially switched on, from a non-fluorescent state to a 
brightly fluorescent metal ion complex.  Since the ligand of our choice, the 
dithiaazacrown, is known to be highly Hg (II) selective,13 other metal ions do not 
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interfere and thus, there is no change in either electronic absorption or fluorescence 
spectra	  
 
 
 
 
 
 
 
 
 
Figure 62.  Electronic absorption and emission spectra of 1 (0.5 µM) in THF in absence and 
presence of various metal ions. Added metal ion concentrations were 5 µM. Excitation 
wavelength was 710 nm (Copyright © 2014, Royal Society of Chemistry, Reprinted with 
permission from ref (142)). 
under the experimental conditions of the study. Thus, we have a highly selective 
chemosensor for Hg (II) operating at near IR region of the spectrum.  
Surprisingly, electronic absorption spectrum of isomer 2 shows a peak at 745 nm and 
the addition of Hg (II) ions does not alter the electronic absorption  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 63.  Electronic absorption and emission spectra of 2 (1.0 µM) in THF in absence and 
presence of various metal ions. Added metal ion concentrations were 10 µM. Excitation 
wavelength is 725 nm (Copyright © 2014, Royal Society of Chemistry, Reprinted with 
permission from ref (142)). 
characteristics. However, just like the isomer 1, emission intensity of 2 shows a 
remarkable increase (excitation wavelength is 725 nm). Similarly, as a well-known 
Hg (II) specific ligand, dithiaazacrown moeity does not respond to other metal ions 
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(Figure 63). Data for comPeTition/interference experiments with isomers 1 and 2 
(using Hg (II) and selected metal ions) are given in Figure 64 and Figure 65. 
 
	  
Figure 64. Emission intensity response of 1 (0.5 µM) , with 5 µM of a comPeTing metal ion 
followed by addition of 5 µM Hg2+ in THF.Excitation wavelength was 710 nm with a slit 
width of 5-5 nm (Copyright © 2014, Royal Society of Chemistry, Reprinted with permission 
from ref (142)). 
	  
Figure 65. Emission intensity response of 2 (1.0 µM) with 10 µM of a comPeTing metal ion 
followed by addition of 10 µM Hg2+ in THF. Excitation wavelength was 725 nm with a slit 
width of 5-5 nm (Copyright © 2014, Royal Society of Chemistry, Reprinted with permission 
from ref (142)). 
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Water soluble fluorescent probes are especially in high demand for biological 
applications. To that end, polyethylene glycol (PEG) and triethylene glycol groups 
were attached to BODIPY unit via Knoevenagel condensation reactions, compound 3 
and 4 were obtained with adequate yields. Electronic absorption and emission spectra 
in aqueous solutions (10 mM HEPES: CH3CN, 50:50, v/v, pH=7.2, 25 °C) of probes 
showed results in accordance with the organic soluble counterparts (Figure 66 and 
Figure 67). 
Figure 66. The electronic absorption and emission spectra of 3 (1.9 µM)  in presence of 
excess Hg(II) in 10 mM HEPES:CH3CN (50:50, v/v, pH=7.20, 25 °C). (excitation 
wavelength =730 nm) (Copyright © 2014, Royal Society of Chemistry, Reprinted with 
permission from ref (142)). 
	  
Figure 67. The electronic absorption and emission spectra of 4 (2.8 µM)  in presence of 
excess Hg(II) in 10 mM HEPES:CH3CN(50:50, v/v, pH=7.20,25°C) (Copyright © 2014, 
Royal Society of Chemistry, Reprinted with permission from ref (142)).	  
To determine binding constants, isothermal titration calorimetry (ITC) was 
performed.  Based on the inflection point in the titration curve (heat vs. molar ratio of 
metal ion to ligand), the stoichiometry of complexation was determined.  
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Table 1. Binding Constants Determined by Isothermal Titration Calorimetry (ITC) 
for compound 3 and 4 (Copyright © 2014, Royal Society of Chemistry, Reprinted 
with permission from ref (142)). 
Compound K 
(M-1) 
 
∆H 
(kcal/mol) 
∆S 
cal/(mol · K) 
model 
3 (1:1 binding) (7.15±1.95)x105 -1.82 x104±1.03 
x103 
-34.2 One set of 
sites 
3 (1:2 binding) 4.43 x104±6.90 
x103 
-8288±514 -6.53 Two sets of 
sites 
4 (1:1 binding) (7.23±1.41)x106 -2.64 x104±682 -57.4 One set of 
sites 
4 (1:2 binding) 2.0 x105±2.5 x104 -1.27 x104±285 -18.6 Two sets of 
sites 
 
Table 1 describes the binding characteristics for isomers 3 and 4. These water soluble 
isomeric compounds showed 1:2 complex in acetonitrile as expected (Fig. 68). 
 
 
	  
 
 
 
 
 
 
 
 
Figure 68. Calorimetric binding isotherm for the compound 3 (right, 0.4 mM 3 titrated with 
5 mM Hg(ClO4)2) and 4 (left, 0.14 mM 4 titrated with 2 mM Hg(ClO4)2) in acetonitrile 
(Copyright © 2014, Royal Society of Chemistry, Reprinted with permission from ref (142)). 
 
 Significantly different spectral responses of 1 and 2 to Hg (II) binding indicate an 
electronic structure difference among the two probes. Theoretical studies employing 
the Time-Dependent (TD) formalism of Density Functional Theory (DFT) were 
performed to gain insight	  into the excitation characteristics and fluorescence turn on 
of 1 and 2. The presumed impact of structural differences of 1 and 2 on emission 
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characteristics were studied by constructing the models 1a and 2a (Figure 69). Effect 
of metal binding was 
	  
Figure 69. Computational models (Copyright © 2014, Royal Society of Chemistry, 
Reprinted with permission from ref (142)). 
investigated via protonation at N1 (1aH and 2aH). TD-DFT results (Figures 70, 71 
and Table 2) are in good agreement with the spectroscopic measurements and reveal 
that the fluorescence turn on is due to extinguishing the electron density on N1 lone 
pair upon metal binding. Note that the dative N1:→Hg (II) bonding diminishes the 
n→π* contribution to the S0→S1 excitation. Consequently any input  
 
 
Figure 70. Computed absorption spectra. (Experimental values in parentheses) (Copyright © 
2014, Royal Society of Chemistry, Reprinted with permission from ref (142)). 
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Table 2. Summary of TDDFT Results a (Copyright © 2014, Royal Society of 
Chemistry, Reprinted with permission from ref (142)). 
 
Species Major transitions & orbital contributions 
ΔE 
(eV) 
λCOMP 
(nm) 
λEXP 
(nm) 
Oscillator 
strength 
1a 
237A→238A 0.625 1.51 821 798 1.103 
236A→238A 0.665 1.94 640 584 1.137 
237A→240A 0.675 2.85 436 470 1.325 
1aH 237A→238A 0.621 1.68 739 706 1.185 
2a 
237A→238A 0.629 1.56 797 740 1.141 
236A→238A 0.670 1.82 683 - 0.811 
232A→238A 
237A→239A 
237A→240A 
-0.369 
0.466 
-0.274 
2.90 427 403 0.820 
2aH 
237A→238A 0.615 1.61 769 744 1.132 
236A→238A 0.662 2.22 558 - 0.911 
237A→239A 
234A→238A 
0.579 
0.329 2.71 458 410 0.709 
237A→241A 0.616 3.24 382 - 0.918 
a Experimental values belong to 1 and 2. 
 
(metal or proton) able to utilize the N1 lone pair in binding is well suitable for 
fluorescence turn on. Understanding different spectral responses requires a simple, 
yet fundamental approach. Considering the decisive role of the position of 
substitution on BODIPY core, we compared the frontier MO energies of di- and 
tetra-styryl substituted BODIPY derivatives (Table 1). Remarkably, 3,5 substitution 
was superior to 1,7 in altering the HOMO – LUMO gap of BODIPY, mainly by 
destabilization of HOMO. Improvement by obtaining the tetra-styryl derivative was 
minor when compared to 3,5-distyrylBODIPY. Thus, 3 and 5 positions are more 
important when perturbations to the electronic structure are sought however, this 
observation can be traced back to fundamental features of BODIPY core. 
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Figure 71. MO plots and energies (eV) for transitions with high oscillator strength 
(Copyright © 2014, Royal Society of Chemistry, Reprinted with permission from ref (142)). 
 
 
Comparison of MO plots for di- and tetra-styryl derivatives (Table 3) reveals that 
extension of the π-system at 3,5-positions preserves the character of HOMO of 
BODIPY core whereas 1,7-modification yields  a HOMO with a different character 
than BODIPY HOMO. Moreover, BODIPY HOMO hosts more electronic density at 
3 and 5 positions than 1 and 7 which gives rise to an increased Coulombic repulsion 
that destabilizes the HOMO. The aforementioned difference in destabilization of 
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HOMO (Table 3) is thus justified. Consequently, electronic structure of 1a upon 
proton or cation binding experiences larger perturbations than 2a and this is also the 
case for 1 when compared to 2. Therefore the discrepancy in the absorption shifts of 
1 and 2 is mainly due to the π-system of BODIPY core treating the charge injections 
unequally, i.e. as dictated by the spatial distribution of HOMO. 
Table 3. MO Plots and Energies (eV) of BODIPY and Styryl-Substituted Derivatives at 
UB3LYP/cc-pVTZ//6-31G(d) Level of Theory (Copyright © 2014, Royal Society of 
Chemistry, Reprinted with permission from ref (142)). 
MO BODIPY 3,5-distyryl BODIPY 
1,7-distyryl 
BODIPY 
1,3,5,7-tetrastyryl 
BODIPY 
LUMO  
-3.2 
 
-3.1 
 
-3.3 
 
-3.2 
HOMO  
-6.3 
 
-5.3 
 
-5.7 
 
-5.2 
ΔE 
HOMO-LUMO 3.1 2.2 2.4 2.0 
 
 
 Conclusion 3.4.
In conclusion, we demonstrated that tetrastyryl- BODIPY dyes can be derivatized to 
yield ion responsive compounds functioning in the near IR wavelengths.  Also, we 
provided the first examples of divergent ion response resulting from a difference in 
the locations of styryl-linked donor groups on the BODIPY core and the impact of 
their changing charge donation properties on ion binding. Principles underlying 
different spectroscopic properties and fluorescence turn on response are explained 
via orbital analysis. It is very likely that these stable and near IR emissive probes, or 
others built upon the ideas developed here will be quickly added to growing arsenal 
of ion probes successfully interrogating cellular events, or monitoring environmental 
parameters. 
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 Experimental Details 3.5.
General: 1H NMR and 13C NMR spectra were recorded on Bruker DPX-400 
(operating at 400 MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 with 
tetramethylsilane as internal standard. All spectra were recorded at 250C and 
coupling constants (J values) are given in Hz.  Chemical shifts are given in parts per 
million (ppm). Absorption spectra were performed by using a Varian Cary-100 
spectrophotometer. Fluorescence measurements were conducted on a Varian Eclipse 
spectrofluorometer. Mass spectra were recorded on Agilent Technologies 6530 
Accurate-Mass Q-TOF LC/MS. Reactions were monitored by thin layer 
chromatography using Merck TLC Silica gel 60 F254. Silica gel column 
chromatography was performed over Merck Silica gel 60 (particle size: 0.040-0.063 
mm, 230-400 mesh ASTM). Compounds 5,13 6,143 943 and PEG2000-N3143 were 
synthesized according to literature. All other reagents and solvents were purchased 
from Aldrich and used without further purification. For a typical ITC run, the 
instrument chamber (200 µL) contained a solution of a  ligand (0.125 mM) while a 
2.5 mM solution of Hg(ClO4)2 was taken up  in a 40 µL injection syringe. The 
syringe was assembled into the chamber for equilibration while stirring at 750 rpm. 
The chamber temperature was set to 25 °C. The injections were programmed at 0.5 
µL each, added over 3 sec and spaced 2 min apart.144 Association enthalpy  (∆H° in 
cal/mol), “number of sites” (N), and association constant (K in M-1) were obtained 
by  fitting the titration data using the “Two Set of Sites model” algorithm provided in 
the S3  MicroCal Origin Software package (version 7.0). Association entropy (∆S in 
cal/mol/K) is calculated from fitted values of ∆Hº and K. 
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Synthesis of Compound 7: 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, Compound 5 (0.137 
mmol, 130 mg) and compound 6 (0.342 mmol, 121 mg) piperidine (0.3 ml) and 
acetic acid (0.3 ml) were added. The mixture was heated under reflux by using a 
Dean Stark trap and progress of the reaction was monitored by TLC 
dichloromethane. When all the starting material had been consumed, the mixture was 
cooled to room temperature and solvent was evaporated. Water (100 ml) added to the 
residue and the product was extracted into the chloroform (3 x 100 ml).  Organic 
phase dried over Na2SO4, evaporated and residue was purified by silica gel column 
chromatography using dichloromethane as the eluent. (144 mg, 65%).1H NMR (400 
MHz, Chloroform-d) δ 8.48 (d, J = 16.0 Hz, 2H), 7.69 (d, J = 16.1 Hz, 2H), 7.61 (d, 
J = 8.7 Hz, 4H), 7.48 (d, J = 8.4 Hz, 4H), 7.42 (d, J = 8.5 Hz, 4H), 6.73 (d, J = 8.5 
Hz, 4H), 6.59 (s, 1H), 6.49 (s, 2H), 3.97 (t, J = 6.6 Hz, 4H), 3.84 (t, J = 8.0 Hz, 8H), 
3.74 (m, 8H), 3.68 (s, 8H), 2.97 (m, 8H), 2.84 – 2.78 (m, 8H), 1.78 (m, 10H), 1.51 - 
1.31 (m, 48H), 0.9 (t, 6H). 
Synthesis of Compound 1: 
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In a 100 ml round-bottomed flask containing 50 ml benzene, Compound 7 (0.023 
mmol, 40 mg) and p-anisaldehyde (0.14 mmol, 18 mg) piperidine (0.3 ml) and acetic 
acid (0.3 ml) were added. The mixture was heated under reflux by using a Dean 
Stark trap and progress of the reaction was monitored by TLC chloroform. When all 
the starting material had been consumed, the mixture was cooled to room 
temperature and solvent was evaporated. Water (100 ml) added to the residue and the 
product was extracted into the chloroform (3 x 100 ml).  Organic phase dried over 
Na2SO4, evaporated and residue was purified by silica gel column chromatography 
using chloroform as the eluent. (15 mg, 34%).1H NMR (400 MHz, Chloroform-d) δ 
8.58 (d, J = 16.2 Hz, 2H), 7.74 (d, J = 16.2 Hz, 4H), 7.65 (d, J= 8.5 Hz, 4H), 7.50 – 
7.46 (m, 4H), 7.45 – 7.39 (m, 4H), 7.06 (d, J = 8.8 Hz, 4H), 6.81 (d, J = 8.8 Hz, 4H), 
6.78 – 6.72 (m, 5H), 6.64 (d, J = 2.3 Hz, 2H), 6.08 (d, J = 16.3 Hz, 2H), 3.89 – 3.83 
(m, 18H), 3.81 – 3.72 (m, 8H), 3.71 – 3.64 (m, 8H), 2.99 (m, 8H), 2.81 (m, 8H), 1.60 
(s, 8H), 1.37 (s, 16H), 1.30 – 1.19 (m, 32H), 0.88 (t, J = 6.8 Hz, 6H). 13C NMR (100 
MHz, CDCl3) δ 161.4, 151.4, 149.7, 147.91, 139.4, 137.1, 133.3, 132.7, 130.4, 
130.4, 129.7, 128.0, 125.7, 125.6, 120.9, 119.4, 113.8, 111.9, 111.4, 111.1, 108.51, 
98.4, 74.2, 70.7, 69.5, 68.6, 55.3, 52.0, 34.8, 31.3, 31.2, 29.7, 29.5, 29.3, 28.9, 25.9, 
14.1. Calcd: 1880.962 [M+Na]+ , Found: 1880.969 [M+Na]+, ∆=3.62 ppm. 
 
Synthesis of Compound 8: 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, Compound 5 (0.053 
mmol, 50 mg) and p-anisaldehyde (0.080 mmol, 10.7 mg) piperidine (0.3 ml) and 
acetic acid (0.3 ml) were added. The mixture was heated under reflux by using a 
Dean Stark trap and progress of the reaction was monitored by TLC chloroform. 
When all the starting material had been consumed, the mixture was cooled to room 
temperature and solvent was evaporated. Water (100 ml) added to the residue and the 
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product was extracted into the chloroform (3 x 100 ml).  Organic phase dried over 
Na2SO4, evaporated and residue was purified by silica gel column chromatography 
using chloroform as the eluent. (34 mg, 55%).1H NMR (400 MHz, Chloroform-d) δ 
8.49 (d, J = 16.2 Hz, 2H), 7.77 (d, J = 16.3 Hz, 2H), 7.67 (d, J = 8.8 Hz, 4H), 7.51 – 
7.45 (m, 4H), 7.45 – 7.38 (m, 4H), 7.00 (d, J = 8.7 Hz, 4H), 6.62 (t, J = 2.3 Hz, 1H), 
6.50 (d, J = 2.2 Hz, 2H), 3.99 (t, J = 6.6 Hz, 4H), 3.90 (s, 6H), 1.81 (m, 10H), 1.54 – 
1.28 (m, 46H), 0.91 (m, 6H). 13C NMR (100 MHz, CDCl3) δ 161.4, 161.2, 160.7, 
152.4, 151.6, 144.6, 138.7, 138.7, 136.4, 132.5, 130.8, 130.5, 130.0, 129.3, 125.5, 
117.0, 114.3, 113.8, 106.7, 102.6, 98.5, 98.3, 83.3, 68.51, 55.4, 34.8, 31.9, 31.2, 29.7, 
29.6, 29.6, 29.6, 29.4, 29.4, 29.2, 22.7, 14.1, 13.1. 
 
Synthesis of Compound 2: 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, compound 8 (0.021 
mmol, 27 mg) and compound 6 (0.124 mmol, 44 mg) piperidine (0.3 ml) and acetic 
acid (0.3 ml) were added. The mixture was heated under reflux by using a Dean 
Stark trap and progress of the reaction was monitored by TLC chloroform. When all 
the starting material had been consumed, the mixture was cooled to room 
temperature and solvent was evaporated. Water (100 ml) added to the residue and the 
product was extracted into the chloroform (3 x 100 ml).  Organic phase dried over 
Na2SO4, evaporated and residue was purified by silica gel column chromatography 
using chloroform as the eluent. (11 mg, 29%).1H NMR (400 MHz, Chloroform-d) δ 
8.55 (d, J = 16.3 Hz, 2H), 7.82 (m, J = 22.1, 16.4 Hz, 4H), 7.69 (d, J = 8.7 Hz, 4H), 
7.49 (d, J = 8.4 Hz, 4H), 7.43 (d, J = 8.4 Hz, 4H), 7.01 (d, J = 8.8 Hz, 8H), 6.82 (s, 
1H), 6.66 (d, J = 2.3 Hz, 2H), 6.57 (s, 4H), 6.05 (d, J = 16.1 Hz, 2H), 3.91-3.63 (m, 
34H), 2.98 – 2.90 (m, 8H), 2.84 – 2.75 (m, 8H), 1.63-1.58 (m, 6H), 1.58- 1.18 (m, 
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44H), 0.91 – 0.80 (m, 6H). 13C NMR (100 MHz, CDCl3) δ 161.6, 161.4, 160.6, 
160.6, 153.2, 151.4, 146.9, 142.6, 138.4, 136.9, 134.6, 132.8, 130.8, 130.4, 130.2, 
129.2, 128.6, 127.8, 125.7, 125.6, 117.4, 117.1, 114.3, 114.1, 111.6, 108.3, 103.4, 
98.5, 86.3, 74.3, 70.8, 70.5, 69.6, 68.7, 55.4, 51.9, 39.2, 34.9, 31.9, 31.3, 31.2, 31.15, 
29.7, 29.7, 29.6, 29.4, 29.4, 29.0, 25.9, 22.7, 14.1, 11.0. Calcd: 951.9757 [M+2Na]+2 
, Found: 951.9921   [M+2Na]+2, ∆=17.25 ppm. 
 
Synthesis of Compound 10: 
 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, Compound 5 (0.12 
mmol, 120 mg) and compound 9 (0.25 mmol, 40 mg) piperidine (0.3 ml) and acetic 
acid (0.3 ml) were added. The mixture was heated under reflux by using a Dean 
Stark trap and progress of the reaction was monitored by TLC chloroform. When all 
the starting material had been consumed, the mixture was cooled to room 
temperature and solvent was evaporated. Water (100 ml) added to the residue and the 
product was extracted into the chloroform (3 x 100 ml).  Organic phase dried over 
Na2SO4, evaporated and residue was used without further purification. 
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Synthesis of Compound 11: 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, compound 10 (0.081 
mmol, 100 mg) and compound 6 (0.24 mmol, 86 mg) piperidine (0.3 ml) and acetic 
acid (0.3 ml) were added. The mixture was heated under reflux by using a Dean 
Stark trap and progress of the reaction was monitored by TLC 3:1 Chloroform: 
Hexane. When all the starting material had been consumed, the mixture was cooled 
to room temperature and solvent was evaporated. Water (100 ml) added to the 
residue and the product was extracted into the chloroform (3 x 100 ml).  Organic 
phase dried over Na2SO4, evaporated and residue was purified by silica gel column 
chromatography using 3:1 CHCl3: Hexanes as the eluent. (94 mg, 60%). 1H NMR 
(400 MHz, Chloroform-d) δ 8.54 (d, J = 15.9 Hz, 2H), 7.82 (t, J = 18.1 Hz, 4H), 7.76 
– 7.62 (m, 6H), 7.55 (dd, J = 5.7, 3.3 Hz, 2H), 7.52 – 7.46 (m, 2H), 7.43 (d, J = 8.5 
Hz, 4H), 7.09 (d, J = 8.9 Hz, 4H), 7.01 (d, J = 8.3 Hz, 4H), 6.82 (s, 1H), 6.65 (d, J = 
2.3 Hz, 2H), 6.57 (s, 4H), 6.06 (s, 2H), 4.80 (d, J = 2.5 Hz, 4H), 4.23 (m,4H), 3.87 
(m, 8H), 3.69 (s, 16H), 2.94 (m, 8H), 2.81 (t, J = 5.1 Hz, 8H), 2.60 (t, J = 2.4 Hz, 
2H), 1.78 (m, 4H), 1.51 - 1.31 (m, 46H), 0.9 (t, J = 6.8 Hz, 6H).13C NMR (100 MHz, 
CDCl3) δ 169.7, 167.8, 161.6, 158.4, 151.5, 132.8, 132.5, 131.0, 130.9, 130.4, 129.2, 
128.8, 128.6, 127.8, 125.7, 120.8, 117.6, 115.3, 115.1, 108.2, 103.4, 98.6, 86.1, 78.4, 
75.8, 74.3, 70.8, 68.7, 68.2, 55.9, 52.4, 52.1, 38.7, 34.9, 31.9, 31.4, 31.2, 31.1, 29.7, 
29.6, 29.6, 29.4, 29.0, 28.9, 25.9, 23.7, 22.9, 22.7. Calcd: 1928.962 [M+Na]+ , 
Found: 1928.968 [M+Na]+, ∆=3.07 ppm. 
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Synthesis of Compound 3: 
 
To the solution of the compound 11 (0.017 mmol, 32 mg) in a 6:0.5:0.5 mixture of 
CHCl3, EtOH and water; PEG2000-N3 (0.033 mmol, 67 mg), 0.16 mg sodium 
ascorbate, 0.1 mg CuSO4 and 3-4 drop Et3N are added and it was stirred at room 
temperature for 24 h. Water (50 ml) was added to the residue and the product was 
extracted into the chloroform (3 x 50 ml). (76 mg, 75%). 1H NMR (400 MHz, 
Chloroform-d) δ 8.53 (d, J = 16.3 Hz, 2H), 7.92 (s, 2H), 7.83 (d, J = 8.5 Hz, 2H), 
7.81 (d, J = 8.5 Hz, 2H), 7.77 – 7.65 (m, 6H), 7.54 (m, 2H), 7.5-7.4 (m,  6H), 7.12 
(m, 4H), 6.99 (d, J = 8.4 Hz, 4H), 6.81 (s, 1H), 6.64 (s, 2H), 6.54 (s, 2H), 6.04 (d, J = 
15.9 Hz, 2H), 5.35 (s, 4H), 4.59 (t, J= 5.0 Hz, 4H), 4.31 – 4.11 (m, 6H), 3.97 –3.39 
(s, 225H), 2.92 (s, 8H), 2.80 (s, 8H), 2.24 (s, 4H), 1.65 (m, 4H), 1.49 – 1.01 (m, 
40H), 1.01 – 0.70 (m, 6H). 13C NMR (100 MHz, CDCl3) δ 167.7, 161.6, 159.2, 
151.5, 147.0, 130.9, 130.6, 130.4, 129.2, 128.8, 128.6, 125.7, 120.9, 115.3, 115.2, 
111.7, 108.3, 98.5, 86.2, 74.2, 71.9, 70.6, 68.2, 62.1, 59.0, 51.9, 50.7, 50.4, 38.7, 
31.9, 31.9, 31.3, 31.2, 29.7, 29.6, 29.6, 29.4, 29.4, 29.0, 28.9, 25.9, 23.7, 22.9, 22.69, 
14.1, 14.0, 10.9. MALDI: Distribution around 6000 with separation of 45 
corresponding to ethylene glycol unit. 
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Synthesis of Compound 4: 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, compound 7 (0.092 
mmol, 150 mg) and compound 12 (0.27 mmol, 164 mg) piperidine (0.3 ml) and 
acetic acid (0.3 ml) were added. The mixture was heated under reflux by using a 
Dean Stark trap and progress of the reaction was monitored by TLC 10% Methanol: 
Dichloromethane. When all the starting material had been consumed, the mixture 
was cooled to room temperature and solvent was evaporated. Water (100 ml) added 
to the residue and the product was extracted into the chloroform (3 x 100 ml).  
Organic phase dried over Na2SO4, evaporated and residue was purified by silica gel 
column chromatography using 10% Methanol: Dichloromethane as the eluent. (87 
mg, 34%). 1H NMR (400 MHz, Chloroform-d) δ 8.58 (d, J = 16.1 Hz, 2H), 7.71 (d, J 
= 16.1 Hz, 2H), 7.63 (s, 4H), 7.46 (d, J = 8.2 Hz, 4H), 7.40 (d, J = 8.3 Hz, 4H), 6.74 
(d, J = 8.4 Hz, 4H), 6.61 (s, 2H), 6.52 (s, 1H), 6.32 (s, 2H), 5.90 (d, J = 16.1 Hz, 2H), 
5.66 (s, 4H), 4.16 (t, J = 5.2 Hz, 6H), 4.10 (s, 10H), 3.84-3.37 (m, 102H), 2.97 (t, J = 
8.0 Hz, 8H), 2.80 (t, J = 5.2 Hz, 8H), 1.47-1.12 (m, 50H), 0.85 (t, J = 6.8 Hz, 6H). 
13C NMR (100 MHz, CDCl3) δ 160.9, 153.5, 152.7, 151.6, 148.0, 141.3, 139.6, 
138.6, 136.9, 135.3, 134.0, 132.8, 130.5, 129.8, 129.3, 128.4, 125.6, 124.0, 120.8, 
120.3, 114.6, 112.0, 109.1, 108.1, 105.6, 98.6, 86.2, 74.2, 72.5, 71.9, 70.7, 70.6, 70.6, 
69.8, 68.8, 59.0, 52.0, 34.9, 31.9, 31.4, 31.2, 29.6, 29.3, 29.0, 25.8, 22.7, 14.1. Calcd: 
2793.4763 [M+Na]+ , Found: 2793.4909   [M+Na]+, ∆=5.23 ppm. 
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Computational Details 
 
Density Functional Theory employing the unrestricted B3LYP145,146 hybrid 
functional is used throughout.	   Geometries were fully optimized with CEP-31G 
basis.147 The choice of basis can be justified considering the system size and 
extensive benchmarking from literature.148 Excitation energy and characteristics were 
probed via TDDFT. Solvent environment was treated as a dielectric medium 
(εTHF=7.43) using polarizable continuum model (PCM) as implemented in 
Gaussian03. No restrictions on symmetry were imposed. 
Styryl derivatives of BODIPY were modelled to study the effect of position of 
charge injection on the HOMO-LUMO gap. These species were optimized using 
Pople’sall electron 6-31G149 basis including d-type polarization functions. 
Vibrational frequencies (all positive) confirmed the species to be true minima. Single 
point energy refinements were performed using Dunning type triple-ζ basis (cc-
pVTZ).150 All molecular orbitals are plotted at an isosurface value of 0.04 A.U. All 
calculations were carried out with Gaussian 03 (D.01).150 
We are grateful to TUBITAK ULAKBIM (TR-Grid infrastructure) and to Gazi 
University Physics Department (pizag cluster) for computing resources. 
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CHAPTER 4 
Dendritic Energy Transfer and Determination of 
Energy Transfer Based on Tetra-Styryl BODIPY 
Derivatives 
 
 
 
This work is partially described in the following publication: 
Kostereli, Z.; Ozdemir, T.; Buyukcakir, O.; Akkaya, E.U.  Org. Lett., 2012, 14 , 
3636–3639. 
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 Objective 4.1.
Versatile BODIPY dyes can be transformed into bright near-IR emitting 
fluorophores by quadruple-styryl substitutions. We demonstrated that by leaving 
clickable functionalities on the styryl moieties, an efficient synthesis of a light 
harvester is possible. In addition, we present clear spectral evidence showing that in 
dendritic light harvesters, calculations very commonly based on quantum yield or 
emission lifetime changes of the donor are bound to yield large overestimations of 
energy transfer efficiency. 
 
 
 Introduction 4.2.
Efficient harvesting of solar radiation requires judiciously designed absorbers, 
considering the fact that it would be difficult to have a single molecule with strong 
absorptions in the entire visible spectrum and near-IR (perfect black dye). Therefore, 
it makes more sense to seek for multichromophoric dye ensembles. Different 
chromophoric units can be brought together either by covalent linkages or by non-
covalent interactions. In either case, energy transfer from shorter wavelength emitter 
dyes to the longer wavelength emitting core unit is expected. The efficiency of 
energy transfer from the antenna chromophores to the central core is very important. 
In such multichromophoric light harvesters, energy transfer can be either through 
space151 or through bond.18 Through space energy transfer is also possible between 
two or more free chromophoric units. This kind of energy transfer has been studied 
very carefully and in fact, Forster (through space) energy transfer model is built on 
this kind of freely interacting chromophoric pairs. This energy transfer model was 
later on applied to covalently linked multichromophoric light harvesters. In this way, 
energy transfer efficiency is calculated assuming that the bimolecular model system 
can be directly related to energy transfer process in a large covalently linked light 
harvesting system. It has been recognized for some time that these values for energy 
transfer efficiency represent an upper limit and in most cases a significant 
overestimation. 
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We have been interested in light harvesting systems for some time.152,153 In many 
examples, BODIPY chromophores have been utilized either as energy donors or 
energy acceptors. In recent years, brightly emitting BODIPY dyes are in the focus of 
renewed interest with an eye towards to practical applications and new derivatization 
opportunities.154,155 One particular derivatization which already proved to be highly 
fruitful was Knoevenagel condensation of acidic methyl groups found in methyl-
substituted BODIPYs with selected aromatic aldehydes. Mono and di-styryl 
BODIPY compounds were reported in 2001156 and 2006,157 respectively and in 2009, 
our research group reported43 both tri and tetra-styryl BODIPY derivatives. Each 
styryl unit increases π- conjugation further, shifting the main absorption band 
(S0→S1 transition) to lower energy (longer wavelength region). By these simple 
sequences of reactions, absorption band of BODIPY dyes can be easily tuned in the 
range of 500-900 nm. Relative ease of this modification, alone, puts BODIPY 
derivatives in a very previlaged place among organic chromophores.  
 
 Result and Discussion 4.3.
In order to investigate light harvesting properties of near- IR emitting tetra-styryl 
BODIPY dyes, we targeted modular harvesters 8 and 9. The synthesis plan (Figure 
72) makes us of common intermediate 7. Compound 7 is a tetra-styryl dye obtained 
by quadruple Knoevenagel condensation of a previously reported 2,6-disubstituted 
intermediate with four 4-propynyloxybenzaldeyhde. Key intermediate, compound 7 
carries four clickable terminal alkyne groups. This design conveniently allows 
modular attachment of essentially any azide functionalized chromophore. In the 
synthesis of compound 8, we reacted intermediate 7 and 4. For compound 9, modular 
units 6 and 7 were joined together by click chemistry. 
 
Our light harvesting design involves attachment of four shorter wavelength antenna 
units and one central core. Absorbance spectra of compound 4, 6, 7, 8 and 9 are 
shown in Figure 1. As expected, both light harvesters show two major absorption 
bands corresponding to two different chromophores. In compound 8, absorption 
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bands with peaks at 545 and 730 nm are apparent and in compound 9, the two bands 
are centered around 652 and 732 nm. An experimental confirmation of energy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 72. Reaction pathway of target compounds (Copyright © 2012, American Chemical 
Society, Reprinted with permission from ref (158)).158 
transfer is readily obtained by comparing reference modules and the covalently 
assembled light harvesters. Figure 2 and 3 shows such comparisons. Emission 
spectra at equal concentrations of compounds 4 and 8 reveal a significant quenching 
of shorter wavelength BODIPY emission in compound 8. Similar quenching of 
shorter wavelength emission is apparent in compound 9, as well. This is no doubt 
and indicator of energy transfer efficiency. Another commonly employed 
demonstration of energy transfer is based on “enhanced core emission”159 which is 
essentially obtained by exciting longer wavelength emitting modules at a common 
shorter wavelength used for exciting light harvesting system. As an example, 7/8 and 
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7/9 emissions excited at a shorter wavelength peak of 8 or 9, respectively can be 
compared (Figures 73 and 74). It is clear, but also not surprising that emission from 
core is stronger in light harvester 8 and 9 compared to core module 7. Quantitative  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 73. Absorbance spectra of compounds 4, 6, 7, 8 and 9 at equal absorbances in CHCl3, 
at 525 nm for 4 and 8, at 655 nm for 6 and 9, at 730 nm for 7, 8 and 9 (Copyright © 2012, 
American Chemical Society, Reprinted with permission from ref (158)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 74. The emission spectra of 4, 7, and 8 at equal absorbances at 525 nm in CHCl3. 
Inset: Energy transfer from peripheral BODIPY units 4 to tetrastyryl-BODIPY core 7 in light 
harvesting dendrimer 8 (Copyright © 2012, American Chemical Society, Reprinted with 
permission from ref (158)). 
 
calculations of energy transfer can be based on the changes in lifetime or quantum 
yield.4 This is again valid, only if bimolecular energy transfer arguments can be 
easily carried to larger and flexible unimolecular dendritic light harvesters. Spectral 
data and energy transfer rate/efficiencies are presented at Table 4 and Table 5, 
respectively. In light harvesters 8 and 9, again, as expected shorter wavelength 
absorption is stronger with larger extinction coefficients over 300,000. 
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Figure 75. The emission spectra of 6, 7, and 9 at equal absorbances at 655 nm in CHCl3. 
Inset: Energy transfer from di-styryl BODIPY units 4 to tetrastyryl-BODIPY core 7 in light 
harvesting dendrimer 9 (Copyright © 2012, American Chemical Society, Reprinted with 
permission from ref (158)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 76 . Percent energy transfer efficiency of 8 (black solid). Excitation spectrum of 8 
(dot line) and absorption spectrum of 8 (dashed) (normalized at 735 nm) (Copyright © 2012, 
American Chemical Society, Reprinted with permission from ref (158)). 
	  
Figure 77. Percent energy transfer efficiency of 9 (black solid). Excitation spectrum of 9 
(dot line) and absorption spectrum of 9 (dashed) (normalized at 735 nm) (Copyright © 2012, 
American Chemical Society, Reprinted with permission from ref (158)). 
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Emissions from both compounds 8 and 9 are bi-exponential as expected since there is 
always residual emission from the shorter wavelength chromophores in addition to 
longer wavelength emission from the central core (Table 5). Based on the 
significantly reduced emission lifetimes of the donor moieties, we can calculate 90 
and 92% energy transfer efficiency values for light harvesters 8 and 9, respectively. 
Calculations based on quantum yields, also, result in comparable efficiency values. 
However, a simple inspection of excitation spectra suggests that these efficiency 
values are largely overestimated. Same methodology has been used in assessing 
energy transfer efficiencies in a large number of light harvesting molecules, energy 
cascades and energy transfer cassettes.160-162 Recently, in a dendritic light harvester 
designed for solar concentration, we have experimentally demonstrated that in such 
floppy light harvesting arrangements, Förster theory which was originally developed 
for bimolecular energy transfer is not applicable.163 Deviation between energy 
transfer efficiencies calculated by the application of Förster theory and calculations  
Table 4. Spectral data for BODIPY, distyryl-BODIPY and  tetrastyryl-BODIPY dyes and  
light harvesting dendrimers (Copyright © 2012, American Chemical Society, Reprinted with 
permission from ref (158)). 
Compound[a] λabs (nm) λem (nm) Φf[b] εmax[c] 
4 525 537 0.97[d] 76000 
6 655 672 0.67[e] 48000 
7 730 748 0.31[f] 143000 
8 525 733 
 
750 
 
0.089[d] 
 
349000 
202000 
9 655 734 750 0.058
[e] 396000 
186000     
[a] Data acquired in CHCl3 in dilute solutions. [b] relative quantum yields. [c] unit: cm-1M-1. [d] Rhodamine 6G in ethanol (Φf = 
0.95). [e] Sulforhodamine 101 in ethanol (Φf = 0.90). [f] tetra-styryl7 
 
based on excitation spectra can be very large. One simple way of presenting energy 
transfer efficiency as a function of wavelength was proposed by Wittmershaus in 
1998;164 it is a comparison of absorption and excitation spectra, normalized at the 
peak wavelength of absorption of the putative energy acceptor. 
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Table 5. Energy Transfer rate and efficiencies of Light harvesting dendrimers 8 and 9 
(Copyright © 2012, American Chemical Society, Reprinted with permission from ref (158)). 
Compounds [a] λems[nm] τ[ns] ken(Förster) 
 [s-1]  
Efficiency 
8 537 0.13(40%) 
4.84(60%) 
1.97x109  
(1.39x108) 
90 %  
(41%) 
9 672 0.23(24%) 
4.10(76%) 
2.05x109  
(9.56x107) 
92 %  
(30%) 
4 537 5.02   
6 672 4.55   
7 748 3.41   
[a] Data acquired in CHCl3 in dilute solutions. 
In this way, the ratio of excitation to absorption values yields a plot of energy transfer 
efficiency as a function of excitation wavelength.  Figure 76 and Figure 77 show two 
such operations done for the light harvesters 8 and 9. From these ratios plotted as a 
function of wavelength, it is clear that in the region which corresponds to the 
absorption of energy donor (antenna chromophores) energy transfer efficiency is 
actually closer to 20-30%. This discrepancy, as mentioned previously is due to 
availability of additional vibrational and collisional non-radiative decay pathways in 
larger molecules incorporating a number of chromophores tethered with flexible 
linkers. 
 Conclusion 4.4.
A thorough understanding of energy transfer process in large multichromophoric 
systems is quite important but before that is to be done, some persistent 
misunderstandings and mistakes in the literature have to be addressed and corrected. 
We are hoping that a clarification of energy transfer efficiency issue will facilitate the 
design and synthesis of novel and unequivocally more efficient light harvesters and 
solar concentrators. We are also confident that tetra-styryl BODIPY dyes or similarly 
tetra functionalized BODIPY dyes will continue to be at the core of these improved 
light harvesting assemblies. 
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 Experimental Details 4.5.
General: 1H NMR and 13C NMR spectra were recorded on Bruker DPX-400 
(operating at 400 MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 with 
tetramethylsilane as internal standard. All spectra were recorded at 250C and 
coupling constants (J values) are given in Hz. Chemical shifts are given in parts per 
million (ppm). Absorption spectra were performed by using a Varian Cary-100 
spectrophotometer. Fluorescence measurements were conducted on a Varian Eclipse 
spectrofluorometer. Mass spectra were recorded on Agilent Technologies 6530 
Accurate-Mass Q-TOF LC/MS. MALDI mass spectra were recorded at the Izmir 
Institute of Technology, Izmir, Turkey and at the University of Sheffield, Mass 
Spectrometry Service Laboratory, Shieffield, U.K. Reactions were monitored by thin 
layer chromatography using Merck TLC Silica gel 60 F254. Silica gel column 
chromatography was performed over Merck Silica gel 60 (particle size: 0.040-0.063 
mm, 230-400 mesh ASTM). Compounds 1165, 2165 and 543 were synthesized 
according to literature. Anhydrous tetrahydrofuran was obtained by refluxing over 
sodium/benzophenone prior to use. All other reagents and solvents were purchased 
from Aldrich and used without further purification. 
Synthesis of Compound 3:  
 
Argon gas was bubbled through 200ml CH2Cl2 for 30 min then 3-ethyl-2,4-dimethyl 
pyrrole (1035 mg, 8.41 mmol) and compound 2 (1000 mg, 3.5 mmol) were dissolved 
in it under argon atmosphere. 1-2 drop of TFA was added and the solution stirred at 
room temperature nearly 3-4 h and Argon is removed. At this point, a solution of 
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DDQ (794.5 mg, 3.5 mmol) in 50 ml CH2Cl2 was added, stirring was continued for 
30 min followed by the addition of 3 ml Et3N and 3 ml BF3.OEt2. After stirring 30 
min., the reaction mixture was washed three times with water and dried over Na2SO4. 
The solvent was evaporated and the residue was purified by column chromatography 
on silica gel using CHCl3 as the eluent. Dark red solid (606.9 mg, 31%). 1H NMR 
(400 MHz, CDCl3): δ =1.0 (t, J= 7.52, 6H), 1.35 (s, 6H), 1.50-1.60 (m, 4H), 1.81-
1.92 (m, 4H), 2.3 (q, J= 7.56, 4H), 2.55 (s, 6H), 3.59 (t, J= 6.64 Hz, 2H), 4.05 (t, J= 
6.45 Hz, 2H), 7.0 (d, J= 8.56 Hz, 2H), 7.15 (d, J= 8. 56 Hz, 2H). 13C NMR (CDCl3, 
100 MHz, δ ppm) 11.9, 12.5, 14.6, 17.1, 25.4, 26.7, 29.1, 32.5, 44.9, 67.9, 114.9, 
127.8, 129.4, 130.1, 132.6, 138.4, 140.0, 153.5, 159.5 
 
Synthesis of Compound 4:  
 
A mixture of compound 3 (800 mg, 1.43 mmol) and NaN3 (232 mg, 3.576 mmol) in 
20 ml DMSO was heated at 100 oC for 2h and controlled with TLC. When the 
reaction was completed, water (100 ml) was added to the residue and the product was 
extracted into the chloroform (3 x 100 ml). Organic phase dried over Na2SO4, 
evaporated and residue was used without further purification. Dark red solid (702.4 
mg, 97 %). 1H NMR (CDCl3, 400 MHz, δ ppm) δ =1.0 (t, J= 7.52 Hz, 6H), 1.35 (s, 
6H), 1.50-1.60 (m, 4H), 1.62-1.71 (m, 2H), 1.80-1.91 (m, 2H), 2.3 (q, J= 7.56 Hz,  
4H), 2.55 (s, 6H), 3.32 (t, J= 6.64 Hz, 2H),  4.05 (t, J= 6.45 Hz, 2H), 7.0 (d, J= 8.56 
Hz, 2H), 7.15 (d, J= 8.56 Hz, 2H). 13C NMR (CDCl3, 100 MHz, δ ppm) 11.8, 12.5, 
14.6, 17.1, 25.7, 26.6, 28.8, 29,1, 51.4, 67.9, 115.0, 127.8, 129.4, 131.2, 132.6, 138.4, 
140.3, 153.5, 159.5	   MS (TOF- ESI): m/z: : Calcd: 521.3137 [M]+, Found: 
520.30651[M-H]+ , Δ=1.6 ppm. 
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Synthesis of Compound 6:  
 
Compound 4 (200 mg, 0.384 mmol) and 4-Methoxybenzaldehyde (115 mg, 0.844 
mmol) were added to a 100 ml round-bottomed flask containing 50 ml benzene and 
to this solution, piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The mixture 
was heated under reflux by using a Dean Stark trap and it is monitored by TLC. 
When all the starting material had been consumed, the mixture was cooled to room 
temperature and solvent was evaporated. Water (100 ml) added to the residue and the 
product was extracted with the chloroform (3 x 100 ml). The organic phase dried 
over Na2SO4, evaporated The residue was poured into 2:1 EtOAc: Hexanes solution  
and dissolved by heating then it was cooled to 0 0C. Compound 6 precipitated at that 
temperature then it was filtered and obtained as pure product. Green solid (155.1 mg, 
53%). 1H NMR (CDCl3, 400 MHz, δ ppm) 1.20 (t, J= 7.46 Hz, 6H), 1.40 (s, 6H), 
1.50-1.60 (m, 4H), 1.65-1.75 (m, 2H), 1.85-1.95 (m, 2H), 2.65 (q, J= 7.62 Hz,  4H), 
3.35 (t, J= 6.84 Hz, 2H),  3.89 (s, 6H), 4.10 (t, J= 6.40 Hz, 2H), 6.95 (d, J= 8.56 Hz, 
2H), 7.05 (d, J= 8.44 Hz, 2H), 7.23 (d, J=8.44 Hz, 2H), 7.25 (d, J= 16.70 Hz, 2H), 
7.62 (d, J= 8.60 Hz, 2H), 7.70 (d, J= 16.70 Hz, 2H). 13C NMR (CDCl3, 100 MHz, 
δ ppm) 11.7, 14.0, 18.4, 25.7, 26.5, 28.8, 29.1, 51.4, 55.3, 67.9, 114.2, 115.0, 118.2, 
128.1, 128.7, 129.8, 130.3, 133.3, 133.4, 135.2, 138.1, 138.8, 150.3, 159.5, 160.1.  
MS (HRMS-ESI): m/z: : Calcd: 757.4 [M], Found: 757.5 [M-H]+  
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Synthesis of Compound 7:  
 
Compound 5 (400 mg, 0.42 mmol) and compound 1 (472 mg, 2.95 mmol) were 
added to a 100 ml round-bottomed flask containing 50 ml benzene and to this 
solution, piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The mixture was 
heated under reflux by using a Dean Stark trap and it is monitored by TLC 3:2 
Chloroform: Hexane. When all the starting material had been consumed, the mixture 
was cooled to room temperature and solvent was evaporated. Water (100 ml) added 
to the residue and the product was extracted into the chloroform (3 x 100 ml). 
Organic phase dried over Na2SO4, evaporated and residue was purified by silica gel 
column chromatography using 3:2 CHCl3: Hexanes as the eluent.  Dark green solid 
(416 mg, 65%). 1H NMR  (400 MHz, CDCl3): δ = 0.88 (t; J = 6.8 Hz, 6H), 1.18-1.32 
(m; 28H), 1.35 (s; 18H), 1.55-1.65 (m; 4H), 2.55 (t; J = 2.4 Hz, 1H),  2.60 (t; J = 2.4 
Hz, 1H),  3.83 (t; J = 6.5 Hz, 4H), 4.70 (d; J = 2.4 Hz, 4H), 4.80 (d; J = 2.4 Hz, 4H), 
6.10 (d; J = 16.2 Hz, 2H),  6.61 (d; J = 16.2 Hz, 2H), 6.72 (d; J = 2.2 Hz, 1H), 6.89 
(d; J = 8.8 Hz, 4H), 7.02-7.10 (m; 8H),  7.42 (d; J = 8.7 Hz,   4H), 7.48 (d; J = 8.7 
Hz,   4H), 7.70 (d; J = 8.8 Hz,  4H), 7.78 (d; J = 16.3 Hz, 2H), 7.82 (d; J = 17.0 Hz, 
2H), 8.59 (d; J = 16.3 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ =14.1, 22.7, 25.9, 
29.0, 29.3, 29.6, 31.2, 31.9, 34.9, 55.8, 55.9, 68.7, 75.6, 75.9, 78.4, 78.5, 85.7, 98.9, 
103.2, 108.3, 109.0, 114.9, 115.3, 117.4, 119.7, 120.7, 125.7, 128.0, 129.3, 130.5, 
130.9, 131.2, 132.9, 133.7, 136.7, 137.6, 138.8, 142.1, 151.7, 153.4, 157.7, 158.6, 
161.6.  MS (HRMS-ESI): m/z: Calcd: 1516.819 [M+], Found: 1516.798 [M+] , Δ=14 
ppm 
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Synthesis of Compound 8: 
 
 
 
To the solution of the compound 4 (124 mg, 0.238 mmol) in a 12:1:1 mixture of 
CHCl3, EtOH and water (14 ml); compound 7 (60 mg, 0.040 mmol), sodium 
ascorbate (4.7 mg, 0.0237 mmol), CuSO4 (2.9 mg, 0.0118 mmol) and 3-4 drop Et3N 
are added and it was stirred at room temperature for 24 h. Water (50 ml) was added 
to the residue and the product was extracted into the chloroform (3 x 50 ml). After 
evaporation of the solvents, the crude product was purified by column 
chromatography (CHCl3). Black solid (122 mg, 85%). 1H NMR (CDCl3, 400 MHz, 
δ ppm) 0.75 (t, J= 6.76 Hz, 6H), 0.89 (t, J= 8.3 Hz, 24H), 1.05-1.20 (m, 28H), 1.24 
(s, 18H), 1.26 (s, 24H), 1.36 (p, J= 8.39 Hz, 4H), 1.43-1.55 (m, 16H), 1.74 (p, J= 
7.01 Hz, 8H), 1.92 (p, J= 7.34 Hz, 8H), 2.16-2.26 (m, 16H), 2.44 (s, 24H), 3.75 (t, J= 
6.42 Hz, 4H), 3.91 (t, J= 6.24 Hz, 8H), 4.31 (t, J= 6.66 Hz, 8H), 5.14 (s, 4H), 5.22 (s, 
4H), 6.00 (d, J= 16.20 Hz, 2H), 6.53 (s, 2H), 6.62 (s, 1H), 6.80 (d, J= 8.64 Hz, 4H), 
6.89 (d, J= 8.52 Hz, 8H),  6.96 (d, J= 8.72 Hz, 4H), 6.99 (d, J= 8.64 Hz, 4H), 7.02-
7.08 (m, 8H), 7.32 (d, J= 8.60 Hz, 4H), 7.37 (d, J= 8.48 Hz, 4H), 7.52 (s, 2H), 7.56 
(s, 2H),   7.58 (d, J= 8.68 Hz, 4H), 7.69 (d, J= 16.12 Hz, 4H), 8.46 (d, J= 16.40, 2H).  
(CDCl3, 100 MHz, δ ppm) 11.8, 12.4, 14.1, 14.2, 14.6, 17.0, 21.0, 22.6, 25.6, 25.6, 
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25.9, 26.3, 26.4, 28.9, 29.0, 29.1, 29.3, 29.5, 30.2, 30.2, 31.2, 31.9, 50.3, 60.4, 62.2, 
62.2, 67.7, 68.6, 98.9, 114.8, 114.9, 115.2, 120.5, 122.4, 122.5, 125.7, 127.7, 127.8, 
128.1, 129.3, 129.4, 130.4, 131.2, 132.6, 132.6, 136.6, 137.4, 138.3, 138.4, 138.6, 
138.8, 140.3, 140.3, 142.0, 144.0, 153.4, 153.4, 158.4, 159.3, 159.4, 161.6. MS 
(MALDI): m/z: Calcd: 3602.074 [M]+, Found: 3711.572 [M-Ag]+  
Synthesis of Compound 9: 
 
 
 
To the solution of the compound 6 (335 mg, 0.237 mmol) in a 12:1:1 mixture of 
CHCl3, EtOH and water (14 ml); compound 7 (60 mg, 0.0396 mmol), sodium 
ascorbate (4.7 mg, 0.0237 mmol), CuSO4 (2.9 mg, 0.0118 mmol) and 3-4 drop Et3N 
were added and it was stirred at room temperature for 24 h. Water (50 ml) was added 
to the residue and the product was extracted into the chloroform (3 x 50 ml). After 
evaporation of the solvents, the crude product was purified by column 
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chromatography (CHCl3). Black solid (144 mg, 80%). 1H NMR (CDCl3, 400 MHz, 
δ ppm) 0.90 (t, J= 6.90 Hz, 6H), 1.18 (t, J= 7.60 Hz, 24H), 1.19-1.30 (m, 28H), 1.37 
(s, 18H), 1.40 (s, 24H), 1.41-1.50 (m, 4H), 1.52-1.69 (m, 16H), 1.79-1.90 (m, 8H), 
1.95-2.07 (m, 8H), 2.55-2.65 (m, 16H), 3.86-3.90 (m, 28H), 4.09 (t, J= 6.20 Hz, 8H), 
4.42 (t, J= 7.00 Hz, 8H), 5.25 (s, 4H), 5.32 (s, 4H), 6.11 (d, J= 16.13 Hz, 2H), 6.65 
(d, J= 2.04 Hz, 2H), 6.75 (s, 1H), 6.92 (d, J= 8.56 Hz, 4H),  6.95 (d, J= 8.84 Hz, 
16H), 7.01 (d, J= 8.50 Hz, 8H), 7.06 (d, J= 8.72 Hz, 4H), 7.10 (d, J= 8.00 Hz, 4H), 
7.16-7.25 (m, 16H), 7.43 (d, J= 8.52 Hz, 4H),  7.48 (d, J= 8.52 Hz, 4H), 7.59 (d, J= 
8.72 Hz, 16H), 7.63-7.74 (m, 16H), 7.78 (s, 2H), 7.83 (s, 2H), 8.58 (d, J= 16.13, 2H).  
(CDCl3, 100 MHz, δ ppm) 11.7, 14.0, 14.1, 18.4, 22.7, 25.6, 25.6, 25.9, 26.3, 26.4, 
28.9, 29.1, 29.3, 29.5, 30.2, 30.2, 31.2, 31.9, 34.9, 50.3, 55.4, 62.1, 62.2, 62.2, 67.7, 
68.6, 85.7, 98.9, 108.2, 114.2, 114.8, 114.9, 114.9, 115.3, 118.1, 118.2, 119.5, 120.6, 
122.4, 122.6, 122.7, 125.7, 128.0, 128.1, 128.1, 128.7, 129.3, 129.8, 130.3, 130.4, 
133.2, 133.4, 133.8, 135.3, 138.2, 138.9, 142.1, 144.0, 150.3, 151.8, 153.3, 158.4, 
159.1, 159.5, 160.2, 161.6. MS (MALDI): m/z: Calcd: 4546.4 [M+], Found: 4547.0 
[M+] 
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CHAPTER 5 
Coupling ICT Process to Excitation Energy 
Transfer: Improved Stokes Shift for Selective Hg (II) 
Sensing 
 
 
 
 
This work is partially described in the following publication: 
Atilgan, S.; Ozdemir, T.; Akkaya, E.U.  Org. Lett,. 2010, 12, 4792-4795. 
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 Objective 5.1.
Versatile chemistry of the BODIPY chromophore allows modular assembly of an 
excitation energy donor, acceptor and a cation selective ligand in just a couple of 
steps.  The new approach should be applicable in other designs which target 
molecular sensors with large Stokes shift and red to NIR emission. 
 Introduction 5.2.
Ion sensing and signaling continues to be a vibrant field of study.166-168 The signal 
transduction phenomenon, which is at the core of signal generation, is a binding 
event which changes the spectral signature of a particular chromophore or 
fluorophore. In designing a molecular sensor, typically an ion selective ligand is 
incorporated into the structure. The ion binding is then expected to alter either 
ground state or excited state properties to yield a quantifiable signal. This signal in 
many cases will be in the form of a shift in the absorbance spectra or changes in the 
emission characteristics (intensity, lifetime, or position of the emission maximum). 
While some of the selective ion sensors are actually serendipitous discoveries of 
selective interactions of a particular receptor with the analyte in question, it is indeed 
possible to rationally design molecular sensors. To that end, ion-induced changes in 
internal charge transfer (ICT)169,170 or photoinduced electron transfer (PET)171,172 
appear to be very useful. However, other fluorophore characteristics such as Stokes 
shift or brightness (usually defined as the product of quantum yield and the molar 
extinction coefficient) are more difficult to modulate. 
We recently proposed173 a systematic solution addressing this particular problem via 
coupling of excitation energy transfer to standard signal transduction processes. In 
this way, as long as the energy transfer is efficient, large pseudo-Stokes shifts are 
essentially guaranteed. As a bonus, if the excitation energy transfer (EET) efficiency 
itself can be modulated by ion binding, changes in intensity ratios take place at a 
wider range, thus increasing the dynamic range of the molecular sensor.152 In our 
previous work,174 we demonstrated the utility of this approach by the synthesis of 
fluorophores linked through phenylethynyl groups. In this work, our intention was to 
move the operation wavelengths more into the red/ near IR region and make use of 
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unique BODIPY chemistry157,175,176 together with Huisgen type “Click” 
chemistry159,177 to emphasize the modularity of our approach. 
 Result and Discussion 5.3.
The synthesis (Figure 78) of the target molecule starts with the placement of a 
terminal alkyne moiety at the meso position of a BODIPY dye 4. Azido-tethered 
aromatic aldehyde 7 was also prepared by a series of straightforward reactions. The 
core BODIPY unit 8 was functionalized through Knoevenagel reaction to yield 10. A 
second condensation then places the azido linkage on the other side of the BODIPY 
core (11). Finally, the two chromophores are “clicked” together. Double styryl 
condensation not only creates opportunities for additional functionalization but also 
pushes the absorption and emission wavelengths of the BODIPY chromophore at 
least 150 nm into the red.13,37,143,144,165,178 
 
The target compound 12 is freely soluble in most organic solvents, absorption 
spectrum in THF in the absence and presence of various metal ions is highly 
informative (Figure 79).  In the absence of any metal ions, there are two clearly 
identifiable peaks in the visible region, one around 500 nm (energy donor, shorter 
wavelength absorbing BODIPY) and one for the core distyryl-BODIPY centered at 
690 nm.  The addition of metal ions at 10 µM concentration results in essentially no 
change, except for the Hg (II) ions.  The ligand under the conditions of the study, 
displays a remarkable selectivity.  Thus, in the presence of mercuric ions, the longer 
wavelength absorption peak shifts hypsochromically to 650 nm.  This is perfectly 
understandable considering charge transfer nature of the dialklyamino substituent  
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Figure 78. Synthesis of the target compound (Copyright © 2010, American Chemical 
Society, Reprinted with permission from ref (165)).165 
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Figure 79. Absorbance spectra of the chemosensor compound 12 (1.5 µM) in THF in the 
absence and presence of various metal ions.  Added metal ion concentrations were 10 µM 
(Copyright © 2010, American Chemical Society, Reprinted with permission from ref (165)). 
being subdued by the binding of a Hg(II) ion.  Fluorescence spectra are equally 
useful (Figure 7), free chemosensor shows two emission peaks at 518 nm, and at 725 
nm.  Other metal ions are essentially ineffective, but the addition of Hg (II) ions 
result in a blue shift in the emission together with a large increase in intensity.  The 
decrease in the emission intensity of shorter wavelength emitting BODIPY is also 
noteworthy, as it indicates increased energy transfer efficiency due to larger spectral 
overlap between the donor and acceptor chromophore once the mercuric ion is 
tightly bound to the dithiaazacrown ligand.   
 
Figure 80. Emission spectra of compound 12 in THF (1.5 µM) in THF in the absence and 
presence of various metal ions.  Added metal ion concentrations were 10.0x10-6 M. 
Excitation wavelength is 480 nm (Copyright © 2010, American Chemical Society, Reprinted 
with permission from ref (165)). 
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Excitation spectrum of compound 12 compared to that of the model compound 4 at 
equal concentrations shows the efficiency of energy transfer within the target 
molecule (Figure 81).  When excited at 495 nm, emission can be collected from the 
longer wavelength emitting chromophore.  The emission intensity from the energy 
donor chromophore is significantly quenched.    
 
Figure 81. Excitation spectra of a model compound (4) and compound 12 with and without 
10 µM Hg(II).  For compound 4, the emission data was collected at 518 nm, and for the 
longer wavelength peak the data was collected at the isoemissive point 710 nm (Copyright © 
2010, American Chemical Society, Reprinted with permission from ref (165)). 
Figure 82. Hg(II) titration of the chemosensor compound 12. Hg (II) concentration is varied 
between 0 to 15 µM in THF. The concentration of 12 was 1.5 µM (Copyright © 2010, 
American Chemical Society, Reprinted with permission from ref (165)). 
We then proceeded with the titration of chemosensor compound 12 with Hg(II) ions.  
As expected, the shorter wavelength peak is not altered, but the longer wavelength 
peak is clearly shifted hypsochromically, resulting a clean isosbestic point at 662 nm 
(Figure 82).  The absorption spectra, thus present multiple opportunities of 
ratiometric sensing of ions, in this case mercuric ions. When the titration process is 
103	  
	  
followed fluorometrically, (Figure 83) the results clearly validate our design 
principles.  Shorter wavelength peak diminishes somewhat when the concentration of 
Hg (II) increases due to increased spectral overlap, hence more efficient energy 
transfer.   Titration shows a clean equilibration between the two states, metal-free 
and metal bound, with a single identifiable isoemissive point.  Time resolved  
 
Figure 83. Hg (II) titration of the chemosensor 12 in THF.  Ion concentration was varied 
between 0 to 15 µM. The chemosensor concentration was held at 1.5 µM (Copyright © 
2010, American Chemical Society, Reprinted with permission from ref (165)). 
Table 6.  Lifetimes, FRET rate constants and efficiencies of Compound 4, 12, 12+ 
Hg(II) (Copyright © 2010, American Chemical Society, Reprinted with permission 
from ref (165)). 
 
Compound	   τ 	  (ns)	   kFRET(s-­‐1)	   ε FRET	  
λem(495	  nm)	   	   	  
4	   3.34	   -­‐	   -­‐	  
12	   2.97	   3.76x107	   11%	  
12	  +	  Hg	  (II)	   1.83	   2.47x108	   45%	  
 
Φ = 0.43 for Compound 12 (in THF) for excitation at 488 nm, Rhodamine 6G in water (Φf= 0.95) was used as 
reference. Φ = 0.11 for Compound 12 (in THF) for excitation at 683 nm, Compound 1343  in CHCl3 (Φf= 0.35) 
was used as reference 
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fluorescence spectroscopy provides more quantitative data on the EET process.  For 
compound 12 in THF, without Hg (II) the emission lifetime is 3.34 ns, but when Hg 
(II) is added in the micromolar quantities, the lifetime is reduced to 2.97 ns.  
Corresponding energy transfer efficiencies are 11 % and 45 % respectively (Table 6).   
The selectivity of the chemosensor was further studied in completion experiments 
with other metal ions (Figure 84).  Thus, an excess of the comPeTing ion was added 
(100 µM) in addition to 10.0 µM Hg (II).  The data shows that the presences of large 
excesses of comPeTing ions have practically no effect on the emission intensity at 
660 nm.   
 
Figure 84. The free dye 12 (chemosensor) concentration was set at 1.5 µM, the 
concentration of the comPeTing cation 100 mM and concentration of Hg2+ was 10 mM. 
Excitation was at 500 nm with a slit width 5.0 nm (Copyright © 2010, American Chemical 
Society, Reprinted with permission from ref (165)). 
 Conclusion 5.4.
The principal outcomes of energy transfer coupled to internal charge transfer were 
obtained in a simple modular design.  These are large pseudo-Stokes shift 
(approximately 300 to 250 nm), multiple ratiometric measurement opportunities.  
The applicability of radiometry can be clearly demonstrated by recording the 
emission wavelength ratios at 760 nm to 723 nm (I760/I723) as a function of Hg (II) 
concentrations.  Naturally, radiometry can be clearly demonstrated by recording the 
emission wavelength ratios at 760 nm to 723 nm (I760/I723) as a function of Hg (II) 
concentrations.  Additionally, selectivity is conserved here as well.     
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 Experimental Details 5.5.
General: All chemicals and solvents purchased from Aldrich were used without 
further purification. 1H NMR and 13C NMR spectra were recorded using a Bruker 
DPX-400 in CDCl3 or DMSO-d6 with TMS as internal reference. Absorption 
spectrometry was performed using a Varian spectrophotometer. Steady state 
fluorescence and time-resolved fluorescence measurements were conducted using a 
Varian Eclipse spectrofluorometer and a Fluorolog Horiba Jobin-Yvon (Horiba Jobin 
Yvon Single Photon Counting Controller (FluoroHub) system), respectively. Column 
chromatography of all products was performed using Merck Silica Gel 60 (particle 
size: 0.040–0.063 mm, 230–400 mesh ASTM). Reactions were monitored by thin 
layer chromatography using fluorescent coated aluminum sheets. Solvents used for 
spectroscopy experiments were spectrophotometric grade. Mass spectra were 
recorded on Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS. 
Synthesis of Compound 3:  
 
 
1.50 g of K2CO3 (7.3 mmol) was added into 100 ml of CH3CN and then to this 
solution a mixture of 4-hydroxybenzaldehyde, 1, (100 mg, 0.82 mmol), and 3-
bromoprop-1-yne, 2, (106 mg, 0.90 mmol) in 5 ml CH3CN was added in a dropwise 
manner for an hour. After addition the solution was heated until reflux temperature. 
After stirring for 2 days at this temperature the solution was filtered and filtrate was 
concentrated by rotary evaporation under vacuum. The crude product was purified by 
column chromatography using CHCl3 as the eluent to afford product 3 as a white 
solid (98.4 mg, 74%).[159] 1H NMR (400 MHz, CDCl3) δ; 9.84 (s, 1H), 7.79 (d, J=8.8 
Hz, 2H), 7.02 (d, J=8.8 Hz, 2H), 4.71 (d, J=2.4 Hz, 2H), 2.50 (t, J=2.4 Hz, 1H). 
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Synthesis of Compound 4: 
 
To a deoxygenated solution of aldehyde, 3, (1.25 mmol, 200 mg) and 2,4-
dimethylpyrrole (2.5 mmol, 237 mg) in CH2Cl2 (500 ml), TFA (125 mg, 1.1 mmol) 
was added and the mixture was stirred overnight. The red solution was treated with 
DDQ (284 mg, 1.25 mmol), stirred for 30 min, then 5 ml of Et3N and 3 ml of 
BF3.Et2O were added, and the mixture was stirred at rt for further 40 min. The 
organic phase was separated, dried (MgSO4), filtered, and concentrated.  The residue 
was purified by column chromatography (CHCl3), collecting the first green 
fluorescent fraction afforded the expected BODIPY dye, 4, 47 mg (10% yield), 
orange-red solid. 1H NMR (400 MHz, CDCl3) δ; 7.12 ( d, J=8.8 Hz, 2H), 7.01 (d, 
J=8.8 Hz, 2H), 5.90 (s, 2H), 4.68 (d, J=2.0 Hz, 2H), 2.52 (d, J=2.0 Hz, 1H), 2.48 (s, 
6H), 1.35 (s, 6H). 13C NMR (100 MHz, CDCl3) δ; 158.1, 155.4, 143.1, 141.5, 131.8, 
130.4, 129.3, 128.0, 121.2, 115.6, 78.0, 75.9, 56.0, 14.7, 14.6 
Synthesis of Compound 6: 
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To a solution of K2CO3 (200 mg, 1.45 mmol) in 100 ml freshly distilled acetone was 
added 4-hydroxybenzaldehyde, 1, (100 mg, 0.82 mmol) and 1,6 -dibromo hexane, 5, 
(219 mg, 0.90 mmol) and the mixture was stirred at the reflux temperature for 2 
days. After removal of the solid part by filtration, organic solvent was removed under 
reduced pressure. The crude product was dissolved in CHCl3 to extract it with water. 
Organic layer was evaporated and resulting residue chromatographed (3:1 
Hexane/EtOAc) to give yellow oil. (94 mg, yield 40%)[159] 1H NMR (400 MHz, 
CDCl3) δ; 9.87 (s, 1H), 7.82 (d, J=8.8 Hz, 2H), 6.98 (d, J=8.8 Hz, 2H), 4.03 (t, J=6.4 
Hz, 2H), 3.42 (t, J=6.8 Hz, 2H), 1.93-1.80 (m, 4H), 1.52-1.49 (m, 4H). 13C NMR 
(100 MHz, CDCl3) δ; 189.1, 162.5, 130.3, 128.2, 113.1, 66.5, 32.1, 31.0, 27.2, 26.2, 
23.6. 
Synthesis of Compound 7: 
 
4-(6-bromohexyloxy) benzaldehyde, 6, (80 mg, 0.32 mmol) and NaN3 (24 mg, 0.37 
mmol) was added to DMSO and stirred vigorously. This suspension was then heated 
to 80 οC and stirred at this temperature for 3 hours. When TLC analysis showed 
complete consumption of the starting material the reaction was cooled to room 
temperature and then the crude product was poured onto brine solution and extracted 
three times with CHCl3. The organic layer was removed by rotary evaporator. And 
the residue was purified with column chromatography, EtOAc as an eluent, to give 
the product, 7, as a brown oil. (75 mg, 95% yield) [159] 1H NMR (400 MHz, CDCl3) 
δ; 9.78 (s, 1H), 7.74 (d, J=8.8 Hz, 2H), 6.90 (d, J=8.8 Hz, 2H), 3.95 (t, J=6.4 Hz, 
2H), 3.20 (t, J=6.8 Hz, 2H), 1.78-1.71 (m, 2H), 1.59-1.52 (m, 2H), 1.47-1.33 (m, 4H) 
108	  
	  
13C NMR (100 MHz, CDCl3) δ; 190.7, 164.1, 131.9, 129.8, 114.7, 68.1, 51.3, 28.9, 
28.7, 26.4, 25.6. 
Synthesis of Compound 10: 
 
Tert-Butyl BODIPY, 8, (200 mg, 0.46 mmol), compound 9 (160 mg, 0.46 mmol), 
were refluxed in a mixture of benzene (20 ml), glacial acetic acid (0.5 ml) and 
piperidine (1.0 ml). Any water formed during the reaction was removed 
azeotropically by heating overnight in a Dean–Stark apparatus. Crude product was 
then concentrated under vacuum, and purified by silica gel column chromatography 
(CHCl3). The blue colored fraction was collected and the solvent was removed under 
reduced pressure to yield the bright red fluorescent compound 10 (35 mg, 10%). 1H 
NMR (400 MHz, CDCl3) δ; 7.49 (d, J=16.4 Hz, 1H), 7.43-7.40 (m, 4H), 7.12 (d, 
J=8.4 Hz, 2H), 7.08 (d, J=16.4 Hz, 1H), 6.57 (d, J=8.8 Hz, 2H), 3.74 (t, J=4.8 Hz, 
4H), 3.63-3.58 (m, 8H), 2.84 (t, J=8.0 Hz, 4H), 2.71 (t, J=4.8 Hz, 4H), 2.50 (q, 
J=7.2 Hz, 2H), 2.23 (q, J=7.6 Hz, 2H), 1.50 (s, 3H), 1.30 (s, 9H), 1.23 (s, 3H), 
1.21(s, 3H), 1.06 (t, J=7.2 Hz, 3H), 0.91 (t, J=7.6 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ; 153.2, 137.7, 137.4, 136.6, 135.2, 134.7, 132.1, 131.8, 131.0, 130.5, 128.0, 
127.9, 127.6, 125.3, 115.6, 114.9, 111.7, 74.2, 71.7, 51.1, 35.2, 31.4, 31.3, 29.6, 18.4, 
16.3, 13.6, 13.0, 11.6, 10.6, 10.3. 
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Synthesis of Compound 11: 
 
To a freshly distilled benzene Mono-styryl-BODIPY, 10, (blue-BODIPY) (25 mg, 
0.032 mmol) and 4-(6-azidohexyloxy)benzaldehyde, 7, (16 mg, 0.064 mmol) were 
added. After vigorously stirring glacial acetic acid (0.5 ml), piperidine (1.0 ml) was 
added to this solution, heated to reflux temperature and kept at this temperature until 
TLC observation showed complete consumption of the blue BODIPY and formation 
of the green red fluorescent di-styryl BODIPY. At this point organic layer was 
removed under reduced pressure and the crude product re-dissolved in CHCl3 and 
extracted three times with brine solution. The organic layer was removed and final 
residue was purified with column chromatography, CHCl3 as an eluent. The red 
fluorescent compound was isolated, 11. (24 mg, 75% yield). 1H NMR (400 MHz, 
CDCl3) δ; 7.60 (d, J=16.4 Hz, 1H), 7.55 (d, J=16.8 Hz, 1H), 7.49 (d, J=8.4 Hz, 2H), 
7.46 (d, J=8.8 Hz, 2H), 7.41 (d, J=8.0 Hz, 2H), 7.15-7.06 (m, 4H), 6.86 (d, J=8.8 
Hz, 2H), 6.60 (d, J=8.8 Hz, 2H), 3.94 (t, J=6.4 Hz, 2H),  3.75 (t, J=4.8 Hz, 4H), 
3.65-3.59 (m, 8H), 3.21 (t, J=6.8 Hz, 2H), 2.88-2.84 (m, 4H), 2.71 (t, J=4.8 Hz, 4H), 
2.54-2.51 (m, 4H), 1.80-1.72 (m, 2H), 1.63-1.56 (m, 2H), 1.48-1.47 (m, 4H), 1.30 (s, 
9H), 1.24 (s, 6H), 1.07 (t, J=7.6 Hz, 6H) 13C NMR (100 MHz, CDCl3) δ; 159.4, 
152.1, 151.4, 149.0, 147.4, 139.0, 137.9, 137.5, 136.3, 134.4, 133.6, 133.3, 133.2, 
133.0, 132.7, 130.5, 130.0, 129.2, 128.6, 128.3, 125.9, 125.7, 118.4, 115.9, 114.7, 
111.9, 74.3, 70.8, 67.9, 52.0, 51.4, 34.8, 31.4, 31.3, 29.6, 29.2, 28.8, 26.6, 25.7, 18.5, 
18.4, 14.1, 14.0, 11.4, 11.3. 
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Synthesis of Compound 12: 
 
To a freshly distilled THF, 1.0 equiv of BODIPY-acetylene, 4, (9.01 mg, 0.023 
mmol) and 1.1.equiv. of di styryl-BODIPY-N3, 11, (24 mg, 0.024 mmol) was added. 
Then TEA (10–30 mol% per triple bond) was added to this mixture, and stirred for 5 
min, 10-30 mol% per triple bond of sodium ascorbate was added, followed by 5–15 
mol% of CuSO4·5H2O per triple bond. (A stock solution of sodium ascorbate and 
CuSO4·5H2O in water was prepared in concentration 100 mg/ml) The THF/H2O ratio 
must be 1/1 (v/v). The heterogeneous mixture was stirred vigorously until TLC 
analysis indicated complete consumption of the starting material. The reaction 
mixture was diluted with water and extracted with CH2Cl2. The combined organic 
layers were dried with Na2SO4, and concentrated in vacuo. Purification by column 
chromatography (CHCl3, as an eluent) gave the desired product. (13.6 mg, 90% 
yield) 1H NMR (400 MHz, CDCl3) δ; 7.61 (d, J=16.8 Hz, 1H), 7.58 (s, 1H), 7.53 (d, 
J=16.8 Hz, 1H), 7.50-7.40 (m, 6H), 7.15-7.01 (m, 8H), 6.84 (d, J=8.8 Hz, 2H), 6.59 
(d, J=8.8 Hz, 2H), 5.89 (s, 2H), 5.16 (s, 2H), 3.94 (t, J=6.4 Hz, 2H), 3.74 (t, J=4.8 
Hz, 4H), 3.67-3.57 (m, 8H), 3.47-3.45 (m, 1H), 3.42-3.40 (m, 1H), 2.87-2.83 (m, 
4H), 2.70 (t, J=4.8 Hz, 4H), 2.47 (s, 6H), 2.55-2.51 (m, 4H), 1.95-1.88 (m, 2H), 
1.76-1.70 (m, 2H), 1.54-1.46 (m, 4H), 1.34 (s, 6H), 1.31 (s, 9H), 1.24 (s, 6H), 1.07 (t, 
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J=7.6 Hz, 3H), 1.07 (t, J= 7.6 Hz, 3H).  13C NMR (100 MHz, CDCl3) δ; 159.3, 
158.9, 155.3, 152.2, 151.6, 148.9, 147.5, 143.6, 143.1, 141.6, 139.1, 137.9, 137.6, 
136.4, 134.3, 133.7, 133.3, 133.2, 133.0, 132.7, 131.8, 130.6, 130.4, 129.3, 129.2, 
128.6, 128.4, 127.6, 127.5, 126.3, 126.0, 125.0, 123.5, 123.2, 122.6, 121.6, 121.2, 
118.5, 114.8, 114.6, 111.9, 74.3, 71.7, 71.0, 70.7, 67.7, 62.1, 61.9, 52.0, 50.4, 34.8, 
31.9, 31.7, 31.4, 31.3, 30.2, 29.7, 29.6, 29.4, 28.9, 14.5, 14.1, 14.0, 13.9.  MS (TOF-
ESI): m/z:  Calcd: 1381.704 [M+H]+, Found: 1381.7114 [M+H]+ , ∆=5.35 ppm. 
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CHAPTER 6 
Chromogenic and Fluorogenic Sensing of Biological 
Thiols in Aqueous Solutions Using BODIPY-Based 
Reagent 
 
 
This work is partially described in the following publication: 
Isik, M.; Ozdemir, T.; Simsek Turan, I.; Kolemen, S.; Akkaya, E.U. Org. 
Lett., 2013, 11, 216-219. 
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 Objective 6.1.
Judicious design of BODIPY dyes carrying nitroethenyl substituents in conjugation 
with the BODIPY core, yields dyes which respond to biological thiols by both 
absorbance and emission changes. Incorporation of solubilizing ethylene glycol units 
ensures water solubility. The result is bright signaling of biologically relevant thiols 
in the longer wavelength region of the visible spectrum and in aqueous solutions. 
 
 
 Introduction 6.2.
Sensing and signaling of biological thiols is at the focus of recent flurry of 
work.179,180 These reaction based probes take advantage of high nucleophilicity of 
thiol functions found in biologically relevant species such as Cystein (Cys), 
Homocystein (Hcy) and Glutathione (GSH). These biothiols are vital for the 
maintenance of cellular redox status and alterations in their levels is linked to a 
number of debilitating diseases such as AIDS, cancer and Alzheimer’s.181-183 
Consequently, probes which respond to these thiols by color change, emision change 
or both, are highly valued. If they are made to function in aqueous solutions, 
naturally, they are deemed to be more desirable considering potential applications.   
We now present a nitroethenyl-BODIPY conjugate 1, having both chromogenic and 
fluorescence turn-on responses for fast, selective and sensitive detection of biological 
thiols in aqueous media. The roles of three separate modules of the thiol probe 1 are 
displayed in Figure 85 and can be described as follows: (1) Boron dipyrromethene 
(BODIPY)40,184 fluorophore was chosen as the signaling unit for its widely-accepted 
superiority (e.g. high molar absorptivity, high photostability, visible wavelength 
absorption and its modular nature for facile functionalization etc.) over more 
conventional alternatives. Due to these unique features, a plethora of fluorescent 
sensors/labels,185-187 light harvesting systems,25,188,189 photodynamic therapy 
agents102,190,191 and molecular logic gate systems192,193 are built around BODIPY 
cores and these received considerable attention of the chemical community. (2) 
Incorporation of a nitroalkene unit to the parent dye would transform it into a strong 
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Michael acceptor, which would be highly susceptible to sulfhydryl 
nucleophiles.194,195 Indeed, Michael reaction based thiol sensing  
 
Figure 85. Design elements of the nitroethenyl-BODIPY conjugate thiol probe 1 (Copyright 
© 2010, American Chemical Society, Reprinted with permission from ref (196)).196 
protocols197-199 clearly emerge as the favorite among other strategies.64,200,201 
Nucleophilic attack of the thiol to the β-position of nitroethene is expected to disrupt 
the π-conjugation and block the Intramolecular Charge Transfer (ICT) process, 
which is expected to induce a blue shift in absorbance. (3) Gallic acid derived unit 
placed at the meso-position of BODIPY core plays two crucial functions: i) 
Photoinduced-electron-Transfer (PeT) based modulation of the emission, as the 
electron rich trimethoxyphenyl moiety could quench excited state of the electron 
deficient (due to conjugated nitroethenyl group) BODIPY core by an electron 
transfer ii) ethyleneglycolic entities anchored on phenolic hydroxyl functionalities 
should facilitate water solubility, enhancing the chances for practical applications of 
the probe 1.  
 
 Results and Discussion 6.3.
 
To test the aforementioned hypothesis, we set out to synthesize of a simpler analog of 
1, and studied its 1,4-addition reactivity with thiols.  Thiol sensor 2 was prepared 
from the readily available 2-formylBODIPY191 precursor via tandem 
Henry/elimination reaction. Once β-mercaptoethanol (ME), chosen as the simple 
biothiol model compound, reacted with the thiol sensor 2 an apparent color change 
from red to orange was noticed. This bright green fluorescing adduct 3 was presumed 
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to be the 1,4-conjugate addition product (Figure 86). Due to poor solubility of 2 in 
common polar organic solvents, absorption and emission spectra were not recorded. 
Michael reaction of 2 and ME was amenable to 1H-NMR spectroscopy analysis. 
Comparison of 1H-NMR spectra of 2 and 3 clearly shows that the addition of ME to  
 
	  
	  
Figure 86. Stacked partial 1H-NMR spectra of thiol probe 2 (A) and conjugate addition 
product 3 (B) in CDCl3 at 25 °C (Copyright © 2010, American Chemical Society, Reprinted 
with permission from ref (196)). 
the sensor 2 leads to the disappearance of the vinylic protons (Ha and Hb) resonating 
at 8.07 and 7.44 ppm with the concomitant appearance of α-protons of the newly 
formed nitroalkane showing at 4.80 ppm. About 0.1 ppm upfield shift of aromatic 
hydrogens (meso-H and 6-H) of BODIPY core is an indication of an increase in the 
electron density of the BODIPY core (the signaling unit) upon conjugate addition. 
Once we demonstrated the Michael acceptor reactivity of the nitroethenyl-BODIPY 
derivative 2 towards the thiol ME, we have turned our attention to the water soluble 
derivative 1. Synthetic route followed is depicted in Figure 87. 
Gallic acid derived aldehyde 4 was prepared according to our previous report37 and 
reacted with 2,4-dimethylpyrrole to furnish 5. Fluorescent dye 5 was formylated via 
Vilsmeier-Haack reaction in good yield and subsequent condensation in 
nitromethane in the presence of catalytic amount of NH4OAc (20 mol%) provided 
the thiol probe 1 in reasonable overall yields (14%). 
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Figure 87. Synthetic route for the target Thiol Probe 1 (Copyright © 2010, American 
Chemical Society, Reprinted with permission from ref (196)). 
Figure 88 shows the electronic absorption and fluorescence emission response of 
the thiol probe 1 (4 µM) in 50 mM HEPES:CH3CN (80:20, v/v, pH=7.20) to 
increasing Cysteine (Cys) concentrations (0-400 equiv.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 88. UV-vis absorption spectra (A) and fluorescence spectra (B) of the thiol probe 1 
(4 µM) upon increased Cys concentrations (0-400 equiv.) in 50 mM HEPES:CH3CN (80:20, 
v/v, pH=7.20, λex 500 nm at 25 °C) (Copyright © 2010, American Chemical Society, 
Reprinted with permission from ref (196)). 
Upon addition of Cys, absorption band of free dye 1 centered at 525 nm gradually 
decreased and a new band appeared with a maximum at 510 nm. A 15 nm blue shift 
with a well-defined isosbestic point at 518 nm is apparent from the absorption 
spectrum (Figure 88, left). This Cys-induced hypsochromic shift reveals the 
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suppression of ICT process that occurs between donor BODIPY core and acceptor 
nitroalkene unit, as predicted. Probe 1 is essentially nonfluorescent (Φf = 0.056) as 
evidenced by emission spectrum (Figure 88, right). Fluorescence intensity increases 
up to 20-fold (Figure 88) upon increasing Cys concentrations (0-400 equiv) with an 
emission band centered at 515 nm (λex 500 nm). In agreement with our design 
expectations, this fluorescence enhancement is at least partly due to a reduction in 
the efficiency of the PeT process upon the attack of the Cys thiol on probe 1 resulting 
an increase in the energy level of the BODIPY centered LUMO. Under identical 
conditions, other biological thiols, such as Homocysteine (Hcy) and Glutathione 
(GSH), afforded similar turn on fluorescence responses as well (Figure 89).  
 
Figure 89. Absorption and fluorescence spectra of Thiol Probe 1 (4 µM) upon addition of 
200 eqv. of Cys, Hcy and GSH in 50 mM HEPES:CH3CN (80:20, v/v, pH=7.2, λex 500 nm 
at 25 °C) (Copyright © 2010, American Chemical Society, Reprinted with permission from 
ref (196)). 
However, the response to Cys is much faster than that to Hcy and GSH. Thus, by 
controlling the reaction time, exquisite selectivity for Cys can be obtained (Figure 90 
and inset in Figure 92). 
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Figure 90. Kinetic measurements of Thiol Probe 1 upon addition of 200 eqv. of Cys, Hcy 
and GSH in 50 mM  HEPES:CH3CN (80:20, v/v,  pH=7.2, λex 518 nm at 25 °C, time 
interval: 30s) (Copyright © 2010, American Chemical Society, Reprinted with permission 
from ref (196)). 
Sensing experiments were also carried out in HEPES: CH3CN (60:40, v/v) and 
100% HEPES buffer solutions (pH 7.2 in both).While 40% acetonitrile solution 
produces essentially the same responses as that of 20% acetonitrile solution, 
fluorescence response of 1 toward biological thiols was halved in 100% HEPES 
solution (Figure 90), but the signal is still strong enough for sensitive and selective 
detection of thiols (vide infra). 
 
Figure 91. UV-vis absorption and fluorescence spectra of the Thiol Probe 1 (4 µM) upon 
increased Cys concentrations (0-400 equiv.) in 50 mM HEPES ( pH=7.2, λex 500 nm at 25 
°C) (Copyright © 2010, American Chemical Society, Reprinted with permission from ref 
(196)). 
As a natural extension of this study, we have investigated the selectivity of probe 1 
toward Cys, Hys and GSH over potentially comPeTing biologically relevant natural 
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aminoacids in HEPES: CH3CN (80:20, v/v) at physiological pH (7.20). No 
significant change was observed in both absorption and fluorescence emission 
(Figure 92) spectra when natural amino acids other than cysteine were treated with 
the probe 1. 
 
 
Figure 92. Fluorescence response of the thiol probe 1 (4 µM) towards biothiols (Cys, Hcy 
and GSH; 200 equiv. each)) and other natural amino acids (400 equiv.) in 50 mM 
HEPES:CH3CN (80:20, v/v, pH=7.20, λex 500 nm at 25 °C) (Copyright © 2010, American 
Chemical Society, Reprinted with permission from ref (196)). 
Extending the sensing range of the probe into the red and near IR would be highly 
advantageous.  To that end, we made use of now established protocols for 
Knoevenagel condensation of the methyl substituted BODIPYs and aldehydes. As 
probe 1 was derivatized by reacting with a trialkoxybenzaldehyde, the absorbance 
and fluorescence maxima moved into far red (λabs 623 nm and λem 650 nm) with 
enhanced water solubility as a bonus (Figure 93 and Table 7).  
 
 
Figure 93. Red-emitting nitroolefin-BODIPY conjugate thiol probe 7 (Copyright © 2010, 
American Chemical Society, Reprinted with permission from ref (196)). 
 
120	  
	  
 
Table 7.  Optical properties of the probes 1 and 7 (Copyright © 2010, American Chemical 
Society, Reprinted with permission from ref (196)). 
Compound[a] λabs (nm) λem (nm) Φf[b] εmax[c] 
1 525 540 0.056[d] 58,500 
7 623 655 0.016[e] 51,800 
 
[a] Data acquired in 50 mM HEPES:CH3CN (80:20, v/v, pH=7.20, in dilute solutions. [b] Relative quantum yields. [c] unit: cm-
1M-1. [d] Reference dye: Rhodamine 6G in water (Φf = 0.95). [e] Reference dye: Cresyl violet in methanol (Φf = 0.90). 
 
 
Synthesis of distyryl-BODIPY 7 was achieved in 3 steps starting from compound 5 
(Figure 94). Optical properties of 1 and 7 are given below in Table 6. Compared to 1, 
dye 7 has an extended π-conjugation which causes significant bathochromic shift 
(≈100 nm in absorption and ≈125 nm in emission peaks). However, this extension of 
conjugation diminished the fluorescence quantum yield of 7 to approx. one-third of 
probe 1.  
Sensor 7 displayed good water solubility due to the presence of nine 
triethyleneglycolic arms on the styryl and meso substituents.  
 
 
 
Figure 94. Synthetic route for the target Thiol Probe 7 (Copyright © 2010, American 
Chemical Society, Reprinted with permission from ref (196)). 
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Absorption and fluorescence response (Figure 95) of this red-emitting chromophore 
7 were also examined. An equal magnitude of enhancement response was observed 
with the probe 7 and 1 upon incremental Cys additions (0-400 equiv.).  
 
 
 
Figure 95. UV-vis absorption and fluorescence spectra of the Thiol Probe 7 (4 µM) upon 
increased Cys concentrations (0-1000 equiv.) in 50 mM  HEPES:CH3CN (80:20, v/v,  
pH=7.2, λex 600 nm at 25 °C) (Copyright © 2010, American Chemical Society, Reprinted 
with permission from ref (196)). 
 
 Conclusion 6.4.
Two nitroethenyl-BODIPY derivatives (1 and 7) operating at different wavelengths 
were designed, synthesized and evaluated for biological thiol (Cys, Hcy and GSH) 
sensing in aqueous solutions. Both probes showed very fast and sensitive responses 
with color changes and “turn-on” fluorescence. We are confident that an 
understanding of BODIPY photophysics in relation to PeT efficiency and Internal 
Charge Transfer, would produce newer and more capable sensors for analytes of 
interest.  Compounds 1 and 7 are two examples along that promising road. 
 
 
 Experimental Details 6.5.
General: 1H NMR and 13C NMR spectra were recorded on Bruker Spectrospin 
Avance DPX 400 spectrometer using CDCl3 as the solvent. Chemical shifts values 
are reported in ppm from tetramethylsilane as internal standard. Spin multiplicities 
are reported as the following: s (singlet), d (doublet), m (multiplet). HRMS data were 
acquired on an Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS. UV-Vis 
Absorption spectra were taken on a Varian Cary-100 spectrophotometer.  
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Fluorescence measurements were conducted on a Varian Eclipse spectrofluorometer. 
Flash column chromatography (FCC) was performed by using glass columns with a 
flash grade silica gel (Merck Silica Gel 60 (40–63 µm)). Reactions were monitored 
by thin layer chromatography (TLC) using precoated silica gel plates (Merck Silica 
Gel PF-254), visualized by UV-Vis light and DNP stains as appropriate. All organic 
extracts were dehydrated over anhydrous Na2SO4 and concentrated by using rotary 
evaporator before being subjected to FCC. 2-FormylBODIPY 8 was synthesized 
following reported literature procedure (see manuscript). All other chemicals and 
solvents were supplied from commercial sources and used as received.  
Synthesis of Compound 2: 
	  
NH4OAc (2.8 mg, 0.036 mmol) was added to a nitromethane (3,5 ml) solution of 
compound 8 (100 mg, 0.36 mmol) and the solution was left to stir at 90 oC for 5 
days. Product formation was monitored with TLC using DCM as the eluent. At the 
end of reaction, nitromethane was removed in vacuo and obtained crude mixture was 
subjected to silica gel FCC using DCM as the eluent. Compound 2 was obtained as 
an orange crystalline solid (36 mg, 31.3% yield). 1H NMR (400 MHz, CDCl3) δ 
8.065 (d, J = 13.68 Hz, 1H), 7.44 (d, J = 13.68 Hz, 1H), 7.19 (s, 1H), 6.22 (s, 1H), 
2.66 (s, 3H), 2.60 (s, 3H), 2.39 (s, 3H), 2.31 (s, 3H). Due to the low solubility of the 
compound, 13C-NMR spectrum could not be obtained. MS (TOF-ESI): m/z: Calcd: 
318.1304 [M-H]-, Found: 317.1277 [M-H]-, ∆= 3.09 ppm. 
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Synthesis of Compound 5: 
	  
Trifluoroacetic acid (TFA; 1 drop) was added dropwise to a vigorously stirring 
solution of 3,4,5-tris(2-(2-(2-methoxyethoxy)ethoxy)benzaldehyde (1000 mg, 1.7 
mmol) and 2,4-dimethylpyrrole (352 mg, 3.7 mmol) in 350 ml Ar-deaerrated 
dichloromethane (DCM). The resulting red solution was stirred at room temperature 
in the dark for 1 day. p-Chloranil (415 mg, 1.7 mmol) was then added in one portion 
and reaction was stirred for an additional hour. Triethylamine (TEA) (5.0 ml) was 
then added dropwise to this mixture over a period of 15 min, and the resulting dark 
brown solution was allowed to stir for an additional 15 min. BF3•OEt2 (5.0 ml) was 
then added dropwise over a period of 15 min. and the resulting dark red solution was 
allowed to stir further for 2h at rt. The slurry reaction mixture was washed with water 
(3 × 300 ml) and dried over anhydrous Na2SO4. The solvent was evaporated and the 
residue was purified by silica gel flash column chromatography (FCC) using 
DCM:MeOH (95:5) as the eluent. Standing on air, compound 5 was solidified as a 
dark orange solid (780 mg, 56% yield). 1H NMR (400 MHz, CDCl3) δ 6.55 (2, 2H), 
5.99 (s, 2H), 4.22 (t, J= 4.97 Hz, 2H), 4.12 (t, J= 4.72 Hz, 4H), 3.84 (t, J= 5.29 Hz, 
6H), 3.51-3.76 (m, 25H), 3.38 (s, 2H), 3.36 (s, 6H), 2.54 (s, 6H), 1.52 (s, 6H). 13C 
NMR (100 MHz, CDCl3) δ 155.8, 153.7, 142.9, 141.1, 139.0, 131.1, 129.9, 121.1, 
107.7, 2.7, 71.9, 71.9, 70.8, 70.7, 70.6, 70.5, 69.7, 69.2, 58.8, 29.6 14.4, 14.2. MS 
(TOF-ESI): m/z: Calcd: 809.4286 [M-H]-, Found: 808.4299 [M-H]-, ∆= 6.16 ppm. 
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Synthesis of Compound 6: 
	  
POCl3 (1 ml) was added dropwise to a vigorously stirring anhydrous DMF (1 ml) 
which was kept in ice bath under N2. Resulting pale yellow viscous liquid was 
allowed to stir at room temperature for additional 30 min. To this, 1,2-dichloroethane 
(DCE) (50 ml) solution of compound 5 (810.43 mg, 1.0 mmol) was then slowly 
introduced and the resultant brown solution was heated at 60 °C for 3 h. (Attention!: 
60 °C is critical to get mono-formylated product 6 as the major, side product 
formation was observed otherwise at higher temperatures.) Reaction was cooled to 
room temperature, and poured into ice-cold saturated NaHCO3 solution. This mixture 
was extracted twice with DCM (100 ml portions) and dried over anhydrous Na2SO4. 
Solvent was evaporated in vacuo and compound was purified by silica gel FCC using 
98:2 / DCM: MeOH as the eluent to obtain target compound 6 as orange crystalls 
(769mg, 91.7% yield). 1H NMR (400 MHz, CDCl3) δ 9.98 (s,1H), 6.53 (s, 2H), 6.15 
(s, 1H), 4.23 (d, J= 4.34 Hz, 2H), 4.12 (d, J= 4.29 Hz, 4H), 3.83 ( d, J= 4.81 Hz, 
6H), 3.75-3.49 (m, 25H), 3.37 (s, 2H), 3.34 (s, 6H), 2.80 (s, 3H), 2.59 (s, 3H), 1.78 
(s, 3H), 1.57 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 185.8, 161.6, 156.4, 154.0, 
147.1, 143.0, 142.6, 139.5, 133.9, 129.6, 128.8, 126.2, 123.9, 107.0, 72.7, 71.9, 71.8, 
70.8, 70.6, 70.6, 70.5, 70.5, 69.6, 69.3, 58.9, 14.7, 11.5. MS (TOF-ESI): m/z: Calcd: 
837.4235 [M-H]-, Found: 836.4186 [M-H]-, ∆= 1.47 ppm. 
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Synthesis of Compound 1: 
	  
	  
NH4OAc (1.3 mg, 0.017 mmol) was added to a nitromethane (2 ml) solution of 
compound 6 (139 mg, 0.17 mmol) and the solution was left to stir at 90 oC for 5 
days. Product formation was monitored with TLC using DCM: MeOH (98:2) as the 
eluant. At the end of reaction, nitromethane was removed in vacuo and obtained 
crude mixture was subjected to silica gel FCC using DCM: MeOH (98:2) as the 
eluent. Compound 1 was obtained as a wine-red waxy solid (40 mg, 27% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.05 (d, J= 13.8 Hz, 1H), 7.37 (d, J= 13.63 Hz, 1H9, 
6.56 (s, 2H), 6.18 (s, 1H), 4.26 (t, J= 4.64 Hz, 2H), 4.14 (t, J= 4.52 Hz, 4H), 3.86 (t, 
J=5.15Hz, 6H), 3.52- 3.76 (m, 25H), 3.40 (s, 2H), 3.37 (s, 6H), 2.72 (s, 3H), 2.63 (s, 
3H), 1.64 (s, 3H), 1.59 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 161.5, 154.2, 154.0, 
147.1, 147.2, 140.1, 139.6, 134.6, 133.7, 130.7, 130.6, 128.8, 123.9, 120.0, 107.4, 
72.8,71.9, 71.9, 70.8, 70.7, 70.7, 70.6, 70.6, 69.7, 69.3, 65.3, 59.0, 29.6, 14.7, 
12.8,11.0. MS (TOF-ESI): m/z: Calcd: 880.7612 [M-H]-, Found: 879.4238 [M-H]-, 
∆= 2.09 ppm. 
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Synthesis of Compound 9: 
 
3,4,5-tris(2-(2-(2-methoxyethoxy)ethoxy)benzaldehyde (365 mg, 0.62 mmol) was 
added to a solution of 25 ml of compound 5 ( 200mg, 0.247mmol) in benzene 
containing piperidine acetate (179mg, 1.23mmol). Mixture was refluxed until all the 
starting material consumed and the product formation was monitored by TLC using 
DCM: MeOH (95:5) as the eluent. At the end of the reaction, obtained crude mixture 
was subjected to silica gel FCC using DCM: MeOH (95:5) as the eluent. Compound 
9 was obtained as a dark-blue waxy solid (200mg, 41.4% yield). 1H NMR (400 MHz, 
CDCl3) δ  7.53 (d, J=16.04 Hz, 2H),  7.17 (d, J=15.91 Hz, 2H), 6.85 (s, 4H), 6.64 (s, 
2H), 6.61 (s, 2H), 4.21-4.27 (m, 14H), 4.13-4.17 (m, 5H), 3.86-3.90 (m, 13H), 3.82-
3.84 (m, 5H), 3.73-3.78 (m, 19H), 3.63-3.71 (m, 39H), 3.53-3.60 (m, 19H), 3.41 (s, 
2H), 3.40 (s, 5H), 3.38 (s, 15H), 1.60 (s, 6H).  13C NMR (100 MHz, CDCl3) δ 153.6, 
152.8, 152.6, 141.8, 139.9, 139.1, 138.2, 136.3, 133.2, 132.0, 129.9, 118.4, 117.8, 
108.1, 107.6, 72.7, 72.4, 71.9, 71.8, 70.8, 70.8, 70.6, 70.6, 70.6, 70.5, 70.5, 69.7, 
69.2, 69.1, 58.9, 58.9, 14.5. MS (TOF-ESI): m/z: Calcd: 1958.0264 [M-H]-, Found: 
1956.9858 [M-H]-, ∆= 18.91 ppm. 
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Synthesis of Compound 10: 
 
POCl3 (0.1 ml) was added dropwise to a vigorously stirring anhydrous DMF (0.1 ml) 
which was kept in ice bath under N2. Resulting pale yellow viscous liquid was 
allowed to stir at room temperature for additional 30 min. To this, 1,2-dichloroethane 
(DCE) (50 ml) solution of compound 9 (200 mg,0.102mmol) was then slowly 
introduced and the resultant brown solution was heated at 60 °C for 3 h. (Attention!: 
60 °C is critical to get mono-formylated product 10 as the major, side product 
formation was observed otherwise at higher temperatures.) Reaction was cooled to 
room temperature, and poured into ice-cold saturated NaHCO3 solution. This mixture 
was extracted twice with DCM (100 ml portions) and dried over anhydrous Na2SO4. 
Solvent was evaporated in vacuo and compound was purified by silica gel FCC using 
95:5 / DCM: MeOH as the eluent. Product 10 was obtained as dark blue oily 
compound (178 mg, 87.7% yield). 1H NMR (400 MHz, CDCl3) δ 10.05 (s, 1H), 7.52 
(dd, J= 16.28 Hz, 2H), 7.31 (d, J=17.93 Hz, 1H), 7.03 (d, J=16.16 Hz, 1H), 6.90 (d, 
J= 4.65 Hz, 4H), 6.77 (s, 1H), 6.59 (s, 2H), 4.13-4.27 (m, 19H), 3.81-3.89 (m, 18H), 
3.70-3.75 (m, 18H), 3.61-3.69 (m, 37H), 3.51-3.57 (m, 19H), 3.35-3.39 (m, 24H), 
1.85 (s, 3H), 1.64 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 187.1, 157.1, 153.9, 153.4, 
152.9, 152.8, 146.1, 141.4, 141.2, 141.0, 140.5, 140.3, 139.9, 139.5, 136.1, 131.7, 
131.18, 131.10, 129.1, 126.9, 120.4, 117.5, 116.5, 108.2, 107.8, 107.5, 72.7, 72.5, 
72.4, 71.9, 71.9, 70.8, 70.8, 70.8, 70.7, 70.6, 70.6, 70.5, 70.5, 69.7, 69.3, 69.2, 69.0, 
59.0, 59.0, 58.9, 15.0, 12.3. MS (TOF-ESI): m/z: Calcd: 1986.0213 [M-H]-, Found: 
1984.9894 [M-H]-, ∆= 14.25 ppm. 
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Synthesis of Compound 7: 
 
 
NH4OAc (0.05 mg, 0.0065 mmol) was added to a nitromethane (1 ml) solution of 
compound 10 (130 mg, 0.065 mmol) and the solution was left to stir at 90 oC for 15 
days. Product formation was monitored with TLC using DCM: MeOH (95:5) as the 
eluent. At the end of reaction, nitromethane was removed in vacuo and obtained 
crude mixture was subjected to silica gel FCC using DCM: MeOH (95:5) as the 
eluent. Compound 7 was obtained as a dark blue waxy solid (25 mg, 19% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.16 (d, J=13.6 Hz, 1H), 7.51 (d, J=16.3 Hz, 2H), 7.38 
(d, J=13.6 Hz, 1H), 7.32 (d, J=16.3 Hz, 2H), 6.87 (s, 2H), 6.85 (s, 2H), 6.78 (s, 1H), 
6.61 (s,2H), 3.3-4.29 (m, 135H), 1.69 (s, 3H), 1.65 (s, 3H). MS (TOF-ESI): m/z: 
Calcd: 2028.0235 [M-H]-, Found: 2028.0288 [M-H]-, ∆=2.63 ppm. 
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CHAPTER 7 
Fast Responding and Selective Near- IR BODIPY 
Dyes for Hydrogen Sulfide Sensing 
 
 
 
This work is partially described in the following publication: 
Ozdemir, T.; Sozmen, F.; Mamur, S.; Tekinay, T.; Akkaya, E.U. Chem. Commun., 
2014, 50, 5455-5457. 
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 Objective 7.1.
A BODIPY based, highly selective probe for hydrogen sulfide has been designed, 
synthesized and demonstrated to detect H2S in living cells. In this design, the 
reduction of two arylazido groups change the charge transfer characteristics of the 
3,5-distyryl substituents on the BODIPY core, producing a 20 nm bathochromic 
spectral shift in the absorption band, and quenching of the emission by 85% 
compared to the original intensity, through photoinduced electron transfer. 
 
 Introduction 7.2.
Hydrogen sulfide (H2S) has a characteristic repulsive odor of rotten eggs, and plays 
crucial roles in biological processes; as a result, many groups worldwide are 
interested in potential agents that will allow its real-time monitoring.5,166,202,203  Like 
the other two gaseous signaling molecules, carbon monoxide (CO)204-206 and nitric 
oxide (NO),207-209 hydrogen sulfide is a biosynthetic gasotransmitter.  These small 
gaseous molecules are different from the other messenger molecules regarding their 
production and function.  Furthermore, because of their small size and charge 
neutrality, they can easily pass through the cellular membranes without affecting any 
cell signaling response.210 The important roles of H2S in many metabolic processes, 
such as cardiovascular protection, neuroprotective effect, arrangement of cell growth, 
calcium homeostasis and regulation of neurotransmission are well established in the 
literature.71,211-213   
H2S is an example of reactive sulfur species such as, thiols, S-nitrosothiols, sulfenic 
acids and sulfite, produced enzymatically from cysteine with a series of reactions, 
mainly catalyzed by two pyridoxal 5ʹ′-phosphate-dependent enzymes, cystathionine 
β-synthase (CBS) and cystathionine γ-lyase (CSE) and independently from pyridoxal 
5ʹ′-phosphate by another enzyme, 3-mercaptopyruvate sulfur transferase (3MST).214-
216 Also elemental sulfur is another endogenous H2S source.217,218  
Biological imaging probes working in the near-IR region have attracted considerable 
attention in recent years, since the light used for excitation causes much less 
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photodamage to cells compared to ultraviolet or visible light used in exciting other 
probes.  In addition, with near IR probes, cell autofluorescence is not an issue. On the 
other hand, BODIPY dyes which are difluoroboron-chelated dipyrromethene 
derivatives seem to be very good choices for designing novel H2S probes due to their 
desirable properties such as; high quantum yields, chemical and photochemical 
stability, high molar absorption coefficients, and the fact that they allow 
straightforward access to near-IR emitting derivatives.41,43,184,219 
 
 
 Results and Discussion 7.3.
 
In this work, Knoevenagel type chemistry has been used to obtain a near-IR emissive 
BODIPY derivative 1 with extended conjugation (Figure 96).  Initially, we 
synthesized BODIPY 5 having three triethyleneglycol groups. To that end, 
compound 3 and 4 were prepared according to literature reports.  Then, BODIPY 5 
was constructed by the reaction of the aldehyde 4 and 3-ethyl-2,4-dimethylpyrrole.  
Finally, following recently established protocols,220 condensation reaction of p-
azidobenzaldehyde 3 yielded the probe 1 (Φf= 0.38, cresyl violet in ethanol as a 
reference dye) in analytically pure state following chromatographic purifications. 
This reaction allowed not only the formation of target probe in good yields, but also 
emission and absorption wavelengths of the probe were shifted to near-IR. 
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Figure 96. Synthesis of target probe 1 (Copyright © 2014, Royal Society of Chemistry, 
Reprinted with permission from ref (220)).220 
 
 
H2S probes functioning through the reduction of azido group to amines are available 
in the literature.78,221-223 However, most of them do not respond fast enough.  On the 
other hand, the probe proposed in this study (compound 1) responds to H2S with no 
time delay, practically immediately as the reagents are mixed. 
Upon titration of probe 1 with various concentrations of Na2S at room temperature in 
acetonitrile-buffer mixture (20 mM HEPES/CH3CN, 40:60, v/v, pH=7.20, 25 °C), 
the red shift about 20 nm was observed in the electronic absorption spectrum (Figure 
97a), the color change was easily noticeable with naked eye.  The actual ratio of S2-
/HS-/H2S concentrations (speciation) is dictated by the pH of the buffer. 
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Figure 97. Absorption and emission spectra of 1 (2.0 µM) in 20 mM HEPES:CH3CN (40:60, 
v/v, pH=7.20, 25 °C)  in increasing Na2S concentrations. Excitation wavelength is 650 nm. 
Experiments were done in triplicate (Copyright © 2014, Royal Society of Chemistry, 
Reprinted with permission from ref (220)). 
 
As shown in the fluorescence spectra (Figure 97b), the emission of probe 1 was 
quenched with increased Na2S concentrations at room temperature in 20 mM 
HEPES/CH3CN solutions (40:60, v/v, pH=7.20, 25 °C). The detection limit was 
determined (ESI) to be 0.34 µM.  
The reduction of azido to amine group provides an alternative excited state process 
(photoinduced electron transfer, PeT) which is responsible for quenching the of 
fluorescence emission.  
Selectivity of the probe 1 for sulfide species was also investigated.  To that end, 
fluorescence and electronic absorption spectral data were collected with other 
reactive sulfur species (RSS), reactive oxygen species (ROS) and reactive nitrogen 
species (RNS). Emission data provides clear evidence that the probe 1 offers very 
good selectivity for sulfide in (Figure 98a).  
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Figure 98. Absorption and emission spectra of probe 1 (2.0 µM) in 20 mM HEPES:CH3CN 
(40:60, v/v, pH=7.20, 25 °C) in absence and presence of various anions. Added Na2S 
concentration is 50 µM and anion concentrations were 100 µM. Excitation wavelength is 650 
nm. Experiments were done in triplicate (Copyright © 2014, Royal Society of Chemistry, 
Reprinted with permission from ref (220)). 
No other species were able to reduce the two azido groups to amine groups, so not 
change in fluorescence emission was observed.  ComPeTition experiments in the 
presence of a number of comPeTing anions were also done (Figure 99), again 
corroborating the selectivity of the probe. The electronic absorption spectra were 
unchanged as well.  We also note that, 1000 equivalents of glutathione or cysteine do 
not cause any changes in the emission intensity or absorbance spectrum of the probe 
1 (Figure 98).   
 
	  
Figure 99. Emission intensity response of probe 1 (2.0 µM) with 50 equiv. of a comPeTing 
anions followed by addition of 50 equiv. Na2S in 20 mM HEPES:CH3CN (40:60, v/v, 
pH=7.20, 25 °C). Excitation wavelength was 650 nm with a slit width of 5-5 nm (Copyright 
© 2014, Royal Society of Chemistry, Reprinted with permission from ref (220)). 
An NMR titration experiment was performed in order to investigate the changes in 
the chemical shifts of the aromatic protons during the reduction.  Figure 100 shows 
the partial 1H NMR spectra of the probe before (Figure 100a) and after (Figure 100b) 
Na2S addition in CD3CN. The NMR spectrum clearly shows that, all the aromatic 
protons of probe 1 were shifted upfield due to the formation of electron donor amine 
group as expected.   
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Figure 100. Stacked partial 1H-NMR spectra probe 1 (A) and the same spectrum after the 
addition of Na2S (B) in acetonitrile-D3 at 25 oC (Copyright © 2014, Royal Society of 
Chemistry, Reprinted with permission from ref (220)). 
In addition, mass spectral (Figure 101) data following sulfide treatment of the probe 
1, supports our structure assignment for the reduction product). 
 
 
	  
Figure 101. Mass spectrum of Compound 1 after addition the addition of Na2S (Calcd: 
1094.568  [M+Na]+ , Found:1094.563 [M+Na]+, ∆=4.52 ppm.) (Copyright © 2014, Royal 
Society of Chemistry, Reprinted with permission from ref (220)). 
We also wanted to demonstrate the utility of the probe 1 in living cells (Figure 102). 
Human breast adenocarcinoma cells (MCF-7) were grown to confluence at 37°C 
under 5% CO2 in Dulbecco’s Modified Eagle Serum (DMEM) containing 1% 
penicillin/streptomycin, 10% fetal bovine serum (FBS) and 2 mM L-glutamine.  
MCF-7 cells were incubated with 4.0 µM probe 1 for 30 min. at 37 oC and then 
washed with physiological saline to remove any excess amount of the probe.  Under 
these conditions, confocal microscope image shows intense intracellular red 
fluorescence emission upon excitation at 633 nm. The cells which were treated with 
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probe 1, were then incubated with 400 µM Na2S in HEPES buffer for 2 hours at 37 
oC.  Under microscope, the quenching of intracellular fluorescence intensity of the 
probe 1 was clearly visible for the sulfide treated cells. Again, as noted for the 
spectroscopic experiments, the quenching seems to be only limited by the duration of 
incubation, the reaction seems to be very fast.  Confocal microscope imaging was 
performed with a Leica TCS SP2 laser scanning microscope with an oil-immersion 
40x objective lens. 
 
Figure 102. Confocal microscopy images of showing the H2S response of probe 1 in MCF-7 
cells. (Left) MCF-7 cells incubated with probe 1 (4 µM) for 30 min. at 37 oC (Right) MCF-7 
cells incubated with probe 1 (4 µM) for 2 h, after which 100 eqv. Na2S was added. The cells 
were imaged after additional incubation for 30 min. at 37 oC (Copyright © 2014, Royal 
Society of Chemistry, Reprinted with permission from ref (220)). 
 Conclusion 7.4.
We developed a sensitive H2S detection probe which is operating much faster 
compared to existing H2S probes.  Azide based probe 1 gives response the H2S 
through reduction of two azido groups, resulting instant quenching of the emission 
and noticeable red shift in absorbance. The highly selective and sensitive nature of 
the probe 1 for H2S over other reactive species demonstrates the potential utility of 
the probe 1.  Moreover, due to the presence of hydrophilic moieties in its structure, 
the probe is water soluble and thus appropriate for biological applications. Thus, 
added H2S was successfully imaged inside the cells, suggesting a possibility of 
imaging endogenously produced H2S in real-time and in the near IR region of the 
spectrum.   
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 Experimental Details 7.5.
General: 1H NMR and 13C NMR spectra were recorded on Bruker DPX-400 
(operating at 400 MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 with 
tetramethylsilane as internal standard. All spectra were recorded at 250C and 
coupling constants (J values) are given in Hz.  Chemical shifts are given in parts per 
million (ppm). Absorption spectra were performed by using a Varian Cary-100 
spectrophotometer. Fluorescence measurements were conducted on a Varian Eclipse 
spectrofluorometer. Mass spectra were recorded on Agilent Technologies 6530 
Accurate-Mass Q-TOF LC/MS. Reactions were monitored by thin layer 
chromatography using Merck TLC Silica gel 60 F254. Silica gel column 
chromatography was performed over Merck Silica gel 60 (particle size: 0.040-0.063 
mm, 230-400 mesh ASTM). Compound 4 was synthesized according to literature.13 
All other reagents and solvents were purchased from Aldrich and used without 
further purification.  
Synthesis of Compound 3: 
 
Compound 3 was synthesized according to literature with slight modifications.224 CuI 
(95 mg, 0.5 mmol), 25% aqueous ammonia (0.95 ml, 12.5 mmol of NH3), and water 
(2.5 ml) were stirred in a round bottomed flask at room temperature. After 30 min., 
4- formylphenylboronic acid (2) (745 mg, 5 mmol), NaN3 (1,625 g, 25 mmol), and 
water (5.5 ml) were added to the reaction mixture. The solution was stirred for 24 h 
at room temperature in an open atmosphere to allow the air to get into the reaction 
medium. Aqueous NaOH (2N, 7.5 ml) was added and extraction was performed with 
ethylacetate three times. Organic phase was gathered, dried over Na2SO4 and 
evaporated in vacuo. Column chromatography was performed using with the eluent 
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DCM: Hexane (1:1) to get the desired product. 1H NMR (400 MHz, Chloroform-d) δ 
9.92 (s, 1H), 7.86 (d, J = 8.5 Hz, 1H), 7.13 (d, J = 8.5 Hz, 1H). 13C NMR (100 MHz, 
Chloroform-d) δ 190.56, 146.28, 133.26, 131.54, 119.49. 
Synthesis of Compound 5: 
 
Compound 4 (0.6 g, 1.01 mmol) was dissolved in 400 ml Ar-degassed DCM in a 1 L 
round bottom flask and 2,4-dimethyl-3-ethyl-pyrrole (0.3 ml, 2.22 mmol) was added. 
This was followed by the addition of 1-2 drops of TFA. The mixture was stirred 
about 3 hrs at room temperature. After TLC showed no starting material, p-
chloroanil (297 mg, 1.21 mmol) was poured into the reaction vessel. After 1 hr 
stirring, 6 ml TEA was added dropwise to the solution over a period of 5 min. The 
color turned out to be brown and it was stirred for an additional 30 min. Lastly, 6 ml 
BF3.OEt2 was added to the reaction in a dropwise manner over a period of 5 min, as 
well. The mixture was left to stir overnight at room temperature. Extraction was 
performed with water (3x300 ml) and the organic layer was dried over anhydrous 
Na2SO4. After concentrating the organic layer in vacuo, it was purified by flash 
column chromatography with the eluent 5% TEA: DCM. The product was obtained 
as red solid (367 mg, 42%). 1H NMR (400 MHz, Chloroform-d) δ 6.56 (s, 2H), 4.24 
(t, J = 5.0 Hz, 2H), 4.15 – 4.05 (m, 4H), 3.85 (t, J = 5.0 Hz, 4H), 3.79 – 3.48 (m, 
26H), 3.40 (s, 3H), 3.37 (s, 6H), 2.54 (s, 6H), 2.31 (dd, J = 9.5, 5.2 Hz, 4H), 1.43 (s, 
6H), 1.01 (t, J = 7.3 Hz, 6H). 
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Synthesis of Compound 1: 
	  
	  
	  
	  
	  
	  
	  
	  
	  
In a 100 ml round-bottomed flask containing 50 ml benzene, compound 5 (150 mg, 
0.17 mmol) and 4-azidobenzaldehyde (56 mg, 0.38 mmol), piperidine (0.3 ml) and 
acetic acid (0.3 ml) were added. The mixture was heated under reflux by using a 
Dean Stark trap and progress of the reaction was monitored by TLC. When all the 
starting material had been consumed, the mixture was cooled to room temperature 
and solvent was evaporated. Water (100 ml) added to the residue and the product was 
extracted into the DCM (2 x 100 ml).  Organic phase was dried over Na2SO4, 
evaporated and residue was purified by silica gel column chromatography using 
DCM as the eluent. (67 mg, 35%). 1H NMR (400 MHz, Chloroform-d) δ 7.73 (d, J = 
16.6 Hz, 2H), 7.62 (d, J = 8.6 Hz, 4H), 7.22 (d, J = 16.8 Hz, 2H), 7.07 (d, J = 8.5 Hz, 
4H), 6.59 (s, 2H), 4.26 (dd, J = 5.8, 3.9 Hz, 2H), 4.15 (dd, J = 5.8, 3.8 Hz, 4H), 3.87 
(t, J = 4.8 Hz, 4H), 3.80 – 3.44 (m, 26H), 3.40 (s, 3H), 3.36 (s, 6H), 2.67 – 2.59 (m, 
4H),1.49 (s, 6H), 1.19 (t, J = 7.6 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 153.90, 
153.83, 140.01, 138.98, 134.66, 134.27, 133.98, 128.95, 128.77, 127.50, 124.19, 
119.55, 119.39, 108.25, 72.77, 71.92, 70.88, 70.72, 70.66, 70.57, 69.76, 69.26, 58.99, 
18.36, 14.02, 11.46, 1.00. Calcd: 1147.54 [M+Na]+ , Found: 1147.528 [M+Na]+, 
∆=10.45 ppm. 
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NMR Data of Compound 1 after addition the addition of Na2S:  
 
1H NMR (400 MHz, CD3CN) δ 7.53 (d, J = 16.6 Hz, 2H), 7.43 (d, J = 8.5 Hz, 4H), 
7.28 (d, J = 16.7 Hz, 2H), 6.73 (d, J = 7.5 Hz, 6H), 4.56 (d, J = 9.1 Hz, 2H), 4.25 – 
4.20 (m, 4H), 4.19 – 4.11 (m, 4H), 3.87 – 3.43 (m, 26H), 3.34 (s, 3H), 3.31 (s, 6H), 
2.69 (m, 4H), 1.54 (s, 6H), 1.18 (t, J = 7.4 Hz, 6H). 
 
UV-Vis Titration Experiments: 
Titrations of probe 1 with Na2S: 60 µL portions of 100 µM stock solution of probe 1 
in acetonitrile were added aliquots of 20 mM Na2S solutions (in 20 mM HEPES, 
pH=7.20, 25 °C), (30, 15, 7.5, 3, 1.5, 0.75 µL). Volumes of these solutions were 
adjusted to 3 ml (HEPES: CH3CN, 40:60, v/v). UV-vis absorption spectra were 
recorded at room temperature. 
Detection Limit: 
Fluorescence titrations were employed to determine detection limit of probe 1. 
According to reported method,225,226 by measuring of emission intensity of  probe 1 
in absence of Na2S by 7 times, standard deviation of blank measurements were 
recorded. A linear relationship between the fluorescence intensity and Na2S 
concentration was acquired and according to equation,  
 
detection limit = 3s/m, 
 
where s is the standard deviation of 7 blank measures, m is the slope of emission 
intensity versus Na2S concentration graph.  This calculation gives the detection limit of 
probe 1 as 0.34 µM. 
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CHAPTER 8 
Persistent Luminescent Nanoparticles (PLNP) 
Mediated Activation of Photosensitizers for 
Photodynamic Therapy 
 
 
 
Ozdemir, T.; Kolemen, S.; Tanriverdi- Ecik, E.; Yan, X.-P.; Akkaya, E. U., in 
preparation 
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 Objective 8.1.
PLNP-BODIPY nanoconstruct is designed to be activated in cancer cells and 
generated singlet oxygen and being a selective agent, it is predicted to destroy tumors 
the way PDT does, but without any need for external excitation. This project holds 
great potential to offer a solution to one of the most critical obstacle for the prevalent 
application of photodynamic therapy. 
 Introduction 8.2.
Photodynamic therapy is based on the activation of a nontoxic photosensitizer by an 
appropriate light source in the presence of molecular oxygen. In other words, there 
are three main components of photodynamic therapy: photosensitizer, light, and O2. 
The combination of these components generates the cytotoxic reactive oxygen 
species. One of the important points that should be addressed is the selectivity of the 
photosensitizers. The selective accumulation of photosensitizers can be achieved 
with several approaches including bioconjugation of tumor-specific agents like 
monoclonal antibodies, epidermal growth factors and encapsulation in nanocarriers 
such as silica-based nanoparticles.227-229 In this respect, up-to-date approach is the 
“smart” photosensitizing agents.114 These agents offer the selective activation 
through the tumor-specific parameters. In this approach, photosensitizer can be 
designed to be self-quenched via aggregation or its activity is reduced with the 
quenchers. The activation process is triggered due to the acidic or reducing 
characteristics of tumor’s medium, thus, disaggregation or separation of quenchers 
take place and photodynamic action is achieved.122 With this approach, specific 
activation of photosensitizers brings important advantages compared to non-specific 
phototoxicity. Another important parameter that affects the efficacy of photodynamic 
action is the light. Light used in photodynamic therapy should be in the visible 
region, practically 600-900 nm to be able to pass deeply in the tissue, to prevent self-
absorption of tissues and to lower the light scattering.230 However, the penetration of 
light through mammalian tissue reaches only a few millimeters.231 Thus, to eliminate 
this problem, we aimed to incorporate persistent luminescent nanoparticles (PLNP). 
Persistent Luminescent Nanoparticles (PLNP) is a comparatively new technology to 
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construct long lasting luminescent nanoparticles which emits in the red to near-
infrared range. These type of materials can emit in visible region for hours after the 
irradiation source has been switched off.123 Visible light or UV can be used to 
irradiate the material. The storage of the excitation energy by traps and its slow 
release via thermal energy is the reason of the long decay time. This new technology 
can permit optical excitation before in vivo local or systemic injection.131 Also, its 
luminescence can last several hours and helps the reduction of autofluorescence.232 
Therefore, the significant signal-to-noise ratio improvement allows detection in 
rather deep organs. Activation of PLNP-photosensitizer conjugate will be achieved 
by high glutathione concentration present in cancer cells. Glutathione is a thiol 
containing tripeptide and its concentration in tumor cells is higher up to 1000-fold.  
In tumor cells, the irregular blood flow causes hypoxic state, decreased oxygen level 
and so the activity of reductive enzymes increases (high glutathione 
concentrations).118 In previous studies, it was well-stated that GSH is elevated in 
breast cancer,119 colon cancer,120 etc. In the presence of high intracellular 
concentration of glutathione, disulfide bonds are broken. On the other hand, disulfide 
bonds are thermodynamically stable and provide reasonably good stability in the 
bloodstream in the absence of sulfhydryl groups. 
In this design, functionalized PLNP is attached to photosensitizer which is di-styryl 
BODIPY unit having two iodine atoms in its 2 and 6 positions to enhance the 
intersystem crossing (heavy-atom effect) for effective singlet oxygen generation.  
	  
Figure 103. The chemical structure and the functions of the groups attached.  
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In the absence of glutathione, energy transfer process from PLNP to quencher part 
suppresses the activation of photosensitizer-BODIPY. It is known from studies in our 
laboratory that the energy transfer process is more feasible than passing through 
triplet state.233 Therefore, singlet oxygen will not be produced.  The singlet oxygen 
will be produced only if there is higher concentration of glutathione. In this case, 
disulfide linker is expected to be cleaved and detachment from the quencher will 
facilitate the irradiation of BODIPY so singlet oxygen will be generated (Figure 
104). 
	  
Figure 104. The working principle of the target. 
 
 Results and Discussion 8.3.
In our first design, we thought to use Ca0.2Zn0.9Mg0.9Si2O6 doped with Eu2+, Dy3+, 
Mn2+, because afterglow emission maximum is at 690 nm and its persistent 
luminescence can longer more than 24 hour when kept in dark.131  Addition of small 
amount of Dy3+constitutes trap centers and Mn2+ is the ultimate emitting core getting 
energy from electron-hole pair recombination. It is proposed that the red and the 
near-IR emission is the result of the symmetry and the crystal field strength at the 
Mn2+ site. Also, rare-earth ions behave like primary acceptors of the energy that can 
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be given off thermally to Mn2+ for several hours. Long lasting afterglow emission is 
because of the persistence energy transfer from the rare earth ions. In summary, Eu2+ 
is used to generate electron trapped centers, Dy3+ is to form hole-trapped centers15 
and Mn2+ receives energy from the excitation of the electron-hole pairs. 
The persistent luminescent nanoparticles were obtained by using sol-gel approach to 
get small particles as given below (Figure 105).14  
	  
Figure 105. The synthetic route of the PLNP. 
 
To be able to have small sized nanoparticles, sol-gel approach was performed since 
solid-state reaction gives micrometer sized particles. Adequate amounts of 
magnesium nitrate (Mg(NO3)2.6H2O), zinc chloride (ZnCl2), calcium chloride 
(CaCl2.2H2O), europium chloride (EuCl3, 6H2O), dysprosium nitrate (Dy(NO3)3, 
5H2O), manganese chloride (MnCl2, 4H2O), tetraethoxysilane (TEOS) 4 ml of 
deionized water at pH 2 were stirred at room temperature for 1 hour. To see the sol-
gel transition, reaction mixture was kept at 70 °C for additional 2 hours. To get rid of 
water and ethanol, the gel was dried in an oven at 110 °C.   
By using quartz combustion boat, the opaque dry gel was warmed to 1050 °C in a 
weak reductive atmosphere using 5% H2, 95% Ar  for 10 h and then cool to room 
temperature. At the end of this procedure, white powder was obtained. 
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To acquire small particles, with the help of an agate mortar and a pestle, the powder 
was ground. Selective sedimentation was performed to isolate small particles. 5 mM 
NaOH solution at a concentration of 10 mg of PLNP per ml was used to disperse the 
powder by sonication. Distilled water at a concentration of 2.5 mg/ml was added to 
dilute the suspension. To eliminate the larger particles, centrifugation was done. To 
increase the isolation of small particles, acetone corresponding to 25% of the 
supernatant volume was added. Then, centrifugation process was appled one more 
time. With the removal of supernatant, the PLNP was hold in a vacuum oven to dry 
the particles. 
To measure the size of the nanoparticles, dynamic light scattering was performed. 
This technique offers diffusion coefficient of small particles in a liquid and the light 
scattering intensity of the particles as a function of time gives this coefficient. 
According to DLS results seen in Figure 106, synthesized nanoparticles are in the 
range of 100 nm. The second and third runs show that small nanoparticles come 
together and size increases with time because of aggregation.  Additionally, since 
surface has free hydroxyl groups, Zeta potential measurements showed that NPs have 
negative surface electric potential (Figure 106). 
 
 
 
 
 
 
 
 
 
Figure 106. Size of the different nanoparticles determined by DLS (top) and Zeta potential 
measurements (bottom) of  synthesized PLNP. 
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Moreover, the transmission electronic microscopy (TEM) analysis (Figure 107A) 
indicated that our nanoparticles represented a reasonable narrow size distribution, 
with particles diameter ranging from 50 to 100 nm. Also, when we compare our 
TEM image with the one in literature, similar patterns can be interpreted.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 107. Transmission electron microscopy image (scale bar = 200 nm) (A), XRD pattern 
(B) and excitation spectrum (C) of synthesized PLNP. 
 
Furthermore, The X-ray diffraction (XRD) results (Figure 107B) indicated the 
similar peaks with the literature.9 Excitation spectra of our PLNP (Figure 107C) 
showed almost the same pattern as shown below. 
The photosensitizer part is given in Figure 108. 3-chloropropanol was treated with 
sodium azide in DMSO at 60 °C to get 3-azidopropan-1-ol.  Since tosyl group is a 
good leaving group, 3-azidopropyl 4-methylbenzenesulfonate was obtained with the 
tosylchloride in triethylamine. After getting S-(3-azidopropyl) ethanethioate, 
disulfide bridges with two azido functionality was obtained. To acquire the 3-((3-
azidopropyl)disulfanyl)propan-1-amine, Staudinger reaction was performed. Also, to 
have 6-(4-formylphenoxy)hexanoic acid, Williamson-ether synthesis was used. 
(A) (B) 
(C) 
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4-(prop-2-yn-1-yloxy)benzaldehyde and 2,4-dimetylpyrrole were used to obtain 
desired BODIPY and this BODIPY was iodinated on 2 and 6 positions by 
electrophilic aromatic substitutions.  
When we decided to use Ca0.2Zn0.9Mg0.9Si2O6 doped with Eu2+, Dy3+, Mn2+ 
nanoparticles, to get effective spectral overlap between the emission of nanoparticle 
and absorbance of BODIPY derivative, we synthesized mono-styryl BODIPY  
 
  
Figure 108. Previous reaction pathway of target compounds. 
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derivative. Then, click reaction with mono-styryl BODIPY and linker part was 
performed. Since we are not able to get reasonable amount of nanoparticles due to 
the difficulties in synthesis and obtaining small sized particles, we could not 
conjugate photosensitizer part with nanoparticles. The amount of nanoparticles was 
needed to be increased for further modification. However, not only the synthetic 
procedure is highly demanding but also the yield of the nanoparticles and the 
afterglow properties were not adequate so we had to change the type of 
nanoparticles.  
Due to the highly demanding synthesis of persistent luminescent nanoparticles, we 
collaborate with Prof. Xiu-Ping Yan at State Key Laboratory of Medicinal 
Chemical Biology (Nankai University) where the synthesis and characterization 
of nanoparticles that we used in the study were done. The nanoparticles described 
in the paper “Functional Near Infrared-Emitting Cr3+/Pr3+ Co-Doped Zinc 
Gallogermanate Persistent Luminescent Nanoparticles with Superlong Afterglow for 
in Vivo Targeted Bioimaging” were used.234 These nanoparticles have very intense 
near-IR emission and their afterglow time is comparatively long. Also, these 
nanoparticles are compatible in biological medium and toxicity is very low. Thus, 
these mentioned features permit the long-term in vivo imaging. 
The synthesis of this nanoparticle relies on the citrate-gel method together with 
reducing-atmosphere free calcination. The general composition of the long-persistent 
luminescent nanoparticles (LPLNPs) is Zn2.94Ga1.96Ge2O10:Cr3+, Pr3+. The persistent 
luminescence brightness and duration is dependent on several factors. One of them is 
pH of the starting solution. It was emphasized that pH 5 is a convenient value. 
Another factor is calcination temperature. If the calcination temperature is below 600 
°C, emission is not observed. Also, higher calcination temperatures bring about 
higher emission intensity at 695 nm and a decrease in host emission was observed. 
The explanation for this is the creation of more vacancies of Ge4+, Zn2+, and oxygen. 
Codoping with Pr3+/Cr3+ and introduction of Zn deficiency in zinc gallogermanate 
(ZGGO) host offers an increase in the intensity of persistent luminescence and 
afterglow time. To find optimum codoping composition, several experiments were 
conducted with varying contents. It was observed that the increase in the amount of 
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Cr3+ in ZGGO host is inversely proportional to intensity of persistent luminescence. 
The reason for this is the immediate release of energy of excitation storage and decay 
of afterglow emission.127,235 The brightest afterglow emission is gained with 
Zn3Ga1.96Ge2O10:Cr0.01Pr0.03. The codoping with Pr3+ affects the duration of persistent 
luminescence by altering the trap density and depth since trivalent lanthanide ions 
with plentiful energy levels of 4f electron configurations allows more effective traps 
to increase the brightness and duration of the afterglow.236,237  The introduction of 
Zn2+ improves the afterglow emission and enables the persistent energy transfer 
between host emission and Cr3+ by creating more cation vacancies as hole traps to 
improve afterglow intensity.238  
The size of the nanoparticles were characterized by transmission electron microscopy 
(TEM) which gives 48.7 ± 15.3 nm (calculated from 100 randomly selected 
particles) and dynamic light scattering analysis which demonstrates a hydrodynamic 
diameter of 71.3 nm with a polydispersity index of 0.253.  
Polyethylene groups were attached to persistent luminescent nanoparticles by using 
3-amino propyltriethoxysilane (APTES)-functionalized LPLNPs and succinimidyl 
carbonate-poly (ethylene glycol)-carboxymethyl in order to develop 
biocompatibility, solubility, colloidal stability, and blood circulation time. 
In Figure 109, emission and excitation properties of LPLNPs powder, undoped 
ZGGO and aqueous solution of LPLNPs are given. The emission band centered at 
695 nm with excitation at 254 nm is because of 2E → 4A2 transition in distorted Cr3+ 
ions in gallogermanate.235 There are four different peaks in the excitation spectrum. 
Peak at 260 nm is caused by the combination of the ZGGO host excitation and the O-
Cr charge transfer band.239 3d intrashell transitions of Cr3+ lead to other peaks at 407 
nm (4A2 → 4T1 (te2) transition), 464 nm (4A2 → 4T1 (t2e) transition), and 558 nm (4A2 
→ 4T2 transition). Also, electrons-holes recombination between the native defects 
(oxygen-defect, interstitial monovalent Zn, Ge-related centers, Zn-defect, and 
gallium−oxygen vacancy pair) of ZGGO host triggers a broad white emission band 
in the range of 350−660 nm with a maximum emission at 505 nm (Figure 109b).240 
151	  
	  
However, host emission is quenched with codoping with Pr3+/Cr3+ because of 
nonradiative energy transfer between the host emission and the absorption of Cr3+ 
 
Figure 109. (a) Excitation (blue curve, at the emission of 695 nm) and emission (red curve, 
excitation at 254 nm) spectra of the LPLNPs powder. The inset shows the digital photos of 
LPLNPs powder under 254 nm UV excitation (left), and 5 s after stopping UV irradiation 
(right). (b) Excitation spectra of undoped ZGGO powder (red curve) and LPLNPs powder 
(blue curve) at the emission of 695 nm, and emission spectra of undoped ZGGO powder 
(black curve) under the excitation of 254 nm. The inset shows the digital photo of undoped 
ZGGO powder under 254 nm UV excitation. (c) Excitation (blue curve, emission at 700 nm) 
and emission (red curve, excitation at 254 nm) spectra of the aqueous dispersion of LPLNPs 
(1 mg ml−1). The inset shows the digital photo of the aqueous dispersion of LPLNPs under 
254 nm UV excitation (Copyright © 2013, American Chemical Society, Reprinted with 
permission from ref (234)). 
 (4A2 → 4T1 (te2), 4A2 → 4T1 (t2e) and 4A2 → 4T2 transition) resulting from their large 
spectral overlap (Figure 109b). The aqueous LPLNPs show a bright emission 
centered at 700 nm and very low emission at 521 nm upon excitation at 254 nm 
(Figure 109c) which is the demonstration of effective energy transfer in water. Other 
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excitation peaks disappeared in aqueous LPLNPs because of the presence O-H 
vibrations. Afterglow intensity is high and it is durable up to 24 hours after ceasing 
the excitation source. Thus, these long-lasting nanoparticles are suitable for in vivo 
imaging.  
 
Figure 110. The proposed mechanism for persistent energy transfer between ZGGO and Cr3+ 
(Copyright © 2013, American Chemical Society, Reprinted with permission from ref (234)). 
The proposed mechanism for energy transfer is given in Figure 110. With the 
excitation at 254 nm, ZGGO host electrons are excited from valence band to the 
conduction band. This is followed by the capturing of free excited electrons by native 
defects upon non-radiative relaxation. Ceasing the excitation source causes the 
recombination of electrons and holes from native defects causing broad afterglow 
emission. Due to the spectral overlap between the host emission and the three 
absorption band peak of Cr3+, energy of host is given to the Cr3+ ion in a persistent 
manner.241 This persistent energy transfer allows the concurrent raise of the 3d 
electrons of Cr3+ from ground state to (4A2) to three dissimilar energy levels of 
excited-states (4T1 (te2), 4T1 (t2e) and 4T2). The electrons in 4T1 (te2) are caught by 
shallow electron traps by conduction band and by non-radiative processes, they may 
go to deep traps.127 By the way, the energy corresponding traps are occupied by 4T1 
(t2e) and 4T2 electrons upon tunneling.242 When the energy transfer terminates, the 
released electrons from shallow traps are combined with ionized Cr3+ yielding a 
bright afterglow at first. Then, the gradual opposite tunneling recombination for 
deeper traps’ electrons takes place afterwards and this arises the superlong afterglow. 
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However, since we changed the nanoparticles that we used the absorption and 
emission properties were altered. Hence, a new BODIPY dye was designed and 
synthesized via a multistep approach to have appropriate energy level match with the 
new nanoparticles’ characteristics (Figure 111). Two successive Knoevenagel 
condensation of iodinated BODIPY on 2&6 positions with 4-methoxy benzaldehyde  
 
 
Figure 111. Current reaction pathway of target compounds. 
and 6-(4-formylphenoxy)hexanoic acid were carried out. With the help of click 
reaction, 3-((3-azidopropyl)disulfanyl)propan-1-amine and distyryl BODIPY 
derivative were attached. We used 4-methoxy benzaldeyde to enhance the solubility 
in Knoevenagel condensation condition. Synthesis of the target molecule (PLNP-17) 
will be completed after the introduction of the quencher group and subsequent 
attachment of this compound to nanoparticles. The spectral investigation of PLNP 
and quencher units is in agreement to have effective quenching efficiency. 
Quenching range of BHQ-3 is between 620 and 730 nm and it is the preferred 
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quencher for dyes emitting in the range of 640-775 nm which is well-suited with the 
emission of PLNP. 
We also synthesized compound 16 in order to validate our design principle (Figure 
112). Cleavage of disulfide linker leaves free thiol groups and to account for this, 
free thiol group containing photosensitizer was attached successfully to 
nanoparticles. 
 
 
Figure 112. The synthetic pathway of compound 16 and PLNP-Compound 16 
conjugate. 
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Figure 113. The (a) digital photograph and (b) absorbance spectra of only PLNP and 
PLNP-Compound 16 conjugate. 
Figure 113 implies the attachment of compound 16 to nanoparticles. Both the digital 
photograph and absorbance spectra of only PLNP and PLNP-Compound 16 clearly 
show the conjugation between these units. 
Singlet oxygen generation ability of PLNP-Compound 16 was investigated using 
photobleaching of water soluble singlet oxygen trap 2’-(Anthracene-9,10 diylbis 
(methylene))dimalonic acid (ADMDA). As given in Figure 114, ADMDA reacts 
with 1O2 and absorbance at 376 nm decreases. Since the nanoparticles are activated 
at 254 nm so 254 nm UV lamp was used to irradiate the sample.  
	  
Figure 114. Reaction of singlet oxygen with 2,2'-(Anthracene-9,10-
diylbis(methylene))dimalonic acid. 
In control experiments, only trap and only nanoparticles containing solutions were 
monitored for 10 min intervals for 20 min in dark and 60 min under 254 nm 
irradiation. As expected, no remarkable decrease was observed (Figure 115). 
However, PLNP-Compound 16 conjugate demonstrated a significant decrease upon 
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irradiation which shows the ability of producing singlet oxygen and so the 
photodynamic action of the conjugate. 
 
Figure 115. Relative singlet oxygen efficiency of only trap, only PLNP and PLNP-
Compound 16 conjugate in aqueous solution detected by the absorbance decrease of 2’-
(Anthracene-9,10 diylbis (methylene))dimalonic acid (ADMDA) at 376 nm with time. 
During 20 minutes, the samples were kept under dark and the following 60 min; the samples 
were irradiated with 254 nm light using UV lamp. 
 
As stated above, for practical applications and potential use of this concept, quencher 
moiety will be attached as a control unit.  
 
 Conclusion  8.4.
The design of the PLNP-BODIPY nanoconstruct is achieved and singlet oxygen 
generation experiments showed the efficiency of the photosensitizer activated 
through the energy transfer from PLNP to BODIPY. This construct is a promising 
candidate that signifies a solution to eliminate light issue in photodynamic therapy. 
Addition of control unit will enhance the use of these constructs for practical 
applications.    
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 Experimental Details 8.5.
General: 1H NMR and 13C NMR spectra were recorded on Bruker DPX-400 
(operating at 400 MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 with 
tetramethylsilane as internal  standard. All spectra were recorded at 25 °C and 
coupling constants (J values) are given in Hz.  Chemical shifts are given in parts per 
million (ppm). Absorption spectra were performed by using a Varian Cary-100 
spectrophotometer. Fluorescence measurements were conducted on a  Varian Eclipse 
spectrofluorometer. Mass spectra were recorded on Agilent Technologies 6530  
Accurate-Mass Q-TOF LC/MS. Reactions were monitored by thin layer 
chromatography using  Merck TLC Silica gel 60 F254. Silica gel column 
chromatography was performed over Merck Silica gel 60 (particle size: 0.040-0.063 
mm, 230-400 mesh ASTM). Compound 7 was synthesized according to literature.243 
All other reagents and solvents were purchased from Aldrich and used without 
further purification.  
Synthesis of Compound 8: 
 
In a 250 ml round-bottom flask, compound 7 (500 mg, 1.32 mmol) and I2 (840 mg, 
3.30 mmol) were dissolved in ethanol (150 ml). Iodic acid, HIO3 (466 mg, 2.6 mmol) 
was dissolved in a few drops of water and was added into the previous solution. The 
reaction mixture was heated to 50 °C and stirred until the starting compounds were 
disappeared at this temperature. When the reaction was completed, saturated sodium 
thiosulfate solution was added (50 ml) and extraction with dichlorometane followed 
by a was with water was performed. Organic layer was dried with Na2SO4 and 
evaporated under reduced pressure. The final product was purified by silica gel 
column chromatography using DCM/Hexane (1:1, v/v). Fraction containing target 
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compound was collected, after removal of solvent under reduced pressure, final 
product was obtained (330 mg, 40%). 1H NMR (CDCl3, 400 MHz, δ ppm) 7.1 (d, 
J=8.8 Hz, 2H), 7.0 (d, J=8.8 Hz, 2H), 4.7 (s, 2H), 2.6 (s, 6H), 2.5 (s, 1H), 1.3 (s, 6H). 
Calcd: 629.96 [M]+ , Found: 629.76 [M]+ 
  
Synthesis of Compound 2: 
 
Compound 1 (10.0 g, 106 mmol) was dissolved in 70 ml DMSO and NaN3 (14.0 g, 
212 mmol) was added. The reaction mixture was heated to 100 °C and stirred for 
overnight at this temperature. Then, water (100 ml) was added and the product was 
extracted with the ethylacetate (3 x 100 ml). Organic phases were combined, dried 
over Na2SO4 and the volatiles were evaporated under reduced pressure. The residue 
was used without further purification (4g, 37 %).  1H NMR (CDCl3, 400 MHz, δ 
ppm) 3.7 (t, J=6.0 Hz,  2H), 3.3 (t, J=6.6 Hz, 2H), 1.7 (m, 2H). 13C NMR (CDCl3, 
100 MHz, δ ppm) 59.6, 48.4, 31.4. 
Synthesis of Compound 3: 
 
In a 250 ml round-bottom flask, compound 2 (3.5 g, 35 mmol) was dissolved in 100 
ml DCM and triethylamine (7.3 ml, 52 mmol) was added. Then, reaction mixture 
was cooled to 0 °C using ice bath and p-toluene sulfonyl chloride (7.9 g, 42 mmol) 
was added portion-wise. After stirring for 12 hours at room temperature, extraction 
was performed with water. Organic layer was dried over Na2SO4 and the solvent was 
evaporated under reduced pressure. The final product was purified by silica gel 
column chromatography using DCM/Hexane (1:1, v/v). Fraction containing target 
compound was collected, after removal of solvent under reduced pressure, final 
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product was obtained. (4.8 g, 55%) 1H NMR (CDCl3, 400 MHz, δ ppm) 7.8 (d, J=8.3 
Hz, 2H), 7.3 (d, J=8.6 Hz, 2H), 4.1 (t, J=6.0 Hz, 2H), 3.3 (t, J=6.5 Hz, 2H), 2.4 (s, 
3H), 1.84 (p, J=6.3, J=6.1 Hz, 2H). 13C NMR (CDCl3, 100 MHz, δ ppm) 145.1, 
132.7, 130.3, 129.9, 127.9, 127.0, 67.1, 47.3, 28.4, 21.6. 
Synthesis of Compound 4: 
 
Compound 3 (4.8 g, 18 mmol) was dissolved in 60 ml acetonitrile and potassium 
thioacetate (4.3 g, 37 mmol) was added to resulting solution. The reaction mixture 
was heated to 60 °C and stirred for 12 hours at this temperature. Then, resulting 
mixture was filtered using suction filtration and acetonitrile was evaporated under 
reduced pressure. After extraction with DCM, organic phase was dried over Na2SO4 
and the solvent was evaporated under reduced pressure. The residue was used 
without further purification (2.0 g, 67 %). 1H NMR (CDCl3, 400 MHz, δ ppm) 3.4 (t, 
J=6.6 Hz, 2H), 2.9 (t, J=7.1 Hz, 2H), 2.3 (s, 3H), 1.85 (p, 2H, J=6.8, J=6.9 Hz). 13C 
NMR (CDCl3, 100 MHz, δ ppm) 50.1, 30.6, 28.9, 26.1. 
Synthesis of Compound 5: 
 
Compound 4 (587 mg, 3.70 mmol) was dissolved in 25 ml dry methanol and 
potassium methoxide (1.5 ml, 7.4 mmol) was added. The reaction mixture was 
stirred for 2 hours at room temperature. Then, 0.6 ml DMSO was added and resulting 
mixture was stirred and for additional 20 hours at this temperature. Then the pH was 
adjusted to 7 by using amberlite CG-50-II and the reaction mixture was filtered using 
suction filtration and solvent was evaporated under reduced pressure. The residue 
was purified by silica gel column chromatography using DCM/Hexane (1:1, v/v). 
Fraction containing target compound was collected, after removal of solvent under 
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reduced pressure, the final product was obtained (300 mg, 35%). 1H NMR (CDCl3, 
400 MHz, δ ppm) 3.4 (t, J=6.5 Hz, 4H), 2.8 (t, J=7.0 Hz, 4H), 1.9 (p, J=6.8, 6.7 Hz, 
4H)  
Synthesis of Compound 6: 
 
In a 250 ml round-bottom flask, compound 5 (500 mg, 2.2 mmol) was dissolved in 7 
ml THF and 30 µl water was added. Then, reaction mixture was cooled to 0oC using 
ice bath and triphenylphosphine (450 mg, 2.2 mmol) was added portion-wise. After 
stirring for 18 hours at room temperature, THF was evaporated under reduced 
pressure. The resulting mixture was dissolved in ethyl acetate and 1N HCl was 
added. Then, aqueous phase was separated and the treated with NaOH (10%, w/w) to 
adjust pH to 10-12. Ethyl acetate was used for extraction and organic phase was 
dried over Na2SO4 and the solvent was evaporated under reduced pressure. The final 
product was purified by silica gel column chromatography using DCM/methanol 
(10:1, v/v). Fraction containing target compound was collected, after removal of 
solvent under reduced pressure, final product was obtained. (100 mg, 23%) 1H NMR 
(CDCl3, 400 MHz, δ ppm) 3.7 (broad, 2H), 3.4 (t, J=6.4 Hz, 2H), 2.9 (t, J=6.8 Hz, 
2H), 2.8 (t, J=7.3 Hz, 4H), 1.99-1.93 (m, 4H)  
Synthesis of Compound 9: 
 
K2CO3 (3.2 g, 23 mmol) was added into 200 ml of acetonitrile and then to this 
solution, 4-hydroxybenzaldehyde (460 mg, 3.7 mmol) and 6-bromophenylhexanoic 
acid (1.1 g, 5.6 mmol) was added. After addition of catalytic amount of 18-crown-6 
the resulting mixture was heated at reflux for 2 days. The solution was then filtered 
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and the residue was washed with acetonitrile two times. The residue was dissolved in 
water and neutralized with 4 M HCl. A white precipitate was formed. The mixture 
was filtered and the solution was concentrated by rotary evaporation under vacuum. 
The crude product was purified by column chromatography using MeOH: DCM 
(5:95, v/v) as the eluent to afford product 9 as a white solid (98.4 mg, 74%). 1H 
NMR (400 MHz, CDCl3) δ 9.90 (s, 1H), 7.85 (d, J = 8.9 Hz, 2H), 7.01 (d, J = 8.6 Hz, 
2H), 4.07 (t, J = 6.4 Hz, 2H), 2.43 (t, J = 7.4 Hz, 2H), 1.95 – 1.81 (m, 2H), 1.76 (dt, J 
= 15.0, 7.5 Hz, 2H), 1.63 – 1.51 (m, 2H). 
Synthesis of Compound 10: 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, compound 8 (225 mg, 
0.36 mmol) and compound 9 (78.0 mg, 0.36 mmol) piperidine (0.15 ml) and acetic 
acid (0.15 ml) were added. The mixture was heated under reflux with a Dean Stark 
trap and progress of the reaction was monitored by TLC. When all the starting 
materials were consumed, the mixture was cooled to room temperature and the 
solvent was evaporated. Water (100 ml) added to the residue and the product was 
extracted into the DCM (1x 100 ml).  Organic phase dried over Na2SO4 and the 
solvent was evaporated. The residue was purified by silica gel column 
chromatography using MeOH: DCM (5:95, v/v) as the eluent to give 10 (140 mg, 
53%). 1H NMR (CDCl3, 400 MHz, δ ppm) 8.2 (d, J=17 Hz, 1H), 7.6 (d, J=8.8 Hz, 
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2H), 7.5 (d, J=17 Hz, 1H), 7.2 (d, J=8.8 Hz, 2H), 7.1 (d, J=8.7 Hz, 2H), 6.9 (d, J=8.8 
Hz, 2H), 4.8 (s, 2H), 4.0 (t, J=6.8 Hz, 2H), 2.7 (s, 3H), 2.6 (s, 1H), 1.8-1.6 (M, 8H), 
1.4 (s, 3H), 1.3 (s, 3H). 13C NMR (CDCl3, 100 MHz, δ ppm): 177.7, 160.2, 158.4, 
156.5, 150.7, 146.1, 144.7, 139.7, 139.1, 132.1, 130.4, 129.43, 129.40, 129.3, 129.2, 
129.1, 127.9, 116.4, 115.9, 115.0, 114.9, 114.8, 67.7, 56.1, 56.0, 53.4, 47.4, 42.5, 
33.8, 31.5, 29.2, 26.4, 24.7, 21.4, 17.6, 17.1. Calcd: 849.29 [M+H]+ , Found: 848.11 
[M+H]+ 
 
Synthesis of Compound 11: 
 
To the solution of the compound 10 (138 mg, 0.18 mmol) in a 6:0.5:0.5 mixture of 
CHCl3, EtOH  and water; compound 6 (38 mg, 0.18 mmol), 7.3 mg sodium 
ascorbate, 4.6 mg CuSO4 and 3-4 drop Et3N were added and it was stirred at room  
temperature for three days. The crude product was purified by column 
chromatography using MeOH: DCM (5:95, v/v) as the eluent to afford product 11 
(20 mg, 10%).1H NMR (CDCl3, 400 MHz, δ ppm) 8.2 (d, J=17 Hz, 1H), 7.6 (d, 2H, 
J=8.7 Hz), 7.5 (d, J=17 Hz, 1H), 7.2 (d, J=8.7 Hz, 2H), 7.1 (d, J=8.8 Hz, 2H), 6.9 (d, 
J=8.8 Hz, 2H), 4.5 (s, 2H),4.0 (t, J=6.7 Hz, 2H), 3.5 (m, 2H),  2.8 (t, J=6.7 Hz, 2H), 
2.7 (s, 3H), 2.4-2.3 (m, 4H), 2.1-1.7 (m, 8H), 1.5 (s, 3H), 1.4 (s, 3H), 1.3 (m, 4H). 
13C NMR (CDCl3, 100 MHz, δ ppm): 213.7, 178.3, 160.2, 159.1, 156.5, 150.6, 
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146.1, 144.7,  143.6, 139.8, 139.1, 132.5, 132.1, 129.5, 129.3, 129.1, 127.7, 123.0, 
116.4, 115.7, 114.8, 85.9, 82.2, 67.7, 62.0, 49.6, 48.5, 35.1, 34.4, 33.7, 29.6, 29.4, 
29.2, 28.8, 28.2, 24.7, 24.4, 22.6, 17.6, 17.1, 16.1, 14.1. Calcd: 1056 [M+H]+ , 
Found: 1060 [M+H]+ 
Synthesis of Compound 12: 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, compound 8 (230 mg, 
0.37 mmol), p-anisaldehyde (30.0 mg, 0.22 mmol), piperidine (0.20 ml) and acetic 
acid (0.20 ml) were added. The mixture was heated under reflux with a Dean Stark 
trap and progress of the reaction was monitored by TLC. When all the starting 
materials was consumed, the mixture was cooled to room temperature and solvent 
was evaporated. Water (100 ml) added to the residue and the product was extracted 
with DCM (1x 100 ml).  Organic phase was dried over Na2SO4 and the solvent was 
evaporated. The residue was purified by silica gel column chromatography using 
DCM: hexane (1:1, v/v) as the eluent to give compound 12 (67 mg, 25%). 1H NMR 
(400 MHz, CDCl3) δ 8.15 (d, J = 16.6 Hz, 1H), 7.62 (d, J = 8.7 Hz, 2H), 7.56 (d, J = 
16.6 Hz, 1H), 7.21 (d, J = 8.7 Hz, 2H), 7.15 (d, J = 8.7 Hz, 2H), 6.96 (d, J = 8.7 Hz, 
2H), 4.81 (d, J = 2.4 Hz, 2H), 3.89 (s, 3H), 2.77 – 2.65 (m, 3H), 2.58 (s, 1H), 1.50 (s, 
3H), 1.45 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 160.7, 158.5, 156.64, 150.7, 146.1, 
144.8, 139.8, 139.0, 129.5, 129.4, 129.2, 127.98, 116.6, 115.9, 114.3, 76.7, 76.1, 
56.1, 55.4, 17.6, 17.2, 16.2. Calcd: 748.0067 [M]+ , Found: 748.0178 [M]+ 
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Synthesis of Compound 13: 
 
 
In a 100 ml round-bottomed flask containing 50 ml benzene, compound 12 (120 mg, 
0.14 mmol) and compound 9 (33 mg, 0.14 mmol), piperidine (0.20 ml) and acetic 
acid (0.20 ml) were added. The mixture was heated under reflux with a Dean Stark 
trap and progress of the reaction was monitored by TLC. When all the starting 
materials were consumed, the mixture was cooled to room temperature and solvent 
was evaporated. Water (100 ml) added to the residue and the product was extracted 
with DCM (1x 100 ml).  Organic phase was dried over Na2SO4 and the solvent was 
evaporated. The residue was purified by silica gel column chromatography using 
MeOH: DCM (2:98, v/v) as the eluent to give compound 13 (88 mg, 65%). 1H NMR 
(400 MHz, CDCl3) δ 8.15 (d, J = 16.6 Hz, 2H), 7.61 (dt, J = 13.3, 6.5 Hz, 6H), 7.22 
(d, J = 8.7 Hz, 2H), 7.14 (d, J = 8.7 Hz, 2H), 6.96 (t, J = 9.0 Hz, 4H), 4.81 (d, J = 2.4 
Hz, 2H), 4.03 (t, J = 6.3 Hz, 2H), 3.88 (s, 3H), 2.60 (s, 1H), 2.43 (t, J = 7.4 Hz, 2H), 
1.95 – 1.79 (m, 2H), 1.75 (dd, J = 15.2, 7.6 Hz, 2H), 1.64 (dd, J = 9.4, 3.3 Hz, 2H), 
1.58 -1.51 (m, 7H). 13C NMR (100 MHz, CDCl3) δ 177.9, 160.7, 160.2, 158.5, 150.6, 
150.4, 145.7, 145.6, 139.20, 139.1, 138.2, 133.2, 132.0, 129.7, 129.6, 129.5, 129.3, 
129.0, 128.3, 82.7, 67.8, 56.1, 55.4, 48.0, 33.8, 29.7, 28.9, 25.8, 25.6, 24.7, 24.5, 
17.7. Calcd: 988.0938 [M+H]+ , Found: 988.0986 [M+H]+, ∆=4.84 ppm. 
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Synthesis of Compound 14: 
 
 
To the solution of the compound 13 (93 mg, 0.096 mmol) in a 6:0.5:0.5 mixture of 
CHCl3, EtOH  and water; compound 6 (200 mg, 0.096 mmol), 3.8 mg of sodium 
ascorbate, 2.4 mg of CuSO4 and 3-4 drop of Et3N were added and the mixture was 
stirred at room  temperature for three days. The solvent was evaporated and the crude 
product was purified by column chromatography using MeOH: DCM (5:95, v/v) as 
the eluent to afford product 3 (17 mg, 15%). 1H NMR (400 MHz, CDCl3) δ 8.15 (d, J 
= 16.7 Hz, 2H), 7.75-7.7.55 (m, 7H), 7.22 (d, J = 7.8 Hz, 2H), 7.16 (d, J = 7.7 Hz, 
2H), 6.96 (t, J = 8.3 Hz, 4H), 5.31 (s, 2H), 4.56 (t, J = 6.4 Hz, 2H), 4.04 (t, J = 5.6 
Hz, 2H), 3.88 (s, 3H), 2.78 (t, J = 6.9 Hz, 2H), 2.71 (t, J = 6.5 Hz, 2H), 2.42 (dd, J = 
16.7, 7.4 Hz, 4H), 2.06 – 1.91 (m, 2H), 1.86 (s, 2H), 1.75 (dd, J = 14.5, 6.8 Hz, 2H), 
1.63 (d, J = 19.6 Hz, 2H), 1.58 (s, 2H), 1.51 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 
160.7, 160.3, 159.2, 139.1, 139.0, 133.2, 132.5, 129.8, 129.6, 129.5, 129.3, 128.0, 
123.1, 116.6, 115.7, 114.9, 114.3, 67.8, 62.2, 55.4, 49.7, 48.5, 35.2, 34.5, 33.6, 31.9, 
29.7, 29.3, 29.2, 29.2, 29.1, 28.9, 28.3, 25.6, 24.5, 17.7. Calcd: 1210.1337 [M+K]+ , 
Found: 1210.1180 [M+K]+, ∆=12.99 ppm. 
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Synthesis of Compound 15: 
 
Compound 4 (100 mg, 0.62 mmol ) was dissolved in 7 ml EtOH and K2CO3 (95 mg, 
0.69 mmol) was added into solution. After stirring at room temperature for 4 hours, 
water was added and the mixture wasextracted with ethyl acetate. Organic phase 
dried over Na2SO4 and the solvent was evaporated. The residue was purified by silica 
gel column chromatography using DCM: Hexane (1:1, v/v) as the eluent to give 
compound 15 (25 mg, 35%). 1H NMR (400 MHz, CDCl3) δ 3.45 (t, J = 6.5 Hz, 2H), 
2.78 (t, J = 7.0 Hz, 2H), 2.05 – 1.95 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 49.72, 
35.27, 28.26.  
Synthesis of Compound 16: 
 
 
167	  
	  
To the solution of the compound 13 (35 mg, 0.036 mmol) in a 3 ml: 0.25 ml: 0.25 ml 
mixture of CHCl3, EtOH  and water; compound 15 (4.2 mg, 0.036 mmol), 1.5 mg of 
sodium ascorbate, 1.0 mg of CuSO4 and 1-2 drop Et3N are added and it was stirred at 
room  temperature for three days. The crude product was purified by column 
chromatography using MeOH: DCM (5:95, v/v) as the eluent to afford product 16 
(17 mg, 15%). 1H NMR (400 MHz, CDCl3) δ 8.06 (dd, J = 16.5, 12.0 Hz, 2H), 7.73 
(s, 1H), 7.53 (dd, J = 16.2, 10.7 Hz, 6H), 7.14 (d, J = 8.1 Hz, 2H), 7.08 (d, J = 8.2 
Hz, 2H), 6.89 (t, J = 8.5 Hz, 4H), 5.21 (s, 2H), 4.49 (t, J = 6.6 Hz, 2H), 3.96 (t, J = 
6.3 Hz, 2H), 3.80 (s, 3H), 2.63 (t, J = 6.7 Hz, 2H), 2.31-2.7 (m, 4H), 1.85 – 1.71 (m, 
2H), 1.66-1.58 (m, 2H), 1.56 – 1.31 (m, 8H).13C NMR (100 MHz, CDCl3) δ 160.7, 
160.7, 160.3, 160.2, 159.1, 145.6, 145.5, 143.6, 140.9, 140.8, 139.2, 139.0, 138.9, 
138.8, 138.5, 138.2, 133.1, 132.3, 129.8, 129.7, 129.5, 129.3, 129.2, 127.9, 127.5, 
123.4, 67.8, 61.8, 55.3, 49.6, 49.4, 49.2, 49.0, 48.8, 48.5, 48.3, 34.3, 33.9, 29.1, 28.8, 
25.5, 24.6, 17.6, 13.8. Calcd: 1105.1298 [M+Na]+ , Found: 1105.1658 [M+Na]+, 
∆=32.5 ppm. 
Synthesis of PLNP-Compound 16: 
 
To the solution of the compound 16 (20 mg, 0.018 mmol) in 1 ml DMF, 5 mg of 
APTES-functionalized PLNP, (benzotriazol-1-
yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (10 mg, 0.022 mmol) 
and 1 drop of Et3N was added. Resulting solution was stirred overnight in the dark at 
room temperature. The unreacted reagents were removed by centrifugation and the 
resulting PLNP-Compound 16 was washed with DMF with several times 
 
168	  
	  
PDT Measurements:  
1O2 dependent degradation of water soluble trap, 2,2'-(anthracene-9,10- 
diylbis(methylene)dimalonic acid was used to measure photodynamic activity 
because  the absorption of this compound at 376 nm decreases indicating the 
generation of  1O2.  
Measurements were performed using 254 nm UV lamp and samples were irradiated 
with the light source from a 40 cm distance. All samples were bubbled with O2 for 5 
min prior to experiments. D2O was used for the solutions since the lifetime of 1O2 in 
this solution is higher. 
At first, several dark measurements were taken followed by irradiation of the mixture 
at absorption maximum of a sensitizer. Absorbance decrease of trap molecules was 
monitored suggesting singlet oxygen generation in the presence of light and 
sensitizers. 
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CHAPTER 9 
CONCLUSION 
This thesis is aimed to promote the improvement in the topic of the chemistry of 
BODIPY dyes, ion sensing and biologically meaningful molecules, energy transfer 
and as well as photodynamic therapy concepts. Along this way, six different studies 
were employed for those application areas. Of course, straightforward derivatization 
on BODIPY core allows getting functional dyes with desired properties. This is why 
BODIPY dyes have been implemented in distinct utilization and its popularity is 
continuing. 
In the Chapter 3, with the help of tetra-styryl BODIPY derivatives, which are 
isomers, the ion-response properties of BODIPY dyes regarding with Hg (II) binding 
were explored. This study not only enlightens the importance of modification 
positions on BODIPY core, but also provides the near-IR fluorescent dyes which are 
highly important for biological aspects. In this study, Hg (II) selective crown ether 
moiety was incorporated to 1&7 positions and 3&5 positions. According to the 
attached positions, the optical properties of these two isomers demonstrate different 
signaling features. This difference is explained in terms of orbital analysis. 
Moreover, water-soluble equivalents were synthesized to make these dyes 
biologically applicable. In addition to absorbance and fluorescence measurements, 
ITC experiments gave information about binding characteristics. 
Light harvesting concept is harnessed in Chapter 4. Light harvesting energy transfer 
cassettes were synthesized by a convergent synthesis methodology via “click 
chemistry” on versatile BODIPY dyes. Effective through-space energy transfer 
occurs from peripheral BODIPY and distryl-BODIPY units to a 1,3,5,7-tetrastyryl 
functionalized near IR emissive BODIPY core. The resulting cassettes are the first 
examples of tetrastyryl-BODIPY based light harvesting systems and highly 
promising candidates for design and synthesis of similar structures. Furthermore, the 
determination of energy transfer efficiency is performed as a plot of dividing 
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normalized absorption and excitation spectra as a function of wavelength. This 
calculation gives better result considering the large multichromophoric systems. 
Chapter 5 is about the coupling of excitation energy transfer with internal charge 
transfer in the Hg (II) sensing. Internal charge transfer is a known signaling process 
which is highly utilized in the design of chemosensors. Incorporation of this 
mechanism with excitation energy transfer offers increment in pseudo-Stokes shifts 
and signaling characteristics can be observed in a broader range. Thus, in our design, 
two BODIPY dyes were designed as donor and acceptor moieties. Acceptor moiety 
involves the Hg (II) selective crown ether part. With the binding of Hg (II) ions, the 
acceptor moiety shows blue shift resulting increase in spectral overlap and so energy 
transfer.  
Design and synthesis of BODIPY-based probe for biological thiols both 
chromogenically and fluorogenically in aqueous solution is described in Chapter 6. 
Biological thiols are cysteine, homocysteine and glutathione. The abnormal 
concentrations play crucial roles on different deficiencies and diseases. Hence, the 
fluorescent detection of biological thiols is highly important. With this sense, two 
BODIPY-based probes carrying thiol reactive nitro-ethenyl groups were designed 
and characterized with spectroscopic measurements. Results show that both probes 
demonstrate “turn on” fluorescence response to cysteine, homocysteine and 
glutathione due to the blocking PeT process with reaction between thiol group and 
nitroethenyl moiety. However, the controlling of reaction time facilitates the faster 
response  
In Chapter 7, highly selective, fast responding near-IR BODIPY-based hydrogen 
sulfide probe is explained. Being a biosynthetic gasotransmitter, hydrogen sulfide 
has important roles on biological processes such as cardiovascular protection, 
neuroprotective effect, arrangement of cell growth, calcium homeostasis and 
regulation of neurotransmission. Due to the function of hydrogen sulfide in 
metabolic processes, the real-time monitoring of this small molecule becomes very 
important. Hence, we designed BODIPY-based probe having hydrogen sulfide 
reactive two arylazido groups and triethylene groups to enhance water solubility.  
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With the addition of hydrogen sulfide, 20 nm red shift is observed in absorption 
spectra and decrease in fluorescence intensity due to the PeT process. This selective 
and fast responding probe was utilized for in vitro imaging studies. 
In Chapter 8, our aim is to conjugate persistent luminescent nanoparticles to get the 
activation of photodynamic action. To eliminate the use of external light problem in 
photodynamic therapy, we thought to use persistent luminescent nanoparticles 
capable of emitting light for hours without need for external irradiation once 
irradiated. A BODIPY derivative was incorporated to persistent luminescent 
nanoparticles to get photodynamic action. Singlet oxygen generation measurements 
showed efficiency of the design principle. This BODIPY part will be attached to 
quencher part via glutathione responsive disulfide bridge to be effective in cancer 
cells. In conclusion, this nanoassemble is a promising model for photodynamic 
therapy by suggesting solution to problem of light which limits the widespread usage 
of photodynamic therapy. 
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APPENDIX 
 
A1. Rational Design of Ion Responsive, Isomeric Near- IR BODIPY 
Dyes 
A1.1. 1H, 13C and Mass Spectra 
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A2. Dendritic Energy Transfer and Determination of Energy 
Transfer Based on Tetra-Styryl BODIPY Derivatives 
A2.1. 1H, 13C and Mass Spectra 
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A3. Coupling ICT Process to Excitation Energy Transfer: Improved 
Stokes Shift for Selective Hg(II) Sensing 
A3.1. 1H, 13C and Mass Spectra 
 
 
 
 
 
211	  
	  
 
 
 
 
 
 
 
ppm (t1)
5.010.0
ppm (t1)
50100150
212	  
	  
 
 
 
 
 
  
ppm (t1)
5.010.0
ppm (t1)
050100150
213	  
	  
 
 
 
 
ppm (t1)
0.01.02.03.04.05.06.07.0
214	  
	  
 
 
 
 
 
215	  
	  
 
  
 
 ppm (t1)
050100150
216	  
	  
 
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
 
 
 
217	  
	  
A4. Chromogenic and FluorogenicSensing of Biological Thiols in 
Aqueous Solutions Using BODIPY Based Reagents 
A4.1. 1H, 13C and Mass Spectra 
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A5. Fast Responding and Selective Near-IR BODIPY Dye for 
Hydrogen Sulfide Sensing 
A5.1. 1H, 13C and Mass Spectra 
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1H NMR spectrum of Compound 1 after addition the addition of Na2S. 
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A6. Persistent Luminescent Nanoparticles (PLNP) Mediated 
Activation of Photosensitizers for Photodynamic Therapy 
A6.1. 1H, 13C and Mass Spectra 
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